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Abstract 
Dopamine (DA) neurons of the substantia nigra pars compacta (SNc) have a key role in 
regulation of voluntary movement control. Their death is a hallmark of Parkinson’s disease 
(PD), a neurodegenerative illness characterised by inhibited motor control, including muscle 
rigidity and tremor. Excitatory input to SNc-DA neurons is primarily from the subthalamic 
nucleus (STN), and in PD these afferents display a higher frequency firing, as well as 
increased burst firing, which could cause increased excitatory activity in SNc-DA neurons, in 
turn potentially activating regulatory processes. 
NMDA receptors (NMDARs) are widely expressed receptors for the excitatory 
neurotransmitter glutamate, and are essential for learning and memory due to their ability to 
act as synaptic coincidence detectors. In SNc-DA neurons, NMDARs have a putative 
triheteromeric subunit arrangement of GluN1 plus GluN2B and/or GluN2D. Wild type (WT) 
mice, and those lacking the gene for the GluN2D subunit (Grin2D-null), were used to explore 
the role of the GluN2D subunit in various aspects of DA neuronal function and dysfunction 
using whole cell patch clamp electrophysiology, viability assaying, and immunofluorescence. 
Constitutive expression of synaptic NMDARs was assessed in SNc-DA neurons at several 
ages by recording the ratio of AMPA receptor EPSC to NMDAR-EPSC, which revealed a 
nonlinear developmental alteration in this ratio but no genotype-related difference, indicating 
similar overall expression of functional NMDARs at the synapse in Grin2D-null mice. 
Pharmacological intervention using subunit-specific inhibitors ifenprodil and DQP-1105 on 
elicited NMDAR-EPSCs was also explored, with results suggesting a developmental shift 
from primarily GluN2B to GluN2B/D. Activity dependent regulation was then assessed by 
high frequency burst stimulation of glutamatergic afferents: in comparison to controls, 
significant downregulation of NMDARs was observed in SNc-DA neurons from WT mice, 
though no differences were observed based on genotype, indicating that the GluN2D subunit 
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is not essential for it to occur.  This regulatory function may be a neuroprotective or 
homeostatic response. 
Ambient extracellular glutamate elicits tonic NMDAR activity in SNc-DA neurons, which 
may be important for maintaining basal levels of activity: the role of GluN2D was assessed by 
recording baseline currents and recording the deflection caused by application of the 
competitive NMDAR antagonist D-AP5. There was a significantly larger NMDAR-mediated 
current in WT in comparison to Grin2D-null mice, indicating that GluN2D-containing 
NMDARs have a role in binding ambient glutamate. Application of tetrodotoxin had no effect 
on the amplitude of the current, suggesting it is not of action potential-dependent origin. 
Dysfunction of glutamate uptake could be a secondary pathophysiological occurrence in the 
SNc, leading to higher levels of ambient glutamate: the effect of this was explored by 
application of the competitive glutamate transporter blocker TBOA. Under these conditions, 
glutamate-mediated currents significantly increased in SNc-DA neurons, and indeed the 
NMDAR-mediated portion of this current was significantly higher in WT mice in comparison 
to Grin2D-null. 
Interestingly, dose-response data obtained from bath application of NMDA showed 
significantly larger currents in Grin2D-null animals in comparison to WT, but only at the 
upper part of the response curve (~1-10 mM), which may indicate a capability for larger 
conductance in Grin2D-null animals at only the highest levels NMDA/glutamate saturation 
due to the replacement of GluN2D with GluN2B within the receptor.  The presence of 
GluN2D may therefore be neuroprotective, by attenuating peak current flow in response to 
very high agonist concentrations in SNc-DA neurons. 
Lastly, GluN2D has been found to decrease NMDAR open probability under hypoxic 
conditions, potentially conferring resistance to hypoxia / ischemia related excitotoxicity. 
Therefore, low (15% O2 / 80% N2 / 5% CO2) vs high (95% O2 / 5% CO2) oxygen conditions 
were used along with immunofluorescent propidium iodide cell death assaying and 
immunofluorescent labeling for DA neurons in order to compare levels of DA neuronal death 
in the SNc based on oxygen status and genotype. Whilst there was a significant submaximal 
effect based on O2 status, genotype did not confer a practical resistance under these 
conditions. 
In summary, NMDARs have diverse roles in SNc-DA neurons which may both serve to 
maintain normal function and protect the cell against potentially pathological conditions. 
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1 Introduction 
 
The N-methyl-D-aspartate (NMDA) receptor (NMDAR) is one of three major types of 
ionotropic glutamate receptor (iGluR), the others being the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPARs) and the kainate receptor. iGluRs are cation-
permeable, responsible for the majority of excitatory neurotransmission in the central nervous 
system, and are activated by binding of the amino acid L-glutamate. They are differentiated 
by their sensitivities to various ligands and ions, and their gating properties (Davies and 
Watkins 1982; Evans et al. 1982; Traynelis et al. 2010). 
Arguably, the key purpose of the NMDAR is to act as a physiological coincidence detector. 
That is, to sense the simultaneous presence of glutamate and a range of other chemical, 
metabolic, and physical cues, and by conducting a Ca2+-rich cation current as a response to 
this information (Burnashev et al. 1992; Schneggenburger 1996). For example, voltage-
dependent Mg2+ block allows conditional opening of the NMDAR channel when the 
postsynaptic cell is depolarised coincidently with agonist and co-agonist binding. By this 
mechanism, NMDARs are key mediators of neuronal development and plasticity: coincidence 
detection allows the induction of long-term plasticity such as long term potentiation (LTP) or 
depression (LTD) in a manner consistent with Hebb’s predictions (Hebb 1949), often 
expressed as changes in AMPAR-mediated transmission. Changes in NMDAR function or 
expression can therefore modify the induction threshold for AMPAR-mediated plasticity; a 
phenomenon called metaplasticity (Abraham 2008; Hunt and Castillo 2012). 
Ca2+ influx through NMDARs can activate many downstream signal transduction networks. 
Initially, changes in intracellular Ca2+ concentration are detected by calcium/calmodulin-
dependent protein kinases (CaM-kinases; e.g. CAMKI and II) and calcium/calmodulin-
dependent protein phosphatases such as calcineurin (Foster et al. 2001; Flavell and Greenberg 
2008). Excessive Ca2+ influx through NMDARs can also lead to excitotoxicity, and promote 
cell death signaling pathways: this may be a factor in ongoing neuronal degeneration in 
diseases such as Parkinson’s disease (PD), which is mainly characterised by the loss of 
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dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc), a region essential to 
the regulation of voluntary movement control (Koutsilieri and Riederer 2007; Blandini 2010). 
A key component controlling the physiological properties of NMDARs is their subunit 
composition: all NMDARs are composed of four subunits, and depending on which are 
present within the receptor there can be large differences in regulation, open probability, 
conductance, and the rate and length of Ca2+ influx as a result of receptor activation (Wyllie et 
al. 2013). The aim of this thesis was to explore expression and subunit composition within 
functional NMDARs on SNc-DA neurons, as well as their role in responding to potentially 
pathological conditions. Therefore the relevant properties of NMDARs will be discussed in 
this chapter, including structure, biophysical properties, and relevance to excitotoxicity and 
disease. Lastly, the role of SNc-DA neurons will be discussed. 
 
1.1 The NMDA receptor 
1.1.1 The biophysical properties of the NMDAR 
Whilst NMDARs have a key role in classical NMDAR-dependent LTP/LTD of AMPAR-
mediated transmission, they can also play a much larger general role in synaptic transmission, 
particularly under certain physiological conditions, for example during burst firing activity 
(Herron et al. 1986), as well as contribute to neural integration (Larkum and Nevian 2008). 
Neural integration describes how neurons ‘add together’ all of the inputs to the cell, such as 
excitatory or inhibitory currents caused by neurotransmission. The noteworthy role of 
NMDARs in integrative function is enabled by their inherent nonlinear amplification 
properties: Mg2+ block of the channel at resting potentials, high Ca2+ permeability, and slow 
gating kinetics allowing for temporal current summation (Wollmuth et al. 1998a, 1998b; Hunt 
and Castillo 2012). 
Most excitatory synapses have a mix of AMPARs and NMDARs, which affects the shape of 
the excitatory postsynaptic current (EPSC) arising as a consequence of concurrent activation 
of these receptor populations: AMPAR currents rise and subside quickly, determining the 
speed of onset and maximal amplitude of the EPSC. NMDAR-mediated currents rise and 
decline much more slowly and therefore strongly influence the decay timecourse, and the total 
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charge transfer over the course of the EPSC (Takumi et al. 1999; Iacobucci and Popescu 
2017). 
NMDARs are composed of four subunits, typically in a diheteromeric configuration of two 
GluN1 subunits and two GluN2 or GluN3 subunits. Crystallography has shown that the dimer 
of the GluNl and GluN2/3 subunit is assembled with the agonist binding domains in a back-
to-back configuration (Furukawa et al. 2005; Paoletti et al. 2013), with identical subunits 
positioned diagonally from one another within the tetrameric complex (Salussolia et al. 2011). 
In total, there are seven genetically encoded subunits: GluN1, of which there are eight distinct 
splice variants, four GluN2 (GluN2A–D) and two GluN3 (GluN3A-B; Sugihara et al. 1992). 
NMDARs require two GluN1 subunits, each of which contains a glycine binding site, and 
usually two GluN2 subunits, which contain the glutamate binding site as well as conferring 
many of the functional properties of the receptor, such as agonist sensitivity, channel open 
time, and open probability (Chen and Roche 2007; Suárez et al. 2010; Paoletti et al. 2013; 
Wyllie et al. 2013). GluN3 subunits, like GluN1, bind co-agonist glycine rather than 
glutamate and therefore the role of the diheteromeric GluN1/GluN3 NMDAR remains unclear 
(Traynelis et al. 2010), but it may serve to antagonise classical NMDAR functions and act as 
a gatekeeper for the synaptic refinements which occur during postnatal development (Pérez-
Otaño et al. 2016).  
Because the subunits confer the functional properties of the receptor, altering the subunit 
composition of the NMDAR therefore allows control over cellular activity that arises as a 
consequence of local conditions and agonist availability. Kinases such as cAMP-dependent 
protein kinase A (PKA), protein kinase C (PKC), protein kinase B (PKB), CaMKII, cyclin-
dependent kinase-5 (Cdk5), and casein kinase II (CKII) are able to interact with the NMDAR 
subunits, and may alter synaptic plasticity by way of regulating NMDAR trafficking or 
channel properties (Lee 2006; Chen and Roche 2007). 
NMDAR function is enabled by the presence of external epitopes which recognise ligands 
such as glutamate and glycine, as well as H+ (pH), Mg2+, and Zn2+. Each subunit of the 
NMDAR has a large ectodomain composed of an amino-terminal domain (ATD) and a 
ligand-binding domain (LBD; formed by regions S1 and S2) as well as a short transmembrane 
domain (TMD) which contains the ion channel, and a cytoplasmic carboxyl-terminal domain 
(CTD; Furukawa and Gouaux 2003; Wyllie et al. 2013). The CTD is where the majority of 
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structural differences between the GluN2 subunits are found: this region allows interaction 
with intracellular proteins involved in NMDAR trafficking, regulation, and coupling to other 
intracellular signalling cascades (see section 1.2). The LBD binds glycine or D-serine in 
GluN1 and GluN3, and glutamate in GluN2 (Paoletti et al. 2013). The TMD is composed of 
three transmembrane helices (M1, M3, M4) and a pore loop (M2) that is essential for ion 
selectivity (Paoletti et al. 2013; Lee et al. 2014): this is explored in more detail below. A 
schematic of a GluN1/GluN2 dimer is presented in Figure 1.1. 
In contrast to AMPA or kainate receptors, the ATD of the NMDAR has a unique ‘twisted 
clamshell’ conformation, resulting in looser ATD dimer assemblies than the tightly-packed 
AMPA and kainate ATD dimers (Paoletti et al. 2013). The ATD is essential for allosteric 
regulation: in GluN2A subunits this region binds Zn2+, which directly and specifically inhibits 
NMDAR activity (Yuan et al. 2009; Amico-Ruvio et al. 2011). Additionally, the ATD has a 
substantial influence on deactivation time course: diheteromeric GluN2A-containing 
NMDARs have a relatively fast deactivation (30-50 ms), therefore allowing more temporally 
precise encoding with a lower probability of current summation in comparison to GluN2B 
and GluN2C (300-400 ms), and particularly GluN2D (2000-4000 ms; Monyer et al. 1994; 
Yuan et al. 2009; Wyllie et al. 2013). Removal of the ATD from GluN2A has been shown to 
slow the rate of deactivation of the receptor, whilst removal from GluN2B accelerates it 
(Yuan et al. 2009). 
NMDAR channel behaviour is not strictly binary. The channel does not always open or close 
fully and instead visits an intermediate conductance level. GluN2A and GluN2B-containing 
NMDARs visit short lived subconductance levels of 80% of the main open state (~50 pS fully 
open with 40 pS sublevel). In contrast, GluN2C and GluN2D-containing receptors are as 
equally likely to settle on the full conductance level (~36 pS) as the subconductance level, 
which in this case is lower at just 50 % (18 pS; Wyllie et al. 1996; Blanke and VanDongen 
2009). This property of single channel behaviour can therefore be useful in identifying the 
subunit composition of native NMDARs (Jones and Gibb 2005). 
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Figure 1.1 – Transmembrane architecture of the NMDAR 
A schematic diagram of an example NMDAR subunit dimer, including the structures of 
the obligatory GluN1 subunit and the GluN2 subunit. The extracellular region includes the 
amino terminal domain (ATD) which contains modulatory sites which bind Zn2+ in 
GluN2A, or ifenprodil in GluN2B. The S1 and S2 domains together form the ligand 
binding domain (LBD) for glycine or D-serine in GluN1, and glutamate or NMDA in 
GluN2. The transmembrane domain (TMD) is formed of the three M1, M3, and M4 alpha 
helices, along with a re-entrant loop (M2) which forms part of the channel pore. The 
channel is permeable to Na+, K+, and Ca2+. Extracellular Mg2+ is able to bind deep within 
the channel, allowing voltage-sensitive block. The C-terminal domain (CTD) is able to 
bind to many intracellular proteins involved in NMDAR trafficking, regulation, and other 
intracellular signalling cascades. Adapted from Cull-Candy and Leszkiewicz 2004; Blanke 
and VanDongen 2009; Paoletti et al. 2013. 
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Interestingly, whilst NMDARs are highly permeable to Ca2+, typically allowing 3-4 times 
more Ca2+ influx than AMPARs (Iino et al. 1990), single channel conductance decreases as 
extracellular Ca2+ increases (Ascher and Nowak 1988; Wyllie et al. 1996). This effect is 
concentration-dependent but voltage-independent: as well as sites deep within the channel, 
Ca2+ binds to the GluN1 subunit near the entrance to the channel pore, potentially reducing 
cation conductance by electrostatic interaction (Schneggenburger 1998; Maki and Popescu 
2014). The TMD is essential for the ion selectivity of the receptor (Paoletti et al. 2013; Lee et 
al. 2014): as above, this is composed of three transmembrane helices, and a pore loop 
composed of the M2 helix and an extended region. The extended region forms the narrowest 
part of the ion channel, called the selectivity filter: this structure plays a central role in ion 
permeation, ion selectivity, and channel block. Six M2 region asparagine residues line the 
pore at the tip of the selectivity filter with their side chains extended into the central cavity of 
the pore, and it is these side chains which distinguish the larger Ca2+ ion from Mg2+, allowing 
only Ca2+ to pass through (Burnashev et al. 1992; Mesbahi-Vasey et al. 2017). Intracellular 
Ca2+ concentration is tightly controlled, with a low amount of free Ca2+ within neurons at rest, 
whereas the extracellular concentration is around 10,000-fold greater. Neurons control 
intracellular [Ca2+] using binding proteins and organelles that compartmentalize Ca2+ 
(Clapham 2007). Ca2+ permeability varies between the subunits, with diheteromeric GluN2A- 
or GluN2B-containing NMDARs possessing a Ca2+ / Cs+ permeability ratio (pCa/pCs) of 
~7.5. By contrast, diheteromeric GluN2C- or GluN2D-containing receptors have a lower 
pCa/pCs of 4.5 (Paoletti et al. 2013). 
The key feature of the NMDAR is its Mg2+ block capability: the binding of Mg2+ deep within 
the channel pore directly blocks currents in a voltage-dependent manner (Mayer et al. 1984; 
Nowak et al. 1984; Wollmuth et al. 1998b), allowing the receptor to act as a Hebbian 
coincidence detector (Lüscher and Malenka 2012). Mg2+ block sensitivity also varies between 
GluN2 subunits, and is controlled by a single residue in the M3 segment (Siegler Retchless et 
al. 2012): diheteromeric GluN2A or GluN2B-containing NMDARs have a high sensitivity to 
Mg2+ blockade, with an Mg2+ IC50 (the concentration at which the response is reduced by 
half) of ~15 μM at −70 mV. By contrast, diheteromeric GluN2C or GluN2D-containing 
NMDARs have a lower Mg2+ IC50 of ~80 μM (Paoletti et al. 2013; Huang and Gibb 2014). 
This, along with the variation in conductance between the subunits, significantly affects the 
relative contribution of NMDAR subtypes to synaptic integration and plasticity (Paoletti et al. 
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2013). The distinct biophysical properties conferred by the GluN2D subunit mean that it may 
also have unique regulatory roles, such as detection of low levels of glutamate, potentially 
from synaptic spillover (Dubois et al. 2016): this extra sensitivity and often extrasynaptic 
location may also mean that it is a mediator of currents which could activate cell death 
signalling pathways (see section 1.3). Additionally, the slow gating kinetics of GluN2D-
containing NMDARs could increase the time window for coincidence detection during 
induction of synaptic plasticity (von Engelhardt et al. 2015), but at the cost of temporal 
fidelity in excitatory synaptic transmission. Where GluN2D is involved in either detecting 
spillover or mediating plasticity, only a small amount of postsynaptic depolarisation may be 
required, if any, for them to initiate cation influx, due to their relative insensitivity to Mg2+ 
(Hrabetova et al. 2000). For these reasons it is important to ascertain the distribution of 
GluN2D subunits, both across neuronal populations and indeed on a subcellular level: both of 
these factors may provide evidence for the function of GluN2D in each individual context. 
 
1.1.2 NMDAR desensitisation 
Desensitisation of iGluRs is a conformational change in the receptor resulting from agonist 
exposure (Sornarajah et al. 2008), which reduces current flow through the channel and may 
constitute a negative feedback mechanism to prevent against excitotoxicity (Zorumski et al. 
1990). Entry of iGluRs into a desensitised state may also be important in determining the 
overall time course of synaptic responses (Jones and Westbrook 1996). Channel opening is 
quickly followed by receptor desensitisation, with both of these conformational changes 
taking around 2-3 ms (Colquhoun et al. 1992; Meyerson et al. 2014). 
The mechanism of desensitisation in AMPA and kainate receptors involves disruption of the 
arrangement of the LBD, which allows glutamate to remain bound but with a closed pore 
similar to that in the resting state (Plested 2016). NMDAR desensitisation is not as well 
understood, and in contrast to AMPARs, appears to be determined by elements in the ATD as 
well as the TMD (Krupp et al. 1998; Villarroel et al. 1998; Alsaloum et al. 2016). In 
NMDARs, interaction between the ATD and LBD is much more extensive, and so these 
domains may function less autonomously (Lee et al. 2014). Therefore, desensitisation is not 
as extensive, as the LBD cannot freely change conformation as it does in AMPA and kainate 
Chapter 1 – Introduction 
 
32 
 
receptors (Plested 2016). For this reason, AMPARs are able to desensitise almost fully, 
whereas NMDAR desensitisation is incomplete (Iacobucci and Popescu 2017). 
There are two principal Ca2+-independent mechanisms by which NMDARs can desensitise. 
Glycine-dependent desensitisation describes a reduction in NMDAR current which occurs in 
the continued presence of glutamate and when glycine concentration is not oversaturated, 
occurring due to a negative allosteric interaction between the glutamate binding and glycine 
binding sites (Zheng et al. 2001). This form of desensitisation manifests as a decrease in 
glycine affinity and can be overcome by increasing the glycine concentration (Benveniste et 
al. 1990; Villarroel et al. 1998; Dingledine et al. 1999a). GluN1/GluN2A diheteromers have 
been shown to deactivate in this manner with a time constant of around 650 ms (Wyllie et al. 
1998). Diheteromeric GluN1/GluN2C and GluN1/GluN2D NMDARs, however, do not 
display any significant glycine-dependent desensitisation (Wyllie et al. 1998; Vance et al. 
2011; Alsaloum et al. 2016). 
Glycine-independent desensitisation is defined as a Ca2+-independent desensitisation of 
NMDA receptors which cannot be overcome by increasing the concentration of glycine 
(Sather et al. 1992; Dingledine et al. 1999a; Hu and Zheng 2005). Glycine-independent 
desensitisation is reportedly observed in GluN1/GluN2A and GluN1/GluN2D diheteromers, is 
less pronounced in those containing GluN2B, and absent in GluN2C (Krupp et al. 1996; Hu 
and Zheng 2005). 
The elevation of intracellular Ca2+  by the activation of NMDARs can also lead to a reduction 
in NMDAR channel activity (Zilberter et al. 1991): this may be mediated by a direct 
interaction between calmodulin and the receptor (Ehlers et al. 1996; Villarroel et al. 1998). 
This phenomenon has previously been known as Ca2+-dependent inactivation, but is not 
considered a genuine desensitisation because it can be evoked by a rise in intracellular levels 
of Ca2+  triggered independently of NMDA receptor activation (Villarroel et al. 1998; Zheng 
et al. 2001). 
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1.1.3 NMDAR pharmacology 
Many compounds are available which are able to modulate the activity of NMDARs, with 
some relevant examples discussed below. 
 
(i) Competitive compounds 
NMDAR mediated current can be specifically and competitively inhibited by antagonists such 
as D-α-aminoadipate and D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5; Evans et al. 
1982), and therefore the discovery of these compounds played an essential role in confirming 
the presence of NMDARs in neurons (Jespersen et al. 2014). Regarding subunit selectivity, a 
phenanthrene-based competitive antagonist, piperazine-2,3-dicarboxylic acid (PPDA) was 
identified more than a decade after D-AP5 which has a moderate selectivity for GluN2C/D 
over GluN2A/B (Feng et al. 2004), but as the glutamate binding pocket is highly conserved 
across the GluN2 subunits, competitive antagonists do not in general display high degree of 
subunit specificity (Jespersen et al. 2014). There is some variation in the outer edge of the 
binding pocket between GluN2 subunits, and therefore only larger antagonists which block 
the glutamate binding site whilst also binding at sites outside of this pocket are able to show 
subunit selectivity, such as PPDA, R-AP7, or R-CPP (Monaghan et al. 2012). However, 
selectivity for GluN2D was further improved by discovery of UBP141, a competitive 
compound at the glutamate binding site with a 7- to 10- fold selectivity for GluN2D over 
GluN2A/GluN2B (Morley et al. 2005; Costa et al. 2009). 
 
(ii) Uncompetitive compounds 
These compounds are use-dependent, and can only bind to a site within the NMDAR channel 
pore when it is opened by the binding of glutamate and glycine. Mg2+ ions behave in this way, 
as described above. Apart from Mg2+, materials which block the NMDAR pore usually 
discriminate poorly between NMDAR subtypes; this being true of phencyclidine (PCP), 
thienylcyclohexylpiperidine (TCP), and ketamine. Whilst the selective and irreversible 
NMDAR channel blocker dizolcipine (MK-801) is more selective for GluN2A and GluN2B 
in comparison to GluN2C and GluN2D, the difference in affinity is relatively small (Paoletti 
and Neyton 2007). 
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As described in section 1.3, excessive NMDAR activation can lead to excitotoxicity under 
some circumstances, though putatively neuroprotective agents that block most NMDAR 
activity will inevitably have unacceptable clinical side effects. The adamantane derivative 
memantine, however, appears to preferentially block excessive NMDAR activity without 
disruption of normal synaptic activity (Wild et al. 2013). Memantine is a low affinity open-
channel blocker with a fast off-rate, and does not substantially accumulate in the NMDAR 
channel (Lipton 2004). Memantine is therefore well-tolerated and used clinically to help 
prevent potential excitotoxic damage to neurons in Alzheimer’s and Parkinson’s diseases (van 
Marum 2009; Emre et al. 2010; Wild et al. 2013). At resting membrane potentials and 
physiological [Mg2+], memantine shows a moderate selectivity for GluN2C and GluN2D-
containing NMDARs (Kotermanski and Johnson 2009). 
 
(iii) Noncompetitive compounds 
There have been several discoveries of noncompetitive allosteric compounds with high 
subunit selectivity, which are useful experimentally for elucidating the subunit composition of 
functional NMDARs within the cell membrane: these include ifenprodil (GluN2B; (Gallagher 
et al. 1996; Hess et al. 1998), TCN 201 (GluN2A; Bettini et al. 2010), QNZ46 (GluN2D; 
Mosley et al. 2010), and potentiator CIQ (GluN2C/D; Mullasseril et al. 2010). Ifenprodil has 
a 140-fold preference for GluN2B over GluN2A (Gallagher et al. 1996), and it and its 
analogues have been used extensively in neuroscience research due to the ubiquity of 
GluN2B. 
Ifenprodil binds to residues located deep within the dimer interface between the extracellular 
ATD regions of the GluN1 and GluN2B subunits, increasing the energy barrier for activation 
and resulting in an increased mean closed time of the channel (Amico-Ruvio et al. 2011; 
Karakas et al. 2011; Tomitori et al. 2012). Inhibition is incomplete, and noncompetitive with 
other known NMDA receptor agonists or modulators (Amico-Ruvio et al. 2011; Tajima et al. 
2016). 
DQP-1105, a compound identified by the Traynelis group in 2011, is a noncompetitive 
antagonist which binds the S2 region of the GluN2D subunit, and blocks a conformational 
change necessary for channel opening. DQP-1105 is also around 50 times more selective for 
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GluN2C/D-containing NMDARs over those containing GluN2A or B (Acker et al. 2011), 
which makes it a good candidate for potential inhibition of GluN2D-containing NMDARs on 
SNc-DA neurons. 
Overall, the pharmacological tools for identifying the subunit composition of native 
NMDARs are limited. While some insight is obtained by applying a spectrum of compounds 
at carefully considered concentrations that offer some subunit preference, the outcome is not 
definitive. Therefore, other approaches would ideally be used in combination with 
pharmacological intervention. One aim of this PhD was to explore the pharmacological 
properties of NMDARs in SNc-DA neurons in mice where the GluN2D subunit has been 
genetically removed. 
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Compound 
 
GluN2A GluN2B GluN2C GluN2D Reference 
 
Competitive 
 
Ki (μM) 
 
Ki (μM) 
 
Ki (μM) 
 
Ki (μM) 
 
 Racemic AP5 0.28 0.46 1.6 3.7 Feng et al. 2005 
 PPDA 0.55 0.31 0.096 0.125 Feng et al. 2005 
 UBP-141 14 19 4.2 2.8 Morley et al. 2005 
 
 
Uncompetitive 
 
IC50 (μM) 
 
IC50 (μM) 
 
IC50 (μM) 
 
IC50 (μM) 
 
  MK-801 0.015 0.009 0.024 0.038 Dravid et al. 2007 
 Ketamine 5.4 5.1 1.2 2.9 Kotermanski and 
Johnson 2009 
 PCP 0.82 0.16 0.16 0.22 Dravid et al. 2007 
 Memantine 13 10 1.6 1.8 Kotermanski and 
Johnson 2009 
 
 
Noncompetitive  
 
IC50 (μM) 
 
IC50 (μM) 
 
IC50 (μM) 
 
IC50 (μM) 
 
 Ifenprodil 39 0.15 29 76 Hess et al. 1998 
 DQP-1105 206 121 9 3 Acker et al. 2011 
 TCN 201 0.109 >30 no data >30 Bettini et al. 2010 
 QNZ46 229 >300 6 3 Mosley et al. 2010 
 
Noncompetitive 
potentiators 
 
EC50 (μM) 
 
EC50 (μM) 
 
EC50 (μM) 
 
EC50 (μM) 
 
 CIQ NE NE 2.8 3 Mullasseril et al. 2010 
 
Table 1.1 – Compounds acting on NMDARs, and their subunit specificity 
PCP = phencyclidine; TCP = thienylcyclohexylpiperidine; NE = no measurable effect. Ki is 
the inhibitory constant, with a smaller value reflective of greater binding affinity. IC50 is the 
half maximal inhibitory concentration, and EC50 is concentration of potentiator giving a half-
maximal response. Table partially adapted from Ogden and Traynelis 2011. 
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1.1.4 Grin2D-null mice 
Mice lacking expression of the GluN2D subunit have been previously generated by a gene-
targeting recombination technique: the exon encoding the GluN2D transmembrane M4 region 
was disrupted by the insertion of a neomycin phosphotransferase gene (Ikeda et al. 1995). 
These mice grow and mate normally and exhibit no major structural brain abnormalities, 
though show a slight reduction in spontaneous behavioural activity in novel environments and 
a reduction in sucrose preference (Ikeda et al. 1995), as well as a lower sensitivity to stress 
induced by elevated maze, light/dark box, and forced swimming tests (Miyamoto et al. 2002). 
The only morphological anomaly observed is a reduction of dendritic branching in mitral cells 
in the accessory olfactory bulb (AOB; Yamamoto et al. 2017): GluN2D mRNA has 
previously been reported in the periglomerular (PG) cells of the mouse AOB (Watanabe et al. 
1993), and it is hypothesized that functionally altered PG cell synapses at mitral cell dendrites 
may inhibit their normal development (Yamamoto et al. 2017). 
 
1.1.5 Development and distribution of NMDARs 
The distribution of NMDAR subunits throughout the brain alters with development (Monyer 
et al. 1994). Whilst the essential GluN1 subunit (and therefore the NMDAR as a whole) is 
ubiquitously expressed in all brain regions throughout development, expression of GluN2 is 
much more variable: notably, GluN2B expression is high at birth, particularly in the cortex 
and hippocampus, and gradually declines to a lower level in the same brain regions in 
adulthood. Conversely, GluN2A expression is very low at birth and increases throughout 
development: it was initially thought to replace GluN2B in the cortex and hippocampus, but 
both GluN2A and GluN2B-containing NMDARs are considered to remain present. GluN2A 
also increases its expression in the olfactory bulb and striatum (Wenzel et al. 1995, 1997). 
GluN2C is expressed later in development, and in adult mice and rats is mostly confined to 
the cerebellum and olfactory bulb (Watanabe et al. 1992; Monyer et al. 1994; Wenzel et al. 
1997). GluN2D subunit expression is prominent in the brainstem and diencephalon in 
neonates but decreases throughout development, with much lower levels in the adult. It is, 
however, reportedly expressed in the adult rat brain in some cerebellar nuclei, the striatum, 
the olfactory bulb, and in dopaminergic neurons of the substantia nigra (Watanabe et al. 1993, 
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1994; Monyer et al. 1994; Standaert et al. 1994; Wenzel et al. 1995, 1997; Jones and Gibb 
2005; Brothwell et al. 2008; Mullasseril et al. 2010). More recently, the presence of GluN2D 
has been observed at the synapse in adult mouse hippocampal interneurons (but not pyramidal 
cells) along with GluN2A and GluN2B (von Engelhardt et al. 2015; Perszyk et al. 2016); as 
well as synapses on adult rat subthalamic nucleus (STN) neurons, along with GluN2B 
(Swanger et al. 2015). However, these studies have at least in part relied on pharmacological 
tools, the limitations of which are outlined above. NMDARs in SNc-DA neurons at around P7 
are thought to be arranged in two populations of diheteromeric receptor: those composed of 
GluN1/GluN2B and those composed of GluN1/GluN2D. By P17, SNc-DA neurons are 
thought to possess NMDARs in a triheteromeric GluN1/GluN2B/GluN2D configuration 
(Jones and Gibb 2005; Brothwell et al. 2008; Suárez et al. 2010). 
NMDARs are also distributed in a specific way on the cell surface (Figure 1.2). Synaptic 
receptors in general are defined by their ability to be activated by neurotransmitter released 
from presynaptic terminals in response to a single action potential under normal physiological 
conditions. The synaptic receptor pool is involved in signal transduction mechanisms which 
may be specific to the synapse. The population of receptors termed ‘perisynaptic’ can also be 
activated by synaptically released neurotransmitter, but only under conditions of increased 
release in response to strong or high frequency synaptic stimuli. Perisynaptic NMDARs are 
generally located 100–300 nm from the edge of the PSD, and may be anchored at these 
locations by submembrane receptor scaffolding proteins (Zhang and Diamond 2006): these 
may be NMDARs which are ready to be internalised (Pérez-Otaño et al. 2006), or which have 
been recently exocytosed (Petralia et al. 2009). Finally, extrasynaptic receptors are those not 
included in the previous two definitions, and are located elsewhere within the cell surface 
membrane, away from synapses, and are not bound to PSD-95. However, some activation of 
extrasynaptic NMDARs by presynaptic glutamate release may occur during abnormally high 
levels of synaptic activity, especially when glutamate reuptake is compromised (Angulo et al. 
2004; Pál 2015; Wild et al. 2015). In the rat hippocampus, extrasynaptic NMDARs account 
for two thirds of all surface NMDARs during early postnatal development, and around a third 
in adults (Tovar and Westbrook 1999; Groc et al. 2006; Petralia et al. 2010a). In the 
cerebellum, hippocampus, and spinal cord, GluN2D subunits have been found to comprise a 
greater proportion of the extrasynaptic NMDAR population than the synaptic population 
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Figure 1.2 – The glutamatergic synapse 
A simple schematic showing vesicular glutamate release, as well as the various putative 
populations of synaptic, perisynaptic, and extrasynaptic NMDAR, as well as AMPARs. 
Glutamate transporters (GluTs) on nearby astrocytes take up glutamate, and may help to 
prevent ‘spillover’ of glutamate from the synapse. 
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(Momiyama et al. 1996; Misra et al. 2000; Momiyama 2000; Brickley et al. 2003; Lozovaya 
et al. 2004), although the presence of GluN2D at the synapse is also supported by several 
studies (Harney et al. 2006, 2008; Logan et al. 2007; Brothwell et al. 2008; von Engelhardt et 
al. 2015). 
While extrasynaptic receptors are able to diffuse laterally through the membrane, they have 
also been found to accumulate at points in close contact with adjacent cell processes, 
including axons, axon terminals, and glial cells (Kharazia and Weinberg 1999; Petralia et al. 
2010a), where they may associate with scaffolding proteins such as GAIP-interacting protein 
C-terminus (GIPC), which is primarily excluded from the synapse (Groc et al. 2006; Yi et al. 
2007). 
There is evidence of a more well defined role for these extrasynaptic populations of NMDAR, 
in that they can be activated by ambient extracellular glutamate, something which has 
previously been demonstrated in the hippocampus (Sah et al. 1989; Angulo et al. 2004; Fellin 
et al. 2004). As the level of desensitisation in NMDARs is much lower than AMPARs, they 
are likely to mediate the majority of excitation in response to this ambient glutamate, away 
from the synapse (Iacobucci and Popescu 2017). Blockade of voltage-gated sodium channels 
or vesicular release has been shown to have no effect on levels of ambient glutamate in the 
hippocampus (Herman and Jahr 2007; Le Meur et al. 2007), indicating that it is not released 
by neurons in an action potential dependent manner, but may originate from glial cells 
(Parpura et al. 1994; Bezzi et al. 1998; Angulo et al. 2004; Fellin et al. 2004). As 
extrasynaptic NMDARs in the hippocampus are arranged in high density regions opposing 
astrocytic processes (Jourdain et al. 2007; Petralia 2012), glutamate released from these 
processes may activate them and therefore influence network synchrony (Angulo et al. 2004; 
Fellin et al. 2004). 
 
1.2 NMDAR regulation and trafficking 
Overall NMDAR activity can be regulated by alteration of membrane NMDAR numbers, by 
trafficking to different sites within the membrane (for example between synaptic and 
perisynaptic or extrasynaptic sites), and by alteration of the physiological properties of the 
receptor (Dingledine et al. 1999b; Groc et al. 2009). Many of these effects occur when 
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NMDARs bind via the heterogenic C-terminal domains of their subunits to various signal 
transduction complexes, which can vary depending on their subcellular location (Petralia et al. 
2010b; Baucum 2017). Proteomic analysis using diheteromeric GluN1/GluN2B NMDARs 
has shown that these receptors are associated with around 190 different proteins via the CTD 
(Collins et al. 2006) including kinases, phosphatases, Ca2+-dependent proteins, scaffolding 
proteins, and proteins which couple the receptor to the cytoskeleton (reviewed in Kennedy 
2000), all of which may play some role in regulation of the activity of the receptor. 
Regarding GluN2D, The E3 ligase Nedd4, which allows binding of regulatory protein 
ubiquitin, has been found to directly bind the CTD of the GluN2D subunit (Gautam et al. 
2013). This provides a mechanism which may allow specific targeting of GluN2D-containing 
NMDARs for intracellular trafficking and degradation (Clague and Urbé 2010), and may be 
responsible for the developmental downregulation of GluN2D due to the subsequent 
reduction in Nedd4 expression (Gautam et al. 2013). 
Constitutive changes in functional NMDAR expression between synaptic and 
peri/extrasynaptic locations have been demonstrated to occur by lateral movement of 
NMDARs within the membrane (Dupuis et al. 2014): GluN2B-containing NMDARs have 
been shown to be more laterally mobile than those containing GluN2A (Groc et al. 2006), 
though neither GluN2C or GluN2D were investigated in this way. It is possible that this 
increased mobility due to the presence of GluN2B may also apply to diheteromeric and/or 
triheteromeric GluN2B/GluN2D-containing NMDARs, such as those proposed to be present 
in SNc-DA neurons (Jones and Gibb 2005; Brothwell et al. 2008; Suárez et al. 2010). 
The Ca2+-dependence of NMDAR-regulation via the subunit CTD has previously been 
demonstrated: deletion of the GluN1 subunit CTD removes the Ca2+-dependent element of 
NMDAR inactivation (Ehlers et al. 1996). Additionally, Ca2+-dependent serine/threonine 
kinases such as protein kinase A (PKA) and protein kinase C (PKC) can upregulate NMDAR 
activity (Tingley et al. 1997): upon activation, PKC integrates itself from the cytoplasm into 
the membrane, binding to anchoring proteins where it is able to then interact with 
neighbouring NMDARs, promoting increased expression of NMDARs and also increasing the 
channel opening rate (Lin et al. 2006; Salter et al. 2009). Conversely, serine/threonine 
phosphatases such as PP1, PP2A, and PP2B (calcineurin) can effect a decrease in NMDAR 
activity by decreasing the open probability of the channel (Salter et al. 2009). Additionally, 
Chapter 1 – Introduction 
 
42 
 
internalisation of NMDARs has been demonstrated by inhibiting the action of dynamin, a 
GTPase essential for the reformation of clathrin-coated synaptic vesicles for endocytosis 
(Carroll et al. 1999; Montgomery et al. 2005; Lau and Zukin 2007). 
 
1.2.1 Regulation of ‘extrasynaptic’ NMDARs 
It has previously been shown in SNc-DA neurons that ‘whole-cell’ NMDARs activated by 
bath application of NMDA, which putatively includes a large population of extrasynaptic 
NMDARs, are regulated in a use-dependent manner whereby repeated application of the 
agonist leads to a persistent reduction in NMDAR-mediated current (Wild et al. 2014). This 
form of downregulation, termed NMDAR ‘rundown’ was also found to be largely Ca2+-
dependent: intracellular Ca2+ chelation, replacement of extracellular Ca2+ with Ba2+, and 
holding the cell at +40 mV to reduce the driving force on Ca2+ influx all reduced the effect. 
Rundown was also measured after incubation with the GluN2B-preferring antagonist 
ifenprodil. Significant rundown of the ifenprodil-insensitive NMDAR component was 
observed, but this remaining current showed no sensitivity to intracellular Ca2+ chelation, 
which suggested that the ifenprodil-insensitive component may have been GluN2D-mediated 
due to the lack of evidence for GluN2A or GluN2C expression in SNc-DA neurons (Wild et 
al. 2014). In the same study, synaptic NMDAR current rundown was also observed in 
response to repeated low-frequency presynaptic stimulation (0.1 Hz). This rundown was 
insensitive to intracellular Ca2+ buffering using BAPTA; however rundown was significantly 
reduced by clamping at +40 mV, which reduces the driving force on Ca2+ influx. This 
insensitivity to Ca2+ chelation may be due to the mode of NMDAR activation (brief versus 
prolonged), or due to a closer coupling of the synaptic NMDARs to the Ca2+-dependent 
mechanism of run-down, such that even the fast chelator BAPTA is not able to bind Ca2+ 
before it initiates this mechanism (Wild et al. 2014). 
 
1.2.2 Activity-dependent regulation of synaptic NMDARs 
NMDARs are key mediators of neuronal development and plasticity in the forms of classical 
Hebbian long-term potentiation (LTP) and long-term depression (LTD), which comprise 
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mostly the addition and removal of AMPARs from the synapse. To effect these forms of 
plasticity, iGluRs interact with many proteins within the PSD; some of which regulate 
receptor function and some of which govern insertion or removal from the membrane, or 
trafficking within it. An important protein for classical NMDAR-mediated plasticity of 
AMPARs is stargazin, a regulatory protein (TARP) that affects the conductance, kinetics, and 
rectification of AMPARs. Another regulatory protein, PICK1, interacts primarily with GluA2 
to effect insertion and removal from the membrane (Lüscher and Malenka 2012). 
While it has been long recognised that the NMDAR is essential for classical long term 
plasticity with regards to AMPAR regulation, previous work suggested that the NMDAR 
itself is immune to activity induced synaptic plasticity (Lissin et al. 1998; Montgomery et al. 
2005). However, many studies have subsequently shown that both LTP and LTD of 
NMDAR-mediated currents (NMDAR-LTD and NMDAR-LTD) can be induced by 
alterations in presynaptic activity (Montgomery et al. 2005; Harnett et al. 2009; Hunt and 
Castillo 2012).  Because NMDARs contribute significantly to information transfer at the 
synapse, plasticity involving regulation of NMDARs themselves will therefore significantly 
alter the characteristics of postsynaptic currents (Hunt and Castillo 2012). 
In the hippocampus (CA1, CA3, and the dentate gyrus), high-frequency stimulation (HFS) 
can rapidly induce NMDAR-LTP (Lozovaya et al. 2004; Harney et al. 2006, 2008; Lau and 
Zukin 2007). Induction of NMDAR-LTP involves several stages and requires activation of 
three types of postsynaptic receptor: NMDARs, metabotropic glutamate receptors (mGluRs; 
in this case mGluR5), and adenosine A2A receptors. Intracellularly, NMDAR-LTP also 
requires activation of a G-protein (via A2A receptor activation) and a rise in intracellular Ca
2+ 
leading to activation of the intracellular kinases PKC and Src (Kotecha et al. 2003; Harney et 
al. 2006, 2008; Kwon and Castillo 2008; Rebola et al. 2008). 
Plasticity of NMDAR-mediated currents effected by the same activity paradigm can vary 
greatly: for example, it has been shown in the hippocampus that bidirectional plasticity of 
NMDAR-EPSCs is possible in dentate gyrus granule cells using the same high frequency 
stimulation protocol, whereas only NMDAR-LTD occurs in dentate gyrus interneurons 
(Harney and Anwyl 2012). The bidirectionality of HFS-induced NMDAR plasticity in granule 
cells is Ca2+-dependent: NMDAR-LTD is induced in the presence of a high intracellular 
concentration of Ca2+ buffer EGTA (Ethylene-bis(oxyethylenenitrilo)tetraacetic acid ; 10 
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mM) and NMDAR-LTP with a lower concentration (0.2 mM). Interestingly, dentate gyrus 
interneurons that express only NMDAR-LTD appeared to express GluN2B- and GluN2D-
containing NMDARs at the synapse (Harney and Anwyl 2012), whereas granule cells only 
express synaptic GluN2A and GluN2B- containing NMDARs: however, induction of LTP in 
granule cells may recruit extrasynaptic GluN2D-containging NMDARs to the synapse 
(Harney et al. 2008). 
At the calyx of Held–principal neuron synapse in the medial nucleus of the trapezoid body 
(MNTB), a subset of fast synapses in the auditory system, spike timing is critical for sound 
localisation. The ability of postsynaptic neurons to phase-lock spikes to presynaptic inputs is 
compromised in immature synapses by the presence of NMDARs, due to their slow gating 
kinetics. NMDARs are therefore present only transiently within the first two postnatal weeks 
(Joshi et al. 2007). To preserve timing fidelity during high-frequency neurotransmission at 
mature synapses, NMDARs are downregulated: auditory activity begins in mice when the ear 
canal opens at P10–P12 resulting in high frequency firing of the presynaptic calyx of held 
neurons, and it is this excitatory activity which may begin to cause downregulation of 
postsynaptic NMDARs in MNTB neurons (Futai et al. 2001). Recordings made from these 
neurons in acute mouse brain slices at P10-13 along with presynaptic burst stimulation (100 
Hz bursts every 1 s for 60 s and paired with postsynaptic depolarisation), showed that 
summated NMDAR-EPSCs 18 minutes following this activity were significantly decreased, 
whilst single NMDAR-EPSCs remained stable (Joshi et al. 2007): this suggested that 
perisynaptic or extrasynaptic NMDARs were being preferentially downregulated. However, 
differences in morphological structure between the giant calyx synapse and typical small 
central nervous system (CNS) synapses may lead to different transmitter release and spillover 
profiles and, therefore, a different profile of NMDAR regulation in these neurons. The 
downregulation observed at these synapses was found to be prevented by BAPTA-mediated 
Ca2+ chelation, as well as by inhibiting the activity of dynamin, suggesting internalisation of 
NMDARs in this process (Takei et al. 1996; Joshi et al. 2007). The potential for activity 
dependent synaptic regulation of NMDRs has not yet been explored in SNc-DA neurons, and 
was one of the aims of this thesis. 
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1.3 NMDARs and Excitotoxicity 
Excessive Ca2+ influx through NMDARs is implicated in excitotoxicity through activation of 
cell death signalling pathways (Choi 1987; Hardingham and Bading 2010; Surmeier et al. 
2010, 2011). This increased NMDAR activity can promote cell death under pathological 
conditions, for example during ischemia, or as part of the pathophysiology of 
neurodegenerative illnesses such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) 
(Dong et al. 2009). The role of NMDARs under potentially excitotoxic conditions is 
discussed in this section, beginning with hypoxia. 
1.3.1 NMDARs and hypoxia-ischemia 
Hypoxic conditions, such as may be caused by ischemia, can lead to metabolic stress and 
excitotoxicity in neurons (Lai et al. 2014). Low oxygen availability causes cellular ATP levels 
to deplete, which disrupts the ionic gradients maintained by ATP-powered Na+/K+ pumps, 
therefore leading to depolarisation. Depolarisation causes increased glutamate release from 
excitatory neurons, and this, along with potential impairment of glutamate reuptake (see 
section 1.3.2), leads to increased extracellular glutamate and therefore an increase in 
NMDAR-mediated Ca2+ influx, and consequent neuronal cell death (Dugan and Choi 1999; 
Lai et al. 2014). 
The effects of hypoxia have been extensively studied in the mammalian hippocampus 
(Bickler and Hansen 1998; Larson and Park 2009; Peterson et al. 2012). In rat hippocampal 
CA1 neurons, the concentration of intracellular Ca2+ is increased by around 20 % during 
periods of hypoxia, which is frequently associated with a decrease in NMDAR responses. 
Ca2+ increase in this case can downregulate NMDARs via the cytoskeleton, as application of 
the actin stabiliser phalloidin has been shown to prevent the hypoxic treatment from 
decreasing receptor function (Bickler et al. 2003). 
The effects of hypoxia have also previously been studied in mammalian/rodent SNc-DA 
neurons, but less extensively (Häusser et al. 1991; Röper and Ashcroft 1995; Singh et al. 
2007). At glutamatergic synapses onto rat SNc-DA neurons, oxygen and glucose depravation 
(OGD) treatment for 5 minutes was found to cause a potentially neuroprotective presynaptic 
depression of glutamate release (Singh et al. 2007). Postsynaptic AMPAR and NMDAR-
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mediated currents were depressed to a similar extent, and presynaptic inhibition was mediated 
by activation of G protein-coupled presynaptic adenosine A1 receptors (A1Rs), as the effect 
was blocked by application of A1R-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine 
(DPCPX; Singh et al. 2007). This inhibitory effect did not recover following the withdrawal 
of OGD. SNc-DA neurons have also been shown to exhibit a postsynaptic hyperpolarisation 
in response to low ATP levels, which is mediated via ATP-sensitive K+ (KATP) channels  
(Häusser et al. 1991; Röper and Ashcroft 1995). These receptors open in response to an 
increase in the ADP/ATP ratio, thereby coupling neuronal excitability to metabolic status, a 
mechanism which is neuroprotective during acute metabolic stress (Roeper et al. 1990; Singh 
et al. 2007; Sun and Feng 2013). 
Young animals have greater resistance to hypoxic conditions than adults. Survival of CA1 
neurons in slices from rats at around postnatal day (P)5 following hypoxic stress is greater 
than in ~P20 animals, with young neurons also displaying smaller increases in and enhanced 
recovery of intracellular Ca2+, less accumulation of glutamate, and less NMDAR-mediated 
Ca2+ influx (Bickler and Hansen 1998). This effect may be partially due to the actions of 
GluN2D-containing NMDARs, which are much more widely expressed in neonates. 
Recordings made from xenopus laevis oocytes expressing different configurations of 
NMDAR show that diheteromeric GluN1/GluN2D NMDAR currents are significantly 
decreased under low oxygen conditions, and that GluN1/GluN2C NMDAR currents are 
increased, due to alterations in the channel open probability (Popen). GluN2A and GluN2B 
subunits were not found to alter their properties in response to low to O2 (Bickler et al. 2003). 
A reduction in Popen reduces the amount of Ca
2+ entering the cell, thereby reducing 
depolarisation and potentially cell death signalling. High GluN2D expression is therefore 
thought to be an important mechanism for hypoxia resistance in neonatal mammals (Bickler et 
al. 2003; Peterson et al. 2012) 
Neurons from turtles are able to survive long periods of anoxia: under these conditions, Ca2+-
dependent protein phosphatases have been found to play a critical role in regulating the open 
probability of NMDARs (Bickler and Buck 1998; Bickler et al. 2000). Another animal which 
has adapted to surviving under conditions of low oxygen is the naked mole-rat: these notably 
long-living, eusocial, and poikilothermic mammals live in low O2, high CO2 conditions due to 
sharing underground colonies with up to 300 other animals (Larson and Park 2009; 
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Schuhmacher et al. 2015). Much of the adaptation to survive in low oxygen conditions comes 
from their haemoglobin, which has a higher O2 affinity than mice; from their low basal 
metabolic rate, which is further reduced during more intense periods of hypoxia 
(Schuhmacher et al. 2015); and the ability to switch to anaerobic metabolism pathway 
powered by fructose-driven glycolysis (Park et al. 2017). In addition, their NMDAR 
composition may also play a major role in this tolerance. In most mammals a developmental 
reduction in GluN1 expression (which reflects a reduction in NMDARs) occurs; an effect 
which is blunted in naked mole rats. However, whilst adult naked mole rats therefore have 
higher overall expression of NMDARs, they also retain far higher expression of GluN2D, 
which as outlined above is associated with hypoxia tolerance in neonatal mammals. As with 
other species, GluN2A expression is increased and GluN2B is decreased with development 
(Peterson et al. 2012). Interestingly, because GluN2D-containing NMDARs have different 
biophysical properties even under normoxic conditions in comparison with those containing 
other GluN2 subunits, a high expression of GluN2D in the naked mole rat might be expected 
to affect behaviour or cognition: however, naked mole-rats are able to learn operant 
conditioning tasks as well as rats (LaVinka et al. 2009). A similar profile of high adult 
GluN2D expression has also been measured in the subterranean mole rat, spalax, which also 
is highly adapted to similar low-oxygen conditions (Band et al. 2012). 
During a 10 minute period of hypoxia, hippocampal neurons from naked mole-rats display an 
attenuated increase in internal Ca2+ concentration comparable to that observed in neonatal 
neurons from many mammalian species (Peterson et al. 2012). Hippocampal neurons from 
naked mole-rats are even able to recover fully from periods of anoxia exceeding 30 minutes. 
Low oxygen treatment (15 %) can cause unrecoverable disruption of synaptic activity after 40 
minutes in 60 % of mouse neurons, whereas no disruption of synaptic activity is observed in 
the naked mole rat under the same conditions (Larson and Park 2009). Therefore the presence 
of GluN2D in neurons may confer a practical resistance to hypoxia-related excitotoxicity, 
something which may also apply to dopaminergic neurons within the SNc. One aim of this 
thesis was to explore the potential role of GluN2D in conferring resistance to hypoxia-
mediated excitotoxicity using Grin2D-null mice. 
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1.3.2 Glutamate transporters: regulation of extracellular glutamate & NMDAR activity 
Glutamate concentration at the synapse normally exceeds 1 mM for a period of less than 10 
ms, before quickly returning to 20 nM or less due to glutamate reuptake by 
glutamate/aspartate (excitatory amino acid) transporters (GluTs; Clements 1996; Diamond 
and Jahr 1997; Shimamoto et al. 1998; Dzubay and Jahr 1999). The most accepted estimates 
of the concentration of glutamate in the extracellular space, away from the synapse, are in the 
range of 1-5 μM (Moussawi et al. 2011), and GluTs have a role in controlling diffusion of 
glutamate away from the synapse (McCullumsmith and Sanacora 2015), thereby preventing a 
loss of synaptic specificity and potential excitotoxicity. GluT activity may be important in 
human patients with PD, in which glutamatergic fibres from the STN fire at a much higher 
frequency (Magnin et al. 2000; Piallat et al. 2011; see section 1.3.3). GluT activity can be 
compromised in PD, and in several other neurodegenerative disorders including amyotrophic 
lateral sclerosis, Huntington’s disease, and Alzheimer’s disease. It is not clear whether 
glutamate dysfunction contributes to pathogenesis, or results from the disease pathology 
(Sheldon and Robinson 2007), but in either case GluTs are therefore considered to be 
potential therapeutic targets (Jensen et al. 2015). 
In vivo pharmacological GluT inhibition in rat substantia nigra using DL-threo-β-
Benzyloxyaspartate (TBOA) has been shown to generate a neurodegenerative process 
mimicking several PD symptoms, caused by excitotoxic cell death of dopamine neurons: this 
was mediated by NMDARs, as application of NMDAR antagonists ifenprodil and memantine 
provided significant neuroprotection (Assous et al. 2014). Other work in the SNc has shown 
that rat dopamine neurons are preferentially affected by GluT dysfunction when compared 
with non-dopamine neurons using the selective GluT inhibitor L-trans-Pyrrolidine-2,4-
dicarboxylate (Nafia et al. 2008). SNc-DA neurons may be highly dependent on maintaining 
adequate levels of the essential brain antioxidant glutathione (GSH), and preferential toxicity 
for DA neurons by GluT inhibition may occur by decreasing the availability of GSH 
precursors such as cysteine, which are also directly transported by GluTs (Hayes et al. 2005; 
Nafia et al. 2008). Therefore susceptibility to oxidative stress caused by low GSH may be an 
additional factor in SNc-DA degeneration, in addition to the increased likelihood of 
glutamate-mediated excitotoxicity caused by GluT dysfunction. 
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In SNc-DA neurons, application of TBOA alone been shown to have no effect on the 
amplitude of elicited summated EPSCs (Wild et al. 2015). Whilst TBOA likely does bind to 
glutamate transporters, evidenced by a slower NMDAR response decay (which may indicate 
diffusion of glutamate further from the synapse), it was found that additional inhibition of 
presynaptic group II metabotropic glutamate receptors (mGluR2) by antagonist LY 341495 
was necessary to allow a TBOA-induced increase in amplitude. Application of LY 341495 
alone had no effect (Wild et al. 2015). Presynaptic feedback mechanisms therefore exist at 
excitatory synapses onto SNc-DA neurons which limit glutamate release in situations where 
spillover is likely, or where extracellular concentration of glutamate is likely to reach 
excitotoxic levels. One aim of this thesis was to explore the role of TBOA in regulating 
NMDAR activity, and whether this was altered in mice lacking the GluN2D subunit. 
 
1.3.3 Pathophysiology of Parkinson’s disease 
Parkinson’s disease (PD) is a neurodegenerative disease characterised by inhibited motor 
control, including bradykinesia, muscle rigidity, and tremor (Bolam et al. 2000; Shulman et 
al. 2011; Surmeier et al. 2017). Many of the motor manifestations of PD are attributed to the 
progressive loss of SNc-DA neurons (Hammond et al. 2007), which form part of the basal 
ganglia system, discussed in section 1.4. Lewy pathology is also a commonly observed 
characteristic of PD: this comprises abnormal, proteinaceous aggregates in the neuronal 
cytoplasm that are rich in α-synuclein. However, LP also occurs in other age-related 
neurodegenerative diseases, with its precise relationship to disease progression remaining 
unclear (Surmeier et al. 2017). Previous studies have observed morphological changes to 
SNc-DA neurons in human Parkinson’s patients, including reductions in dendritic branching 
and partial loss of dendritic spines (Patt et al. 1991), which may be in response to abnormal 
neuronal function. 
In PD, one neurophysiological change is that glutamatergic afferents originating from the 
subthalamic nucleus (STN) to dopaminergic neurons of the SNc reportedly display a higher 
frequency firing, as well as increased burst firing. This was originally observed in primates 
after treatment with MPTP (a compound with preferential toxicity for nigrostriatal 
dopaminergic neurons; Bergman et al. 1994), and electrophysiological recordings have 
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subsequently been gathered from human patients undergoing surgery for deep brain 
stimulation (DBS; Magnin et al. 2000). Whilst this kind of data is not obtainable from healthy 
human subjects, control recordings have been possible from patients with other neurological 
disorders: one study showed that patients with severe obsessive-compulsive disorder (OCD) 
had a mean STN neuron firing rate of 20.5 Hz, with a mean discharge frequency during 
bursting phases of 50.9 Hz. In comparison, PD patients had an overall mean of 30.8 Hz, with 
a much higher mean during burst frequency of 83.4 Hz (Piallat et al. 2011). Other studies 
showed that late stage PD patients had a higher mean firing frequency than early stage PD 
patients (28.7 vs 36.3 Hz; Remple et al. 2011), and that PD patients had a higher mean firing 
(40.5 Hz) frequency in comparison to those with essential tremor (ET; 19.3 Hz) (Steigerwald 
et al. 2008). 
A consequence of this increased bursting activity is likely to be increased NMDAR activity 
due to increased glutamate release and NMDAR-EPSC summation, as well as increasing the 
likelihood of spillover of glutamate from the synapses and activating perisynaptic or 
extrasynaptic NMDARs: this pathological STN activity may therefore promote excitotoxicity 
in SNc-DA neurons (Bergman et al. 1994; Wild et al. 2013). Activity-dependent rundown or 
downregulation of NMDARs in response to repeated agonist application may be a response to 
such activity, and consequently one of the aims of this thesis was to explore this idea. 
As stated above, PD is characterised by the progressive loss of SNc-DA neurons, and proper 
NMDAR regulation may be important for neuronal function and survival under these 
conditions. The sensitivity of a neuron to excitotoxicity is determined by several factors 
relating to NMDARs, such as the surface localisation of the receptor (Hardingham and 
Bading 2010), the subunit profile (Liu et al. 2007; Martel et al. 2012), and the ability of 
NMDARs to be regulated in an activity-dependent manner (Wild et al. 2014). Firstly, with 
regards to surface localisation, several studies have reported that sole activation of synaptic 
NMDARs is able to promote downstream cell survival pathways, such as activation of cAMP-
responsive element binding protein (CREB); and that additional activation of the functionally 
separate population of extrasynaptic NMDARs is able to activate cell death pathways, for 
example by activation of protease enzyme caspase-3 (Liu et al. 2007; Zhou et al. 2013). In the 
hippocampus, around 36% of NMDARs are extrasynaptic, and in the SNc a minimum of 
around 10 % are extrasynaptic, though this figure likely to be higher (Wild et al. 2015). High 
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frequency or burst firing may enable released glutamate to ‘spill over’ from the synapse 
(Rosenmund et al. 1995; Asztely et al. 1997; Clark and Cull-Candy 2002; Harris and Pettit 
2007, 2008) and additionally bind to extrasynaptic NMDARs, promoting cell death 
(Hardingham and Bading 2010; Zhou et al. 2013; Parsons and Raymond 2014). Whilst the 
processes underlying the death of SNc-DA neurons in PD are not fully understood, the 
increased excitatory input to these neurons, discussed above, may lead to NMDAR-mediated 
excitotoxicity: this is therefore implicated as a contributing factor to the ongoing degeneration 
in occurring in PD (Koutsilieri and Riederer 2007; Blandini 2010). With regards to subunit 
profile, there is evidence that the GluN2D subunit may be a mediator of excitotoxicity: its low 
Mg2+ sensitivity may allow it to pass more current in response to glutamate spillover (Paoletti 
et al. 2013), and GluN2D-containing NMDARs have been implicated as extrasynaptic 
mediators of cell death signalling, which are therefore a good target for inhibition 
(Kotermanski and Johnson 2009; Hardingham and Bading 2010). SNc-DA neurons are 
thought to possess NMDARs in a triheteromeric GluN1/GluN2B/GluN2D configuration 
(Jones and Gibb 2005; Brothwell et al. 2008; Suárez et al. 2010). With regards to activity-
depended regulation, due to the clear role for NMDARs in mediating potentially excitotoxic 
influxes in Ca2+ under conditions of overstimulation, it follows that a responsive regulation of 
NMDARs could be an essential mechanism for maintaining equilibrium in postsynaptic 
excitability: this is relevant both as a response to natural alterations in excitatory input, and 
potentially in responding to more pathological changes in glutamatergic input. NMDARs may 
therefore be regulated in response to these changes in order to maintain Ca2+ homeostasis and 
prevent excitotoxicity, or simply overexcitability (Sandoval et al. 2011; Semerdjieva et al. 
2013; Wild et al. 2014). It is possible that this is a mechanism which may be tested to its limit 
in neurodegenerative illness. 
 
1.4 The role of the substantia nigra pars compacta and basal ganglia 
The SNc, located in the midbrain, contains both γ-aminobutyric acid (GABA)-ergic and 
dopaminergic neurons. It is a part of the basal ganglia, which are a group of functionally and 
anatomically interconnected subcortical nuclei consisting of the striatum (caudate and 
putamen in primates), the globus pallidus (internal and external segments), the subthalamic 
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nucleus, and the substantia nigra (pars reticulata and pars compacta); which together have a 
major role in the control of voluntary movement (Nelson and Kreitzer 2014). The basic 
anatomy and connectivity of the basal ganglia are preserved across most vertebrates, and all 
mammals (Reiner et al. 1998; Stephenson-Jones et al. 2012), making rodent data obtained 
from this system highly relevant to humans. The basal ganglia system in mammals is more 
advanced than that observed in birds and reptiles, with considerably more highly developed 
output to the cortex, which contributes to the capacity for more sophisticated behaviours 
(Reiner et al. 1998). 
The primary inputs to the basal ganglia come from the striatum and STN. The striatum, 
composed primarily of GABAergic medium sized spiny projection neurons, receives input 
from almost all areas of the cortex, which can mediate sensorimotor, cognitive, and affective 
(emotional) functions (Redgrave et al. 2010; Nelson and Kreitzer 2014). The striatum also 
receives excitatory input from the thalamus, and from dopaminergic SNc and ventral 
tegmental area (VTA) neurons. Striatal medium spiny neurons can be divided into two groups 
based on their projections: around half project directly to basal ganglia output nuclei (SNr or 
globus pallidus pars interna; GPi) forming the direct pathway, and half project to the globus 
pallidus pars externa (GPe) which then projects to the output nuclei, forming the indirect 
pathway (Nelson and Kreitzer 2014). The other input nucleus to the basal ganglia, the STN, 
receives cortical input from the primary motor, supplementary motor, and premotor cortices 
(Nambu et al. 1996; Nelson and Kreitzer 2014), and sends glutamatergic efferents to the basal 
ganglia output nuclei, and the SNc (Parent and Hazrati 1995; Watabe-Uchida et al. 2012). An 
overview of connections within the basal ganglia is presented in Figure 1.3. 
Inputs from the cortex are processed by the basal ganglia, and then relayed back to the cortex 
via the motor thalamus (Albin et al. 1989; Blandini et al. 2000; Kopell et al. 2006). Uniquely, 
the basal ganglia are dominated by tiers of inhibitory GABAergic neurons. However, the 
output of the basal ganglia is tonically active and exhibits phasic pauses in association with 
movement (Surmeier et al. 2005): the balance between direct and indirect pathways is 
regulated by the opposing actions of dopamine released from SNc-DA afferents onto striatal 
neurons. DA release in the striatum increases activity along the direct pathway (acting on D1 
receptors) and reduces activity along the indirect pathway (acting on D2 receptors). Together 
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increased activity in SNc-DA neurons will result in a net reduction in activity within the GPi 
and SNr (DeLong and Wichmann 2007). 
According to the pathophysiological ‘rate’ model of PD, direct pathway neurons reduce their 
firing frequency, whereas those in the indirect pathway increase their activity in response to a 
reduction in dopamine transmission. As a result, firing in GPe neurons is reduced leading to 
further disinhibition of STN neurons, and promoting excitation of STN targets (SNc, SNr, and 
GPi). The outcome of these changes is that the basal ganglia exert increased inhibition on 
their thalamic and brainstem targets (Galvan et al. 2015). 
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Figure 1.3 – The SNc and basal ganglia 
A simplified diagram of the basal ganglia (BG) system. The substantia nigra pars compacta 
(SNc) receives excitatory input from the cerebral cortex and subthalamic nucleus (STN), 
and releases dopamine in the stratum, which has opposing actions on the direct and indirect 
pathways to the output nuclei. DA release in the striatum increases activity along the direct 
pathway (acting on D1 receptors) and reduces activity along the indirect pathway (acting 
on D2 receptors). Increased activity in SNc-DA neurons results in a net reduction in 
activity within the globus pallidus pars interna (GPi; entopeduncular nucleus in rodents) 
and substantia nigra pars reticulata (SNr; DeLong and Wichmann 2007). Thalamic 
connections not pictured. Diagram adapted from Watabe-Uchida et al. 2012. 
Cortex
Striatum
SNc
GPe
STND
ir
e
ct In
d
ir
e
ct
SNr/GPi
D1 D2
Glutamatergic
GABAergic
Dopaminergic
Chapter 1 – Introduction 
 
55 
 
 
1.4.1 Dopaminergic neurons of the substantia nigra pars compacta 
As part of their role in the regulation of voluntary motor control, SNc-DA neurons display 
tonic or pacemaker firing activity in the range of 4-10 Hz, but when excited will modulate 
into periods of high frequency burst firing (Wilson et al. 1977; Blythe et al. 2009). Tonic 
activity in SNc-DA neurons maintains a low level of DA in the striatum, while the phasic 
increases in firing promote nigrostriatal DA release activating low affinity D1 receptors, 
which are essential to the initiation of movement (Surmeier et al. 2005). In addition, this tonic 
release of DA is essential for glutamatergic corticostriatal induction of Hebbian bidirectional 
long term plasticity in the striatum: pauses in the activity of giant cholinergic interneurons 
elicited by phasic burst firing events in afferent fibres from SNc-DA neurons are thought to 
generate a learning signal in the striatum (Graybiel et al. 1994; Blythe et al. 2009). In models 
of PD, decreased tonic striatal DA levels throw this system out of balance, leading to 
unidirectional changes in plasticity which could cause PD-associated symptoms (Centonze et 
al. 2001; Shen et al. 2008). 
SNc-DA neurons are characterised by a particular combination of features: broad action 
potentials spikes, slow rhythmic (2–10 Hz) autonomous pacemaker activity accompanied by 
large oscillations in intracellular Ca2+, driven by the opening of voltage-dependent L-type 
Ca2+ channels; and low levels of Ca2+-buffering proteins such as calbindin. These features 
together distinguish SNc-DA neurons from others less vulnerable in PD. DA neurons within 
the VTA, for example, show much less PD-related cell death: these neurons are autonomous 
pacemakers with broad spikes, but have smaller L-type Ca2+ channel currents and strong 
intrinsic Ca2+ buffering by calbindin (Surmeier et al. 2017). Glutamatergic inputs to the SNc 
originate mainly from the subthalamic nucleus (STN) and pedunculopontine nucleus (PPN), 
but also from the laterodorsal tegmentum and prefrontal cortex (Kita and Kitai 1987; Charara 
et al. 1996; Tong et al. 1996; Watabe-Uchida et al. 2012; Pearlstein et al. 2015). 
Previously, there was a lack of clear evidence for functioning dendritic spines in SNc-DA 
neurons, and so they have been classically regarded as aspiny. However, recent studies have 
explored the morphology and functionality of spines on SNc-DA neurons in detail using two-
photon confocal microscopy and glutamate uncaging in mouse brain slices (Jang et al. 2015; 
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Hage et al. 2016). Both spine synapses and shaft synapses are present, but only one third of 
the total number of synapses are spiny. In comparison to the shaft synapses, spine synapses on 
SNc-DA neurons have lower EPSC amplitudes and longer decay times, as well as lower 
AMPAR/NMDAR-EPSC amplitude ratios, which together indicate a greater number of 
NMDARs at spiny synapses (Jang et al. 2015). Interestingly, when the authors stimulated 
with 5 consecutive burst pulses, the decay time at spiny synapses was significantly increased 
in comparison to the increase in amplitude, which may be due to receptor saturation and 
glutamate spillover, or potentially a difference in NMDAR subunit composition. Therefore, it 
is possible that these two synapse types may function differently if they receive bursting input 
from glutamatergic afferents. 
 
1.5 Aims of this thesis 
NMDARs present in the membrane of SNc-DA neurons are involved in the maintenance of 
tonic excitability, thereby contributing to normal basal ganglia output; and are essential in 
effecting long term plasticity at the synapse in many cells across the brain. Previous work 
suggests the presence of the GluN2D subunit in adult SNc-DA neurons: however, this is 
largely based on pharmacological compounds with limited selectivity. Therefore, a mouse 
genetically engineered to lack expression of GluN2D (Grin2D-null) was used to investigate 
GluN2D expression profiles along with additional pharmacological intervention using 
GluN2B and GluN2D subunit-preferring antagonists, ifenprodil and DQP-1105. The 
importance of GluN2D in the sensitivity of SNc-DA neurons to ambient extracellular 
glutamate was explored in the Grin2D-null mouse under normal conditions, and under 
conditions where glutamate transport was compromised, such as may occur in 
neurodegenerative disease. 
NMDARs on SNc-DA neurons have been shown to respond to repeated application of agonist 
(NMDA) with downregulation. Glutamatergic neurons originating in the STN and terminating 
on SNc-DA neurons increase their mean firing frequency and peak burst firing frequency in 
PD. Therefore, activity-dependent downregulation was explored at the synapse in response to 
electrically evoked burst firing of excitatory fibres along with postsynaptic depolarisation. 
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The same paradigm was applied in Grin2D-null animals in order to elucidate whether any 
changes were dependent on the presence of the GluN2D subunit. 
Because GluN2D-containing NMDARs decrease their Popen in response to low O2, it was also 
of interest to explore whether the presence of GluN2D in SNc-DA neurons conferred any 
resistance to hypoxia-related excitotoxicity: a previously tested hypoxic treatment protocol 
was applied along with immunofluorescent staining and a cellular viability assay in both wild 
type and Grin2D-null animals. 
Together, the work in this thesis aimed to build a picture of the functional NMDAR 
expression profile in SNc-DA neurons, along with how they and the GluN2D subunit allow 
these neurons to react to various potentially excitotoxic conditions such as inhibited glutamate 
reuptake, increased excitatory burst input, and hypoxia-ischemia. 
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2 Materials and Methods 
2.1 Animals 
C57BL/6 (‘C57’) mice were obtained from Charles River UK. Grin2D-null and Grin2D wild 
type (WT) mice were bred in house from Grin2D +/- mice obtained from the Masayoshi 
Mishina c/o the Riken BRC, Japan, and crossed with each other or with C57 mice to generate 
both Grin2D -/- (‘Grin2D-null’) and WT mice (‘Grin2D-WT’) on the same background. The 
mutant line was originally generated by disruption of the exon encoding the GluN2D 
transmembrane M4 region by insertion of a neomycin phosphotransferase gene (Ikeda et al. 
1995). 
All experiments were performed using these animals at P5-48 as indicated in the text, and 
were carried out in accordance with the United Kingdom Animal (Scientific Procedures) Act 
1986 Amendment Regulations 2012, and local ethical approval. Up to 8 mouse pups were 
housed with the dam in each cage. All animals were provided with ad libitum access to food 
and water, and kept on a 12 hour alternating light/dark cycle. The mice were genotyped from 
crude tail tissue sample lysates using the following primer set: GluR4 WT F 5'-
GTGCTCCTAATAAGTGACTCTGA-3' and GluR4 WT R 5'- 
CCTCCTCGCTCCCTTTCTT-3'  produce a 289 bp product for the WT locus; NeoF 5'-
CGGTGCCCTGAATGAACT-3' and NeoR 5'-CACGGGTAGCCAACGCTATG-3' produce a 
618 bp product for the mutant locus; see Figure 2.1. Samples were outsourced for genotyping 
to the Andrew Huxley Genotyping Facility, University College London. 
2.2 Brain slice preparation 
Animals were anaesthetised using isoflurane until the loss of the withdrawal reflex in 
response to a foot pinch, before decapitation. The brain was then extracted into ice-cold 
slicing solution composed of (mM) NaCl 52.5, NaHCO3 25, KCl 2.5, NaH2PO4 1.25, 
kynurenic acid 0.1, glucose 25, sucrose 100, CaCl2 1, and MgCl2 5, saturated with 95 % O2 /  
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Figure 2.1 – Genotyping of Grin2D-wild type and Grin2D-null mice  
An example electrophoresis gel showing PCR products from genotyping of homozygous 
Grin2D-wild type (WT), heterozygous, and homozygous Grin2D-null (Mut) mice, 
alongside HyperLadderTM 100 bp molecular weight markers from Bioline (London, UK). 
PCR reactions were performed using crude tail tissue sample lysates using the following 
primer set: GluR4 WT F 5'-GTGCTCCTAATAAGTGACTCTGA-3' and GluR4 WT R 5'- 
CCTCCTCGCTCCCTTTCTT-3'  produce a 289 bp product for the WT locus; NeoF 5'-
CGGTGCCCTGAATGAACT-3' and NeoR 5'-CACGGGTAGCCAACGCTATG-3' 
produce a 618 bp product for the mutant locus. 
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5 % CO2 at pH 7.4. The brain was trimmed and glued to the stage of a 7000smz-2 vibrating 
microslicer (Campden Instruments, Loughborough, UK).  Horizontal slices including the 
substantia nigra region (Figure 2.2A) were prepared at a thickness of 230 µm (unless 
specified), and immediately transferred into a Gibb submersion chamber containing (mM):  
NaCl 119, NaHCO3 26, KCl 2.5, NaH2PO4 1.25, glucose 25, CaCl2 2, and MgCl2 6, saturated 
with 95 % O2 / 5 % CO2 at 30 °C, for 1-6 hours prior to use. 
 
2.3 Electrophysiology 
Slices were transferred to a chamber, held in place with a platinum and nylon net and perfused 
with (mM) NaCl 119, NaHCO3 26, KCl 2.5, NaH2PO4 1.25, glucose 10, CaCl2 2, and MgCl2 
(1 or 0.1) saturated with 95 % O2 / 5 % CO2 at 30±2 °C (TC-344B temperature controller, 
Warner Instruments, Hamden, CT, USA), before being visualised using an Olympus BX51W 
microscope with differential interface contrast optics. 
Whole-cell patch-clamp recordings were made using borosilicate glass micropipettes 
(Harvard Apparatus, Holliston, MA, USA) prepared using a Sutter P-87 micropipette puller to 
a resistance of 2-3 MΩ when filled with intracellular solution composed of [mM]: CsMeSO3 
120, CsCl 5, NaCl 2.8, MgCl2 3, HEPES 20, ATP [Adenosine 5′-triphosphate magnesium 
salt] 2, GTP [Guanosine 5′-triphosphate sodium salt hydrate] 0.3, EGTA 5, and CaCl2 0.5, 
giving a final osmolality of 275-285 mOsmoles/kg. The final pH was adjusted to 7.2-7.3 
using CsOH, and the solution passed through a 0.2 µm filter. 
Signals were low-pass filtered at 2-3 kHz, and digitised at 20 kHz using a Micro1401 
interface (Cambridge Electronic Design, Cambridge, UK).  Cells were voltage clamped 
potentials of -60, -50, -20, or +40 mV as indicated in the text, using HEKA Pulse v8.53 
software along with a EPC9 amplifier (HEKA, Hamden, CT, USA). Signals were stored and 
measured using Spike2 version 4 (Cambridge Electronic Design, Cambridge, UK). Series 
resistance (Rseries) was estimated using the HEKA Pulse software, and was typically within the 
range 3.5-10 MΩ: however, the experiment was abandoned if a change of more than 3 MΩ 
was observed. 
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The SNc region was identified under low magnification (Figure 2.2A), and SNc dopamine 
neurons by somatic morphology (large ovoid or polygonal soma; Tepper et al. 1994; Figure 
2.2B) and anatomical location relative to the medial terminal nucleus of the accessory optic 
tract (MT), which is identifiable by its expression of melanin and therefore dark appearance. 
Dopaminergic status was confirmed by the presence of a non-speciﬁc cation current (Ih) 
measured as a sag component of at least 40 pA (Figure 2.2C), in response to a voltage step 
from -60 to -110 mV. This current is a key electrophysiological marker of dopamine neurons 
within the SNc, and is mediated via hyperpolarization-activated cyclic nucleotide–gated 
(HCN) channels (Neuhoff et al. 2002). 
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Figure 2.2 – Identification of SNc-DA neurons 
(A) Horizontal brain slices containing the substantia nigra were freshly prepared from 
C57Bl6 (wild type) or Grin2D-null mice at the age specified. (B) Whole cell patch clamp 
electrophysiology was used to record NMDAR responses from dopaminergic neurons of 
the substantia nigra pars compacta. (C) Current response to holding potential change from 
-60 to -110 mV in a dopaminergic neuron within the substantia nigra pars compacta region. 
Trace taken from a wild type mouse at P18; amplitude of the ‘sag’ component during the -
110 mV holding period is 56 pA. 
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2.4 Experimental design 
2.4.1 NMDAR-mediated current 
Peak currents generated by NMDARs across the whole cell were elicited by bath applications 
of NMDA at the concentration specified in the text, in the presence of picrotoxin (50 µM), 
glycine (10 µM), and TTX (100 nM). Currents elicited by ambient extracellular glutamate via 
NMDARs were measured (with or without TTX at 100 nM) by obtaining a stable baseline 
current in picrotoxin (50 µM) and glycine (10 µM), before applying NMDAR blocker D-(-)-
2-Amino-5-phosphonopentanoic acid (D-AP5; 50 µM) and measuring the amplitude of the 
resulting deflection. Changes in current amplitude resulting from inhibition of glutamate 
reuptake were explored by applying the competitive glutamate transporter blocker TBOA (30 
µM) along with group II metabotropic glutamate receptor antagonist LY 341495 (200 nM), 
and the NMDAR-mediated potion of this isolated by then applying D-AP5 as above. 
When applying electrical stimulation, stainless steel electrodes (Frederick Haer and Co., 
USA) were placed rostral to the cell to optimize the possibility of stimulating afferent 
glutamatergic fibres, and the intensity varied in order to ensure a graded excitatory 
postsynaptic current (EPSC), before being fixed at a submaximal intensity (pulse duration 100 
µs; amplitude 30-250 µA) for the duration of the experiment. 
To determine the ratio of AMPAR/NMDAR (A/N) EPSC amplitude, picrotoxin (50 µM) and 
glycine (10 µM) were added to the perfusion. Cells were held at +40 mV to bypass voltage-
dependent Mg2+ blockade (MgCl2 1 mM) of NMDARs, and EPSCs of a stable amplitude 
elicited at 0.1 Hz for at least 200 s before addition of D-AP5 (50 µM) to the perfusion, leaving 
the AMPAR-EPSC. At least 10 traces immediately before, and 10 traces in the presence of D-
AP5 were averaged using Spike2. The +D-AP5 trace (‘AMPAR-EPSC’) was subtracted from 
the pre-D-AP5 trace (‘total-EPSC’) using Microsoft Excel to give the NMDAR-EPSC 
(Figure 2.5) Peak amplitudes of each component were measured within the period 8-15 ms 
following the stimulus artifact (Figure 2.3). 
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Figure 2.3 – Measurement of single and summated EPSCs 
(A) Example single NMDAR-EPSC at a holding potential of +40 mV, elicited by a single 
pulse stimulation of afferent glutamatergic fibres. Amplitudes are extracted using Spike2 
v4 software, with the pre-EPSC baseline value taken as the mean of all values recorded 
between cursor 1 and 2, and the peak EPSC amplitude as the mean of the 1 ms period 
around the highest value between cursors 3 and 4, as indicated by cursor 5. (B) Example 
summated NMDAR-EPSC at a holding potential of +40 mV, elicited by a train of five 
stimulations of afferent glutamatergic fibres at 50 Hz. Amplitudes are calculated as in A, 
but with different time values specified for cursors 3 and 4. 
20 pA
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For experiments evaluating pharmacological inhibition of synaptic NMDAR currents, the 
patched cell was held at +40 mV to avoid Mg2+ block, and EPSCs elicited at 0.1 Hz with 
picrotoxin (50 µM), glycine (10 µM), and AMPA and kainate receptor selective antagonist 
6,7-dinitroquinoxaline-2,3-dione (DNQX; 10 µM) applied via bath perfusion. Once a stable 
NMDAR-EPSC amplitude was obtained, either GluN2B-selective inhibitor ifenprodil (10 
µM) or GluN2D-selective inhibitor DQP-1105 (‘DQP’; 10 µM) was applied via the bath 
perfusion, and stimulation continued for a further 15-20 minutes. NMDAR-EPSC amplitude 
within the period between 13-20 minutes following ifenprodil/DQP application was compared 
to the pre-drug amplitude to determine the percent inhibition. 
For measurement and comparison of EPSC decays, 6-10 EPSCs at 0.1 Hz in the presence of 
picrotoxin (50 µM), glycine (10 µM), and DNQX (10 µM) were averaged, and a two-
component exponential decay function fitted to the EPSC decay using WinWCP version 5.3.2 
as below:  
	 ( ) 	= 	 1 ∙  (− /τ1) 	+ 	 2 ∙  (− /τ2) 
Where, respectively, A1 and A2 are the fast and slow component amplitudes, and τ1 and τ2 
are the fast and slow time constants (Stocca and Vicini 1998; Brothwell et al. 2008; Wild et 
al. 2015). 
To determine activity-dependent regulation of electrically evoked NMDAR responses, 
picrotoxin (50 µM), glycine (10 µM), and DNQX (10 µM) were added to the perfusion. 
Membrane holding potential was set to +40 mV to avoid Mg2+ block and in order to reduce 
the driving force for Ca2+ influx, and EPSCs were elicited by application of single stimuli (to 
activate synaptic NMDARs) or short high frequency (50 Hz) trains of stimuli (to activate 
synaptic and also potentially extrasynaptic NMDARs; Figure 2.4). After a stable baseline of 
at least 300 s, the holding potential was changed to -20 mV, increasing the driving force for 
Ca2+ influx whilst still alleviating Mg2+ block, and a protocol of patterned activity (trains of 3 
pulses at 100 Hz, each followed by a 1 s break) initiated. This induction paradigm (IP) was 
adapted from Joshi et al. 2007, where it was shown to induce a downregulation in synaptic 
NMDARs. On completion, holding potential was returned to +40 mV and single and 50 Hz 
pulses continued. For analysis of EPSC amplitudes, mean amplitudes of ten single EPSCs and 
four summated EPSCs (taken here to refer to the EPSCs generate in response to trains of 
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stimuli at 50 Hz, Figure 2.3) were taken immediately preceding the onset of the patterned 
activity, and then for 25 minutes (1500 seconds) following. 
Paired pulse data was also extracted from the summated NMDAR-EPSC data: the first two 
EPSCs (p1 and p2) generated from the train of five electrical stimuli at 50 Hz were collected 
and the paired pulse ratio (PPR; p2/p1) calculated. Four pairs of EPSCs generated 20 ms apart 
were therefore collected from immediately before the onset of the patterned activity protocol 
and used to generate an average waveform and PPR: The pairs of EPSCs generated between 
1200-1500 s following the end of the protocol were also averaged and the PPR compared to 
that from before the patterned activity. 
  
 
 
 
Figure 2.4 – Paradigm for determining activity dependent regulation of NMDARs 
“Induction paradigm” (IP; red) applied to glutamatergic afferent fibres in order to evoke 
activity-dependent changes in synaptic (single stimulus; indicated by thin vertical line) and 
synaptic + extrasynaptic NMDAR responses (5 stimulus pulses at 50 Hz; thick vertical 
line). 
INDUCTION PARADIGM (IP)
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Figure 2.5 – AMPAR/NMDAR EPSC amplitude ratio methodology 
On the left is an example trace from a wild type SNc-DA neuron, showing excitatory 
postsynaptic current (EPSC) in response to electrical stimulation before (black - TOTAL) 
and after (red - AMPAR) the application of D-AP5 (50 µM). On the right is the resultant 
NMDAR EPSC calculated by subtracting the AMPAR EPSC from the TOTAL EPSC. 
TOTAL
AMPAR
NMDAR
40 pA
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2.4.2 Hypoxic treatment protocol and immunofluorescence 
The hypoxia treatment protocol was adapted from Larson and Park 2009 and Tasca et al. 
2015. Horizontal slices through the substantia nigra region were carefully made as described 
above (‘Brain slice preparation’) at a thickness of 100 µm. For each slice produced, a cut was 
made along the midline and one hemisphere randomly assigned to a high oxygen (normoxic) 
treatment group, and one to a hypoxic treatment group (below). Previous studies have shown 
that in mice, treatment with 15% O2 / 80% N2 / 5% CO2 as a hypoxic condition for 20-40 
minutes causes a submaximal effect whereby only 60% of cells show functional recovery 
after 95% O2 / 5% CO2 is restored (Larson and Park 2009). Therefore this concentration was 
chosen as a submaximal effect is desirable for comparison between genotypes. 
Following a 40 minute recovery in normoxic conditions (gassed with 95% O2 / 5% CO2) 
slices in both groups were transferred to new Gibb submersion chambers for a 40 minute 
treatment period: the normoxic group to a new chamber gassed again with 95% O2 / 5% CO2, 
and the hypoxic group to a chamber gassed with 15% O2 / 80% N2 / 5% CO2. The slices in 
both groups were then carefully transferred back to their original, separate normoxic 
chambers, and 20 mM fluorescent propidium iodide (PI) was added to the chamber (0.5 mL of 
4 mM stock per 100 mL chamber; Lossi 2009). After 20 minutes, all slices were briefly and 
gently washed twice in Krebs buffer composed of NaCl 126 mM; KCl 2.5 mM; MgCl2 1.2 
mM; CaCl2 2.4 mM; NaHCO3 25 mM; NaH2PO4 1.2 mM; and glucose 11 mM (Pisani et al. 
2006), before being stored in darkness in a vial containing 4% paraformaldehyde (PFA) in 
phosphate-buffered saline (PBS; Sato et al. 2011). After four hours, slices were PBS 
containing 0.1 M glycine for 5 minutes to bind free aldehyde groups (Jamur and Oliver 2010), 
before three more 5 minute washes in PBS. These and all subsequent washes and incubations 
were performed on a rotating shaker. Slices were then transferred into a permeation / blocking 
solution (1% w/v fish gelatine in TBS-T, containing 0.2% Tween-20 and 0.2% Triton X100) 
for 30 minutes at room temperature, before three washes each lasting 15 minutes in TBS (Tris 
50 mM, NaCl 150 mM). 
For immunological staining, slices were incubated in primary antibody (rabbit anti-TH 
polyclonal Ab, Millipore AB152, 1:500 in TBS) overnight, and washed three times (15 
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minutes each) in TBS. Slices were then incubated in the secondary antibody, (Alexa-
fluorophore 488 nm, donkey anti-rabbit, Thermo Fisher A21206, 1:500 in TBS) for 90 
minutes, followed by three 15 minute washes in TBS. 
For viewing and quantification, each hemislice was placed in PBS on the stage of an Olympus 
BX51W microscope with differential interface contrast optics and optional green/red optical 
emission filters. The SNc was visually identified by proximity to MT and then scanned 
systematically using an excitation wavelength of 470 nm in order to count all TH+ cells. For 
each TH+ cell observed, the excitation wavelength was switched to 565 nm in order that the 
PI status of each cell could be recorded. 
 
2.5 Statistical analysis 
Unless otherwise specified, reported n values are each from a different animal. 
In comparing samples from two groups of data, the Student’s t-test was used: if any groups 
were found to be non-normally distributed (using the D'agostino-Pearson Omnibus K2 test), 
then a paired t-test was replaced with the Wilcoxon matched pairs test, and the unpaired t-test 
replaced with the Mann-Whitney U test. For multiple comparisons, a one-way ANOVA was 
applied along with Tukey’s multiple comparison test, or for multiple characteristics a two-
way ANOVA along with the Holm-Sidak or Dunnett tests for post-hoc analysis. If any groups 
were found to be non-normally distributed, a repeated measures ANOVA was replaced with 
the Friedman test, and for unpaired data the Kruskal-Wallis test was applied, along with 
Dunn’s multiple comparison test. 
Throughout, data are displayed as the mean ± the standard error. Graphs and statistical 
analyses were generated using Graphpad Prism 7 (ISI Software, San Diego, CA, USA). 
Nonlinear regression was used to analyse the bath perfused NMDA dose-response data in 
both wild type and Grin2D-null mice. The least squares (ordinary) fit method was used in 
Graphpad Prism 7.03 to fit an [agonist] vs response curve, as defined below: 
  =       	 + 	  ∙ (    −       )/(  50	 + 	 ) 
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Electrophysiological recordings were excluded if the result was classed as a significant outlier 
according to the Grubbs' Extreme Studentized Deviate (ESD) method.  
 
Where    is the sample mean, and s is the standard deviation. The difference between the 
outlier and the mean is divided by s. The G statistic is the largest absolute deviation from the 
sample mean in units of the standard deviation (Grubbs 1950). The only values removed from 
any of the results presented in this thesis as outliers were from the activity dependent 
regulation experiments: one sample was from the wild type induction paradigm treatment 
group, and one from the Grin2D-null induction paradigm treatment group; both of which 
showed very large increases, in stark contrast to the rest of the dataset. 
 
2.6 Materials 
2.6.1 Electrophysiology 
For electrophysiological recordings, standard laboratory salts were obtained from BDH 
Laboratory Supplies (Poole, UK). All drugs were obtained from Sigma-Aldrich (Dorset, UK), 
apart from tetrodotoxin (TTX) and Group II metabotropic glutamate receptor antagonist LY 
341495, which were obtained from Tocris Bioscience (Bristol, UK). 
 
2.6.2 Immunohistochemistry 
For Immunohistochemistry, PFA, tris, Triton-X100, and Tween-20 were obtained from BDH 
Laboratory Supplies (Poole, UK). Fish gelatine and PBS tablets were obtained from Sigma-
Aldrich (Dorset, UK). Antibodies were obtained from either Millipore (MA, USA) or Thermo 
Fisher (MA, USA) as specified. 
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3 Results 
3.1 Characterisation of synaptic NMDARs in SNc DA neurons of Grin2D null 
mice 
3.1.1 Constitutive NMDAR expression at Grin2D-null synapses 
Experiments were performed in order to investigate whether removal of the Grin2D gene 
caused any change in the overall expression of NMDARs at the synapse, relative to AMPARs 
at the same age (A/N ratio). To determine the A/N ratio, picrotoxin (50 µM) and glycine (10 
µM) were added to the perfusion. Cells were held at +40 mV to bypass Mg2+ blockade 
(MgCl2 1 mM), and EPSCs of a stable amplitude recorded at 0.1 Hz for at least 200 s before 
addition of NMDAR blocker D-AP5 (50 µM) to the perfusion, leaving the AMPAR-EPSC 
(Figure 3.1). At least 10 traces immediately before, and 10 traces in the presence of D-AP5 
were averaged using the CED Spike2 software. The +D-AP5 trace (‘AMPAR-EPSC’) was 
subtracted from the pre-D-AP5 trace (‘total-EPSC’) using Microsoft Excel to give the 
NMDAR-EPSC. Peak amplitudes of each component were measured 8-15 ms following the 
stimulus artifact. 
Three age groups were tested: results in P5-7 mice produced an A/N value of 0.840 ± 0.124 in 
Grin2D-WT (n=7), and 0.577 ± 0.113 in Grin2D-null mice (n=7; from 6 different animals). 
P12-15 mice produced an A/N value of 0.389 ± 0.061 in wild type (C57 n=8, and Grin2D-
WT n=1), and 0.460 ± 0.089 in Grin2D-null mice (n=6). Results in P17-21 mice gave an A/N 
value of 0.721 ± 0.079 in wild type (C57 n=9, and Grin2D-WT n=1), and 0.827 ± 0.104 in 
Grin2D-null mice (n=7). An unpaired 2-way ANOVA was performed on all groups, 
examining the effect of age group and genotype. Age had a significant (p=0.0016**) effect on 
A/N, whereas genotype was not significant (Figure 3.2). 
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3.1.2 Altered properties of synaptic NMDARs in Grin2D null mice 
It has been shown previously that NMDAR-EPSCs in rat SNc-DA neurons are inhibited by 
the GluN2B preferring antagonist ifenprodil, and by the GluN2D-preferring antagonist UBP-
141 up to postnatal week 3; consistent with the expression of GluN2B and GluN2D-
containing synaptic NMDARs. These are proposed to form diheteromeric receptors at P7 and 
have a likely triheteromeric composition by P21 (Brothwell et al. 2008). Therefore the 
possibility of an altered pharmacological response was investigated in Grin2D-null mice, with 
picrotoxin (50 µM), glycine (10 µM), and DNQX (10 µM) added to the perfusion. 
Two age groups were tested.  Example recordings and combined data from SNc-DA neurons 
taken from Grin2D WT and null mice are shown in Figures 3.3 (~P7) and 3.4 (~P21). In 
animals aged P5-9, application of the GluN2B-preferring antagonist ifenprodil (10 µM) 
caused a mean inhibition of NMDAR-EPSCs within the 13-20 minute timeframe of 62.9 ± 3.7 
% in Grin2D-WT (n=7), significantly less than the 78.8 ± 2.4 % observed in Grin2D-null 
mice (n=6) (Figure 3.5; p=0.006**; difference of 15.95 ± 4.64 %; two tailed t). In mice aged 
P18-21, application of ifenprodil caused a mean inhibition at of 48.8 ± 5.5 % in wild type 
(n=9 [C57 n=7, Grin2D-WT n=2]), significantly less than the 65.4 ± 4.1 % in Grin2D-null 
mice (n=7) (Figure 3.5; p=0.037*; difference of 16.6 ± 7.2 %; two tailed t-test). 
Similar experiments were also performed using GluN2D-preferring antagonist DQP-1105 (10 
µM). Example recordings and combined data from SNc DA neurons are shown in Figures 3.6 
(~P7) and 3.7 (~P21). In P5-9 mice, there was a mean inhibition of NMDAR-EPSCs 9-20 
minutes following application of DQP of 24.9 ± 7.5 % in Grin2D-WT (n=8), significantly 
greater than the 10.0 ± 4.2 % in Grin2D-null mice (n=11) (Figure 3.8; p=0.042*; difference 
of 14.8 ± 8.1 %; one tailed t). In P17-22 mice, there was a mean reduction at 13-20 minutes of 
23.10 ± 3.10 % in Grin2D-WT (n=7), significantly greater than the 14.5 ± 2.6 % in Grin2D-
null mice (n=7) (Figure 3.8; p=0.036*; difference of 9.4 ± 4.8 %; one tailed t). The one-tailed 
t test is used here because sensitivity is only required for a decreased effect in Grin2D-null 
mice using this GluN2D-specific antagonist. Overall the pharmacological data suggest that 
GluN2D is replaced with GluN2B at the synapse in Grin2D-null animals. The ifenprodil data 
are also consistent with a general developmental decrease in diheteromeric GluN1/GluN2B 
NMDARs in SNc-DA neurons (Brothwell et al. 2008). 
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τ1 decay time constants were also compared between wild type (Figure 3.8; n=10; C57 n=6, 
Grin2D-WT n=4) and Grin2D null mice (n=11) aged P17-21, with a two-trailed t-test 
reporting no significant difference between the two groups (p=0.117). 
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Figure 3.1 – Example EPSC amplitudes before and during application of D-AP5 
To generate AMPAR/NMDAR EPSC amplitude ratios 50 µM D-AP5 was applied via the 
bath perfusion after a stable baseline period. Example experiments including before and after 
traces are shown from a P21 C57 mouse (A), and a P21 Grin2D-null mouse (B). Scale bar 
axes:  x=40 ms; y=100 pA. 
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Figure 3.2 – AMPAR/NMDAR EPSC amplitude ratio alters with age but not by 
genotype.  
Scatter plot showing AMPAR/NMDAR EPSC amplitude ratios in wild type (C57 and 
Grin2D-WT) and Grin2D-null mice at three age groups, approximately one, two, and three 
weeks old. No significant difference was observed based on genotype, whereas age was 
highly significant (p=0.0016, unpaired two factor ANOVA). The P6-8 Grin2D-null group has 
an n=7 from 6 different animals. 
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Figure 3.3 – EPSC amplitudes before and during application of ifenprodil in one-week 
old mice 
NMDAR-EPSCs generated in the presence of glycine, picrotoxin, and DNQX were inhibited 
by application of GluN2B-preferring inhibitor ifenprodil (10 µM) via the bath perfusion 
following a stable baseline period. Example experiments including before and after traces are 
shown from a P9 Grin2D-WT mouse (A), and a P8 Grin2D-null mouse (B). Scale bar axes:  
x=40 ms; y=30 pA. Summary data from P5-9 mice are shown in C: WT n=7, Grin2D-null 
n=6. 
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Figure 3.4 – EPSC amplitudes before and during application of ifenprodil in three-week 
old mice 
NMDAR-EPSCs generated in the presence of glycine, picrotoxin, and DNQX were inhibited 
by application of GluN2B-preferring inhibitor ifenprodil (10 µM) via the bath perfusion 
following a stable baseline period. Example experiments including before and after traces are 
shown from a P21 C57 mouse (A), and a P20 Grin2D-null mouse (B). Scale bar axes:  x=40 
ms; y=30 pA. Summary data from P18-21 mice are shown in C: WT n=9, Grin2D-null n=7. 
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Figure 3.5 – GluN2B inhibition by ifenprodil is greater in mice lacking GluN2D 
Mean reduction in amplitude of NMDAR-EPSCs during the period 13-20 minutes following 
addition of GluN2B-preferring inhibitor ifenprodil (10 µM). (A) In one-week old mice, 
inhibition was significantly greater in Grin2D-null (n=6) compared to Grin2D-WT (n=7) 
mice (p=0.006**; two tailed t). (B) In three-week old mice, inhibition was again significantly 
greater in Grin2D-null (n=7) compared to wild type (n=9 [C57 n=7, Grin2D-WT n=2]) mice 
(p=0.037*; two tailed t). 
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Figure 3.6 – EPSC amplitudes before and during application of DQP-1105 in one-week 
old mice 
NMDAR-EPSCs generated in the presence of glycine, picrotoxin, and DNQX were inhibited 
by application of GluN2D-preferring inhibitor DQP-1105 (10 µM) via the bath perfusion 
following a stable baseline period. Example experiments including before and after traces are 
shown from a P5 Grin2D-WT mouse (A), and a P8 Grin2D-null mouse (B). Scale bar axes:  
x=40 ms; y=30 pA. Summary data from P5-9 mice are shown in C: WT n=8, Grin2D-null 
n=11. 
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Figure 3.7 – EPSC amplitudes before and during application of DQP-1105 in three-week 
old mice 
NMDAR-EPSCs generated in the presence of glycine, picrotoxin, and DNQX were inhibited 
by application of GluN2D-preferring inhibitor DQP-1105 (10 µM) via the bath perfusion 
following a stable baseline period. Example experiments including before and after traces are 
shown from a P17 C57 mouse (A), and a P20 Grin2D-null mouse (B). Scale bar axes:  x=40 
ms; y=30 pA. Summary data from P17-22 mice are shown in C: WT n=7, Grin2D-null n=7. 
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Figure 3.8 – GluN2D inhibition by DQP-1105 is reduced in mice lacking GluN2D 
Mean reduction in amplitude of NMDAR-EPSCs during the period 13-20 minutes following 
addition of GluN2D-preferring inhibitor DQP-1105 (10 µM). (A) In one-week old mice, 
inhibition was significantly greater in Grin2D-WT (n=8) compared to Grin2D-null mice 
(n=11) (p=0.042*; one tailed t). (B) In three-week old mice, inhibition was again significantly 
greater in Grin2D-WT mice (n=7) compared to Grin2D-null mice (n=7) (p=0.036*; one tailed 
t). 
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Figure 3.9 – NMDAR-EPSC decay constants do not differ between wild type and 
Grin2D-null mice 
The decay time constant τ1 was compared between wild type (n=10; C57 n=6, Grin2D-WT 
n=4) and Grin2D null mice (n=11) aged P17-21. There was no significant difference between 
the two groups (two-tailed t; p=0.117).  
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3.2 Activity-dependent regulation of NMDA receptors 
3.2.1 Reduction in NMDA-EPSC amplitude in response to high frequency burst firing of 
excitatory afferents 
To investigate activity-dependent regulation of electrically evoked NMDAR responses, 
picrotoxin (50 µM), glycine (10 µM), and DNQX (10 µM) were added to the perfusion. 
Membrane holding potential was set to +40 mV in order to inhibit Ca2+ entry, and EPSCs 
elicited by application of single stimuli (to activate synaptic NMDARs) or short high 
frequency (50 Hz) trains of stimuli (to activate synaptic and also potentially extrasynaptic 
NMDARs); an example recording is shown in Figure 3.10A). After a stable baseline of at 
least 300 s, the holding potential was changed to -20 mV in order to allow Ca2+ entry whilst 
still alleviating Mg2+ block, and a protocol of burst firing activity (the induction protocol, or 
IP: trains of 3 pulses at 100 Hz, each followed by a 1 s break, adapted from Joshi et al. 2007) 
initiated. On completion, holding potential was returned to +40 mV and single and 50 Hz 
pulses continued. For analysis of EPSC amplitudes, mean amplitudes of ten single EPSCs and 
four summated EPSCs (taken here to refer to the EPSCs generate in response to trains of 
stimuli at 50 Hz) were taken immediately preceding the onset of the IP, and then for 25 
minutes (1500 seconds) following the cessation of the IP. Comparisons were made between 
the NMDAR-EPSC amplitudes pre-IP and those within the 1200-1500 s time window: In wild 
type mice (C57 n=6, Grin2D-WT n=4), where the IP was applied at -20 mV, there was a 
significant reduction in mean NMDAR-EPSC amplitude of 18.05 ± 4.80 pA (Figure 3.10B; 
p=0.0045**; paired two-tailed t-test; n=10). 
Two control experiments were performed in wild type mice. In the first, the holding potential 
was changed to -20 mV but the IP was not applied, there was no change in mean NMDAR-
EPSC amplitude (increase of 0.17 ± 4.50 pA; Figure 3.11A, B; p=0.9711; paired two-tailed t-
test; n=11 [C57 n=4, Grin2D-WT n=7]): these data showed significantly less down-regulation 
of single NMDAR-EPSCs than observed in response to the test IP, as explained in 3.2.3 
below and summarized in Figure 3.12. As the assaying pulses in this protocol were always 
taken at +40 mV in order to minimize Ca2+ entry, another control was performed in which the 
IP was applied at +40 mV, to see whether this holding potential still allowed the cell to 
respond to the IP: in this control there was no change in mean NMDAR-EPSC amplitude 
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(reduction of 5.25 ± 2.34 pA; Figure 3.11C, D; p=0.0552; paired two-tailed t-test; n=9 [C57 
n=3, Grin2D-WT n=6]). 
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Figure 3.10 – Single NMDAR-EPSC amplitude is reduced following treatment by the IP 
at -20 mV in wild type mice 
Following a stable baseline period of NMDAR-EPSCs elicited at +40 mV, the induction 
paradigm (IP) was applied at -20 mV. A: An example experiment including before and after 
traces from a P19 Grin2D-WT mouse. Scale bar axes:  x=20 ms; y=25 pA. Each data point 
represents mean y values from each 100 s period. B: Summary data. In comparison to the pre-
IP period, mean single NMDAR-EPSC amplitudes 1200-1500 seconds following the end of 
the IP were significantly reduced (p=0.0045**; paired two-tailed t-test; n=10).  
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Figure 3.11 – Single NMDAR-EPSC amplitude remains stable where the IP is not 
applied, and where Ca2+ driving force is reduced 
A: Example recording from a P19 Grin2D-WT mouse: following a stable baseline period of 
NMDAR-EPSCs elicited at +40 mV, the holding potential was switched to -20 mV as in the 
treatment group, but no stimulation applied. Scale bar axes:  x=20 ms; y=50 pA. Each data 
point represents mean y values from each 100 s period. B: Summary data of these 
experiments: in comparison to the pre-IP period, mean single NMDAR-EPSC amplitudes 
1200-1500 seconds following the end of the pseudo-IP were not reduced; n=11.  
C: Example recording from a P20 Grin2D-WT mouse: in this case the IP was applied, but the 
holding potential was not changed from +40 mV. Scale bar axes:  x=20 ms; y=15 pA. D: 
Summary data of these experiments: in comparison to the pre-IP period, mean single 
NMDAR-EPSC amplitudes 1200-1500 seconds following the end of stimulation were not 
reduced; n=9.  
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Figure 3.12 – Single NMDAR-EPSC amplitude is reduced by application of the 
induction paradigm 
Scatter plot showing the change in single NMDAR-EPSC amplitude. The treatment group in 
which the IP was applied at -20 mV had a significantly reduced mean NMDAR-EPSC 
amplitude after 1200-1500 s in comparison to the same time period from the control group, in 
which holding potential was changed to -20 mV but no stimulation applied (p<0.05*; 
ANOVA, Sidak post-hoc). The treatment group was also compared to the group in which the 
IP was applied at +40 mV, but this did not yield a significant result. 
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3.2.2 Summated NMDA-EPSC amplitudes were also reduced in response to high 
frequency burst firing of excitatory afferents 
In wild type mice (C57 n=6, Grin2D-WT n=4), where the IP was applied at -20 mV, there 
was a significant reduction in mean summated NMDAR-EPSC amplitude of 36.26 ± 12.41 
pA (Figure 3.13A, B; p=0.0170*; paired two-tailed t-test; n=10). In control experiments 
performed in wild type mice, where the holding was moved to -20 mV but the IP was not 
applied, there was no change in mean NMDAR-EPSC amplitude (increase of 13.81 ± 10.87 
pA; Figure 3.14A, B; p=0.233; paired two-tailed t-test; n=11 [C57 n=4, Grin2D-WT n=7]): 
these data showed significantly less down-regulation of single NMDAR-EPSCs than observed 
in response to the test IP, as explained in 3.2.3 below and summarized in Figure 3.15. In 
control experiments performed in wild type mice where the IP was applied at +40 mV, there 
was no change in mean NMDAR-EPSC amplitude (reduction of 6.07 ± 4.52 pA; Figure 
3.14C, D; p=0.216; paired two-tailed t-test; n=9 [C57 n=3, Grin2D-WT n=6]).  
 
3.2.3 A significant effect of the IP in comparison to control, and a difference based on 
EPSC type 
In order to examine effect of the IP at both -20 and +40 mV, and to compare single and 
summated responses, the data were normalised as a proportion of the pre-IP amplitude. A 
paired two-factor ANOVA was performed. For each group the paired data for the remaining 
EPSC proportion of both single and summated EPSCs were entered. The test reported a 
significant (p=0.0201*) difference between groups (IP applied at -20 mV, IP applied at +40 
mV, and no IP applied at -20 mV), and a significant (p=0.0077**) difference based on EPSC 
type (paired data).  
Multiple comparisons were then performed: for the single NMDAR-EPSC data, Sidak post-
hoc testing reported a significant difference in the remaining EPSC proportion in the ‘no IP’ 
control vs that in the wild type treatment group (p<0.05*). There was no significant difference 
between the wild type and +40 mV IP treatment groups, or the no IP control and the +40 mV 
IP groups. 
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Within the same round of Sidak multiple comparison testing, similar results were reported for 
the summated NMDAR-EPSC data: there was a significant difference in the remaining EPSC 
proportion in the ‘no IP’ control vs that in the wild type treatment group (p<0.01*). There was 
no significant difference between the wild type and +40 mV IP treatment groups, or the no IP 
control and the +40 mV IP groups. 
Together this testing indicates that the IP reduces NMDAR-EPSC amplitude, and that 
summated responses do not proportionally decrease as much as single EPSCs. 
 
3.2.4 The fast Ca2+ chelator BAPTA does not prevent activity dependent downregulation 
The effect of fast Ca2+ chelation was examined by the addition of BAPTA (10 mM) into the 
intracellular patch solution, where the IP was applied at -20 mV. In these experiments there 
was a significant reduction in mean single NMDAR-EPSC amplitude of 12.06 ± 3.60 pA 
(p=0.0203*; paired two-tailed t-test; n=6 [C57 n=4, Grin2D-WT n=2]). A similar reduction in 
summated NMDAR-EPSCs of 17.15 ± 6.10 pA was also observed (p=0.0374*; paired two-
tailed t-test). The alterations in single or summated NMDAR-EPSCs at 1200-1500 with 
BAPTA did not differ from those without (single EPSC p=0.25, two-tailed t. Summated 
EPSC p=0.68, two-tailed t.). These data are summarized in Figure 3.16. 
 
3.2.5 Reduction in NMDA-EPSC amplitude in response to high frequency burst firing of 
excitatory afferents is also seen in Grin2D-null mice 
Given the change in the pharmacological properties of synaptic NMDARs in mice lacking the 
GluN2D subunit (Figures 3.3-3.8), activity dependent regulation of synaptic NMDARs was 
next explored. In Grin2D-null mice, where the IP was applied at -20 mV, there was a 
significant reduction in median single NMDAR-EPSC amplitude of 18.45 pA (Figure 3.17; 
p=0.0244*; paired two-tailed Wilcoxon; n=11). Additionally, there was significant reduction 
in median summated NMDAR-EPSC amplitude of 35.49 pA (Figure 3.18; p=0.0420*; paired 
two-tailed Wilcoxon; n=11). 
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There was no difference in the remaining NMDAR-EPSC proportion between the two IP 
treatment groups in wild type and Grin2D-null mice, in either single (Figure 3.19; p=0.58; 
two-tailed t-test) or summated EPSCs (p=0.54; two-tailed t-test) 
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Figure 3.13 – Summated NMDAR-EPSC amplitude is reduced following treatment by 
the IP at -20 mV in wild type mice 
Following a stable baseline period of NMDAR-EPSCs elicited at +40 mV, the induction 
paradigm (IP) was applied at -20 mV. A: An example experiment including before and after 
traces from a P19 Grin2D-WT mouse. Scale bar axes:  x=40 ms; y=50 pA. Each data point 
represents mean y values from each 100 s period. B: Summary data. In comparison to the pre-
IP period, mean summated NMDAR-EPSC amplitudes 1200-1500 seconds following the end 
of the IP were significantly reduced (p=0.0170*; paired two-tailed t-test; n=10). 
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Figure 3.14 – Summated NMDAR-EPSC amplitude remains stable where the IP is not 
applied, and where Ca2+ driving force is reduced 
A: Example recording from a P19 Grin2D-WT mouse: following a stable baseline period of 
summated NMDAR-EPSCs elicited at +40 mV, the holding potential was switched to -20 mV 
as in the treatment group, but no stimulation applied. Scale bar axes:  x=40 ms; y=50 pA. 
Each data point represents mean y values from each 100 s period. B: Summary data of these 
experiments: in comparison to the pre-IP period, mean summated NMDAR-EPSC amplitudes 
1200-1500 seconds following the end of the pseudo-IP were not reduced; n=11.  
C: Example recording from a P20 Grin2D-WT mouse: in this case the IP was applied, but the 
holding potential was not changed from +40 mV. Scale bar axes:  x=40 ms; y=30 pA. D: 
Summary data of these experiments: in comparison to the pre-IP period, mean summated 
NMDAR-EPSC amplitudes 1200-1500 seconds following the end of stimulation were not 
reduced; n=9.  
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Figure 3.15 – Summated NMDAR-EPSC amplitude is reduced by application of the 
induction paradigm 
Scatter plot showing the change in summated NMDAR-EPSC amplitude. The treatment group 
in which the IP was applied at -20 mV had a significantly reduced mean summated NMDAR-
EPSC amplitude after 1200-1500 s in comparison to the same time period from the control 
group, in which holding potential was changed to -20 mV but no stimulation applied 
(p<0.01**; ANOVA, Sidak post-hoc). The treatment group was also compared to the group in 
which the IP was applied at +40 mV, but this did not yield a significant result. 
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Figure 3.16 – Single and summated NMDAR-EPSC amplitudes are reduced following 
treatment by the IP at -20 mV along with intracellular Ca2+ chelation 
Single (A,B) and summated (C,D) NMDAR-EPSC data where the induction paradigm (IP) 
was applied at -20 mV, along with BAPTA (10 mM) in the patch pipette. A: Summary 
timecourse data. In comparison to the pre-IP period, mean single NMDAR-EPSC amplitudes 
1200-1500 seconds following the end of the IP were significantly reduced (p=0.020*; paired 
two-tailed t-test; n=6). B: Scatter plot showing change in single NMDAR-EPSC amplitude in 
the IP treatment groups with and without BAPTA: there was no significant difference 
between the two groups. C: Summary timecourse data. In comparison to the pre-IP period, 
mean summated NMDAR-EPSC amplitudes 1200-1500 seconds following the end of the IP 
were significantly reduced (p=0.037*; paired two-tailed t-test; n=6). D: Scatter plot showing 
change in summated NMDAR-EPSC amplitude in the IP treatment groups with and without 
BAPTA: there was no significant difference between the two groups. 
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Figure 3.17 – Single NMDAR-EPSC amplitude is reduced following treatment by the IP 
at -20 mV in Grin2D-null mice 
Following a stable baseline period of NMDAR-EPSCs elicited at +40 mV, the induction 
paradigm (IP) was applied at -20 mV. A: An example experiment including before and after 
traces from a P17 Grin2D-null mouse. Scale bar axes:  x=20 ms; y=50 pA. Each data point 
represents mean y values from each 100 s period. B: Summary data. In comparison to the pre-
IP period, mean single NMDAR-EPSC amplitudes 1200-1500 seconds following the end of 
the IP were significantly reduced (p=0.024*; paired two-tailed Wilcoxon; n=11). 
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Figure 3.18 – Summated NMDAR-EPSC amplitude is reduced following treatment by 
the IP at -20 mV in Grin2D-null mice 
Following a stable baseline period of NMDAR-EPSCs elicited at +40 mV, the induction 
paradigm (IP) was applied at -20 mV. A: An example experiment including before and after 
traces from a P17 Grin2D-null mouse. Scale bar axes:  x=40 ms; y=50 pA. Each data point 
represents mean y values from each 100 s period. B: Summary data. In comparison to the pre-
IP period, mean summated NMDAR-EPSC amplitudes 1200-1500 seconds following the end 
of the IP were significantly reduced (p=0.042*; paired two-tailed Wilcoxon; n=11). 
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Figure 3.19 – Regulation of both single and summated NMDAR-EPSCs is similar 
between wild type animals and those lacking GluN2D 
Scatter plots showing the change in single (A) and summated (B) NMDAR-EPSC amplitudes 
at 1200-1500 s following the IP, which was applied at -20 mV in wild type (n=10) and 
Grin2D-null (n=11) mice: there was no significant difference between the two in either case. 
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Figure 3.20 – Membrane resistance does not differ between wild type and Grin2D-null 
mice 
Scatter plot showing the membrane resistance measured at a holding potential of -60 mV in 
both wild type (n=10; C57 n=3, Grin2D-WT n=7) and Grin2D-null (n=4) mice. There was no 
difference in the means of the two groups. 
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3.2.6 Membrane resistance is equal in wild-type and Grin2D-null animals 
The membrane resistance (Rmemb) was recorded in a sample of SNc-DA cells at a holding 
potential of -60 mV using the value estimated by the HEKA Pulse software: the mean value 
was 810.5 ± 156.6 MΩ in wild-type mice (P17-21; n=10 [C57 n=3, Grin2D-WT n=7]), not 
significantly different from that in Grin2D-null mice, 677.3 ± 78.1 MΩ (P17-20; n=4) 
(Figure 3.20; p=0.615; two-tailed t-test). Additionally, within the wild type group the Rmemb 
of the C57 and Grin2D-WT animals did not significantly differ (p=0.37, two tailed t-test). 
 
3.2.7 NMDAR-paired pulse ratio alters slightly over time 
The NMDA paired pulse ratio (PPR) within each experiment was calculated as the amplitude 
of peak 2 divided by the amplitude of peak 1 (or p2/p1). Four pairs of EPSCs generated 20 s 
apart were therefore collected immediately before the onset of the patterned activity protocol 
and used to generate an average waveform and NMDAR-PPR: The pairs of EPSCs generated 
between 1200-1500 minutes following the cessation of the protocol were also averaged and 
the PPR compared to that from before the IP. Because NMDAR-EPSCs summate strongly (a 
postsynaptic effect of NMDAR channel kinetics), p2 amplitude is higher than p1, giving a 
PPR value greater than 1. A two-way ANOVA was performed on four IP groups, examining 
the effect of treatment group and time point (paired: pre-IP vs the 1200-1500 s time window). 
Time point had a significant (p=0.0048**) effect on PPR, with a mean increase from 1.659 ± 
0.067 to 1.763 ± 0.060; whereas treatment group was not significant, implying that PPR was 
likely to increase whether the IP was applied or not. These data are summarized in Figure 
3.21. 
 
3.2.8 Zero-current potential is increased with the use of BAPTA-containing intracellular 
solution 
The overall zero-current potential (VIzero) for SNc-DA cells was measured in the HEKA Pulse 
software by initiating current clamp mode at zero pA. In wild type animals, using the regular 
Cs+-based intracellular solution, VIzero was -8.25 ± 1.33 mV (age P17-21; n=16 [C57 n=5, 
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Grin2D-WT n=11]): this was significantly different to the value produced when 10 mM 
BAPTA was present in the intracellular solution, +11.3 ± 1.9 mV (age P17-20; n=5 [C57 n=3, 
Grin2D-WT n=2]) (Figure 3.22; p=0.0003***; two-tailed t). Additionally a comparison was 
performed in the basic Cs group, and the VIzero did not significantly differ based on the 
breeding background of the animals (p=0.15, two tailed t-test). 
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Figure 3.21 – NMDA-PPR alters slightly over time, but not between groups 
A: Paired data showing the NMDAR-paired pulse ratio (PPR) before the IP (or control 
pseudo-treatment) and at 1200-1500 s afterwards. There was no difference found between the 
groups, but the small increase in NMDAR-PPR at the end of the experiment was highly 
significant (p=0.0048**; paired two-factor ANOVA). B: Scatter plot showing the change in 
the NMDAR-PPR at 1200-1500s, showing more clearly that the means are above the 1.0, 
indicating a small change. 
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Figure 3.22 – VIzero is altered when BAPTA is added to the patch pipette 
The overall zero-current potential (VIzero) for each SNc-DA neuron was recorded in a group of 
wild type (C57 and Grin2D-WT) animals, both with (n=5) and without (n=16) BAPTA (10 
mM) present in the Cs+-based intracellular solution in the patch pipette. The presence of 
BAPTA significantly altered the mean VIzero value from -8.25 ± 1.33 mV to +11.3 ± 1.9 mV 
(p=0.0003***; two-tailed t). 
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3.3 The role of GluN2D and the NMDAR in responding to ambient glutamate 
3.3.1 Ambient extracellular glutamate in the SNc elicits NMDAR-mediated currents in 
dopamine neurons, which are unaffected by pharmacological inhibition of action 
potential firing 
Currents mediated via NMDARs by ambient extracellular glutamate were determined by 
applying a fast bath perfusion to the slice, obtaining a stable baseline current in picrotoxin (50 
µM) and glycine (10 µM), before applying the competitive NMDAR antagonist D-AP5 (50 
µM) and measuring the resulting deflection in current: example recordings are shown in 
Figure 3.23. In wild type mice, application of D-AP5 significantly reduced the baseline 
current from 214.1 ± 15.28 to 197.8 ± 15.07 pA (Figure 3.24A; p=0.0001***; n=19 [C57 
n=15, Grin2D-WT n=4]; paired two-tailed t). Additionally, the D-AP5-sensitive current did 
not significantly differ based on the breeding background of the animals (C57 vs Grin2D-WT) 
(p= 0.92; two-tailed t-test). 
In C57 mice, in the presence of TTX (100 nM) to block action potential-dependent glutamate 
release, application of D-AP5 again significantly reduced the baseline current from 165.3 ± 
22.2 pA to 149.0 ± 19.3 pA (Figure 3.24B; p=0.0180*; n=8; paired two-tailed t-test). There 
was no difference between the D-AP5 sensitive current without TTX; 16.32 ± 3.32 pA 
(n=19), vs. that with TTX 16.25 ± 5.29 pA (n=8) (Figure 3.25; p=0.9999; ANOVA, 
Dunnett’s Multiple Comparisons test: wild type, wild type +TTX, and Grin2D-null groups). 
In SNc-DA neurons from Grin2D-null mice, application of D-AP5 did not alter the amplitude 
of the current (Figure 3.24C; p=0.4057; n=15; paired two-tailed t). The pre-D-AP5 current 
was 200.5 ± 18.04 pA, and in D-AP5 was 197.7 ± 18.44 pA. There was a significant 
difference between the D-AP5-blockable current obtained in wild type mice 16.32 ± 3.32 pA 
(n=19) and that in Grin2D-null mice (Figure 3.25; 2.80 ± 3.26 pA; n=15; p=0.0148*; 
ANOVA, Dunnett’s Multiple Comparisons test). 
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Figure 3.23 – Example traces showing the D-AP5-sensitive current in wild type and 
Grin2D-null mice 
Example traces from SNc-DA neurons held at -50 mV, showing a typical alteration in 
baseline current resulting from the addition of 50 µM D-AP5 in a P20 C57 mouse (A), and a 
P19 Grin2D-null mouse (B). 
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Figure 3.24 – Baseline current is significantly decreased by inhibition of NMDARs in 
wild type but not Grin2D-null mice 
Paired data showing baseline currents at -50 mV in SNc-DA neurons, both before and after 
the addition of 50 µM D-AP5. A: Baseline current in D-AP5 was significantly reduced in wild 
type (C57 and Grin2D-WT) mice (p=0.0001***; paired two-tailed t). B: Baseline current in 
D-AP5 was also significantly reduced in C57 mice in the presence of voltage-gated sodium 
channel blocker TTX (p=0.0180*; paired two-tailed t). C: Baseline current in D-AP5 was not 
altered in Grin2D-null mice. 
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Figure 3.25 – D-AP5-sensitive current is significantly reduced in mice lacking GluN2D 
Scatter plot showing the amplitudes of D-AP5-sensitive currents measured in wild type mice 
(both with and without TTX) and Grin2D-null mice. The mean D-AP5-sensitive current was 
significantly lower in Grin2D-null (n=15) in comparison to wild type mice (n=10; C57 and 
Grin2D-WT; p=0.0148*, ANOVA, Dunnett post-hoc). There was no difference between the 
D-AP5 sensitive current with (n=8) vs. without TTX. 
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3.3.2 Ambient glutamate in the SNc is regulated by glutamate reuptake transporters 
Further experiments were performed in order to evaluate the role of glutamate reuptake in 
regulating tonic NMDAR activity: here a fast perfusion was applied to the slice, obtaining a 
stable baseline current in picrotoxin (50 µM) and glycine (10 µM), before applying the 
competitive glutamate transporter blocker TBOA (30 µM; Herman and Jahr 2007). In order to 
isolate the effects of transporter dysfunction only, the group II metabotropic glutamate 
receptor antagonist LY 341495 (‘LY’; 200 nM) was applied along with TBOA, in order to 
prevent modulation of presynaptic glutamate release in response to altered extracellular 
concentration (Wang et al. 2005; Wild et al., 2015). Following the deflection in current 
arising from TBOA+LY application, and once a plateau had been reached, the NMDAR 
blocker D-AP5 (50 µM) was then applied in the presence of TBOA+LY (Example wild type 
traces shown in Figure 3.26A). 
In wild type mice, Friedman analysis found there to be a significant difference between the 
current at baseline, with TBOA+LY, and then with D-AP5 (Figure 3.27A; p<0.0001****; 
n=26 [C57 n=10, Grin2D-WT n=5]). Application of TBOA+LY significantly increased the 
median baseline current (in picrotoxin and glycine) from 144.0 to 191.2 pA (p<0.0001****; 
Dunn post-hoc): the currents elicited by application of TBOA+LY were highly variable, and 
did not follow a normal distribution. Addition of D-AP5 then significantly reduced this 
current to 153.1 pA (p<0.001***; Dunn post-hoc). The baseline current did not significantly 
differ from the TBOA+LY+D-AP5 final current. 
TBOA and LY were also applied in Grin2D-null mice, as above (Example trace shown in 
Figure 3.26B). Here, ANOVA found there to be a significant difference between the current 
at baseline, that with TBOA+LY, and that with D-AP5 (Figure 3.27B; p=0.0072**; n=15). 
Application of TBOA+LY significantly increased the baseline current from 195.8 ± 16.3 to 
215.5 ± 18.3 pA (p<0.05*; Tukey post-hoc): here, the currents elicited by application of 
TBOA+LY were much less variable than those in those in wild type animals. The addition of 
D-AP5 then significantly reduced this current to 197.3 ± 16.23 pA (p<0.05*; Tukey post-
hoc). The baseline current did not significantly differ from the TBOA+LY+D-AP5 final 
current.  
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Figure 3.26 – Example traces showing the effect of glutamate transporter blockade on 
baseline current in wild type and Grin2D-null mice 
Example traces from SNc-DA neurons held at -50 mV, showing an alteration in baseline 
current resulting from the addition of competitive glutamate transporter blocker TBOA (30 
µM) and group II metabotropic glutamate receptor antagonist LY 341495 (200 nM), before 
blocking NMDARs by application of D-AP5 (50 µM). Desensitisation is not measured in 
these examples, hence the fast addition of DAP5. Trace A is from a P20 Grin2D-WT mouse, 
and trace B is from a P19 Grin2D-null mouse.  
100 pA
200 s
TBOA + LY
200 s
100 pA
TBOA + LY
D-AP5
D-AP5
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Figure 3.27 – Baseline current is significantly increased by addition of TBOA and LY in 
both wild type and Grin2D-null mice 
Paired data showing baseline currents at -50 mV in SNc-DA neurons, at three time points: (1) 
baseline (picrotoxin and glycine only); (2) peak current following addition of competitive 
glutamate transporter blocker TBOA (30 µM) and group II metabotropic glutamate receptor 
antagonist LY 341495 (200 nM); and then (3) after addition of D-AP5 (50 µM). A: There was 
a highly significant difference between groups 1-2 (p<0.0001****) and 2-3 (p<0.001***; 
Friedman, Dunn post-hoc) in wild type mice (n=26; C57 and Grin2D-WT). B: There was also 
a significant difference between groups 1-2 (p=0.0072**) and 2-3 (p<0.05*; ANOVA, Tukey 
post-hoc) in Grin2D-null mice (n=15). 
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Figure 3.28 – The D-AP5-sensitive element of TBOA/LY-induced current is significantly 
reduced in mice lacking GluN2D 
A: Scatter plot showing the peak amplitudes of TBOA/LY-elicited increases in current in both 
wild type (n=26; C57 and Grin2D-WT) and Grin2D-null mice (n=15). There was no 
significant difference between the two groups. B: Scatter plot showing the D-AP5-sensitive 
portions of the currents plotted in A. In this case there was a significant difference between 
wild type and Grin2D-null mice (p=0.0104*; two-tailed Mann-Whitney U). 
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The deflection in baseline current induced by the addition of TBOA+LY (current in 
TBOA+LY, minus baseline current) can be compared between wild type and Grin2D-null 
mice: there was no difference in this current (Figure 3.28A; p=0.119, two-tailed Mann-
Whitney U), with 27.6 pA in wild type and 17.0 pA in Grin2D-null. Additionally, a 
comparison was performed within the wild type group: the TBOA+LY-induced deflection in 
current did not significantly differ based on the breeding background of the animals (p=0.892, 
two-tailed Mann-Whitney U). 
 
We can also compare the D-AP5-blockable (IE NMDAR-mediated) portion of the total 
current in TBOA+LY, between genotypes. Here, in wild type mice, the median D-AP5-
blockable portion of total current in TBOA+LY was 32.6 pA (n=26), significantly higher than 
the 8.2 pA observed in Grin2D-null mice (n=15) (Figure 3.28B; p=0.0104*; two-tailed 
Mann-Whitney U). Additionally, a comparison was performed within the wild type group: the 
TBOA+LY-induced deflection in current did not significantly differ based on the breeding 
background of the animals (p= 0.85, two-tailed Mann-Whitney U). 
 
3.4 Bath application of NMDA elicits larger currents in Grin2D-null mice in 
comparison to wild type at very high concentrations only 
Here, dose-response data were obtained by applying NMDA to the bath perfusion, in order to 
evaluate the current amplitudes elicited by wild type and Grin2D-null mice. A fast perfusion 
was applied to the slice, obtaining a stable baseline current in picrotoxin (50 µM) glycine (10 
µM), and TTX (100 nM) before applying NMDA at one of several concentrations: 0.001, 
0.01, 0.0316, 0.1, 1, or 10 mM; example responses are shown in Figure 3.29. 
Resulting peak current values were subtracted from baseline and normalised to cell 
capacitance. Nonlinear regression was used to analyse the dose-response data in wild type 
(total n=23 [C57 n=4, Grin2D-WT n=19] from 22 different animals; age range P18-21) and 
Grin2D-null mice (total n=37; age range P17-21).  The data were plotted using a logarithmic 
x axis, and the least squares (ordinary) fit method used in Graphpad Prism 7.03 to fit an 
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[agonist] vs response curve to each dataset (Figure 3.30). The curves clearly separated at the 
high concentrations, and therefore the extra sum-of-squares F test was next used in order to 
compare the upper curve plateaus, as well concurrently comparing the EC50 values: the 
analysis returned the result both parameters were significantly different (Figure 3.30; 
p=0.0374*). The top of the wild-type curve peaked at 52.82 ± 4.15 pA/pF, whereas the top of 
the Grin2D-null curve peaked at 68.64 ± 4.45 pA/pF. The wild-type EC50 value was 0.091 ± 
0.037 mM, whereas the Grin2D-null EC50 value was 0.178 ± 0.057 mM. 
With agonist application, a peak inward current will be reached, followed by a period of 
NMDAR desensitisation (Colquhoun et al. 1992; Meyerson et al. 2014), which can be 
measured once a plateau is reached (Figure 3.31A). NMDAR desensitisation was recorded 
from the experiments above where the highest 10 mM concentration of NMDA was applied: 
in Grin2D-WT mice, mean desensitisation was 55.2 ± 3.2 % of peak current, significantly less 
than the 72.4 ± 3.10 % desensitisation recorded in Grin2D-null mice (Figure 3.31B; 
p=0.0068**; two-tailed t-test). 
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Figure 3.29 – Example traces showing currents elicited by bath applications of NMDA in 
wild type and Grin2D-null mice 
Example traces from SNc-DA neurons from approximately three week-old mice, showing 
typical alterations in baseline current resulting from the addition of NMDA at 0.1, 1, and 10 
mM concentrations. Scales matched for comparison based on genotype; note the difference in 
scale bars based on [NMDA]. A: Grin2D-WT, 0.1 mM NMDA; B: Grin2D-null, 0.1 mM 
NMDA. C: C57, 1 mM NMDA; D: Grin2D-null, 1 mM NMDA. E: Grin2D-WT, 10 mM 
NMDA; F: Grin2D-null, 10 mM NMDA. 
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Figure 3.30 – Currents elicited by application of saturating concentrations of NMDA are 
significantly larger in mice lacking GluN2D 
[Agonist] vs response curves showing data obtained at various NMDA concentrations 
increasing along a logarithmic scale from 1 µM to 10 mM, from wild type (total n=23 [C57 
n=4, Grin2D-WT n=19] from 22 different animals) and Grin2D-null mice (total n=37). The 
tops of the curves separated, with significantly larger currents elicited at peak agonist 
concentrations in Grin2D-null mice in comparison to wild type, as well as a higher resulting 
EC50 value in Grin2D-null mice (p=0.0374*; extra sum-of-squares F test; both parameters 
concurrently analysed). 
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Figure 3.31 – NDMAR desensitisation is significantly increased in mice lacking GluN2D 
A: Example trace from a P21 Grin2D-WT mouse showing NMDAR desensitisation with 
sustained application of 10 mM NMDA. Here, D-AP5 was not applied until a stable plateau 
was reached. B: Scatter plot showing desensitisation as a percentage of total NMDA-elicited 
current, which was significantly higher in Grin2D-null mice in comparison to Grin2D-WT 
mice (p=0.0068**; two-tailed t-test). 
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3.5 Hypoxic conditions cause significant but comparable cell death in both wild 
type and Grin2D-null mice 
As above, NMDA-evoked currents were larger in Grin2D-null mice only at very high agonist 
concentrations, indicating that GluN2D limits cation influx at maximum NMDAR saturation. 
This was interesting because under conditions of hypoxia, the open probability of GluN2D-
containing NMDARs has been shown to decrease, thereby also reducing total current flow 
(Bickler et al. 2003). The presence of whole-cell currents being altered in SNc-DA neurons by 
removal of the GluN2D subunit may indicate that a practical hypoxia resistance could be 
conferred by the presence of GluN2D, and an assay was therefore developed to explore 
cellular viability in acute slices from mice aged P28-48 in combination with fluorescent 
staining of dopaminergic neurons. 
Horizontal slices through the substantia nigra region were carefully made at a thickness of 
100 µm. For each slice produced, a cut was made along the midline and one hemisphere 
randomly assigned to a high oxygen (normoxic) treatment group, and one to a hypoxic 
treatment group. Following a 40 minute recovery in normoxic conditions (gassed with 95% 
O2 / 5% CO2) slices in both groups were transferred to new Gibb chambers for a 40 minute 
treatment period: the normoxic group to a new chamber gassed again with 95% O2 / 5% CO2, 
and the hypoxic group to a chamber gassed with 15% O2 / 80% N2 / 5% CO2. The slices in 
both groups were then carefully transferred back to their original, separate normoxic 
chambers, and fluorescent nuclear stain propidium iodide (PI; 20 mM) added to the chamber. 
PI is actively removed from living cells (Lossi 2009; Tasca et al. 2015). After 20 minutes, all 
slices were briefly and gently washed twice in Krebs buffer, before being stored in darkness 
in glass vials containing 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). 
After subsequent washing and blocking / permeation stages, all slices were fluorescently 
labeled for tyrosine hyrdoxylase (TH) in order to visualize dopaminergic cells (Figure 3.32). 
To obtain the data, the SNc region was visually identified by proximity to MT, and the whole 
region scanned systematically in order to count all TH+ cells. For each TH+ cell observed, the 
wavelength of the light was switched to the excitation frequency of PI, in order that the PI 
status of each cell could be recorded. 
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Each animal contributed an n of 1 to each of the normoxic and hypoxic groups (and therefore 
allowed the data to be paired). Each n consists of the percentage value of TH+ cells which are 
co-stained with PI from all the TH+ cells within the slice hemispheres of that group, for that 
animal. In C57 mice (n=7; mean age P41.0), and applying the normoxic treatment, 50.9 ± 6.9 
% of TH+ cells were stained with PI. In hypoxia-treated slices from the same animals, this 
value was 79.3 ± 3.6 %. In Grin2D-null animals (n=7; mean age P35.1), applying the 
normoxic treatment, 54.2 ± 2.3 % of TH+ cells were stained with PI. In hypoxia-treated 
slices, this value was 73.1 ± 3.3 %. 
 
A repeated measures 2-way ANOVA was performed on all the data, comparing the 
interactions between genotype and oxygenation status, and pairing the normoxic and hypoxic 
result from each animal. The effect of oxygenation status was found to be highly significant 
(Figure 3.32A; overall p<0.0001****: post-hoc reports p<0.0001**** in WT (C57), and 
p<0.01** in Grin2D-null, Sidak) whereas there was no effect resulting from genotype 
(p=0.789). The mean number of TH+ cells recorded within the SNc region of each 100 µm 
slice was also analysed. There was a mean of 12.0 ± 2.7 TH+ cells per slice in normoxic 
conditions (n=14), and 11.8 ± 0.82 per slice in hypoxic conditions (n=14), as shown in Figure 
3.32B. A repeated measures 2-way ANOVA was performed on the data: there were no 
interactions affecting TH+ cells per slice based on either oxygen status (p=0.88) or genotype 
(10.1 ± 0.9 per slice for WT (C57), and 13.6 ± 1.3 for Grin2D-null; p=0.068). 
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Figure 3.32 – Example fluorescent images from mouse brain slices after high and low 
oxygen incubations 
Example immunofluorescence images showing tyrosine hydroxylase (TH) staining, green; 
and propidium iodide (PI) viability assay staining, red; in both ‘normoxic’ (95% O2 / 5% CO2, 
for 40 minutes; above) and ‘hypoxic’ (15% O2 / 5% CO2 / 80% N2, for 40 minutes; below) 
treatment groups. Arrows indicate example cells which together demonstrate the specificity of 
the labeling. 
  
Normoxic treatment
Hypoxic treatment
TH PI combined
TH PI combined
25 μm
25 μm 25 μm
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Figure 3.32 – Hypoxic conditions cause significant but comparable cell death in both 
wild type and Grin2D-null mice 
Paired scatter plots showing the percentage of tyrosine hydroxylase-positive (TH+) cells 
which were also positive for cell death marker propidium iodide (PI) in both ‘normoxic’ (95% 
O2 / 5% CO2, for 40 minutes; above) and ‘hypoxic’ (15% O2 / 5% CO2 / 80% N2, for 40 
minutes; below) treatment groups. The effect of oxygenation status was highly significant 
(p<0.0001****, two factor ANOVA), but there was no difference based on genotype. 
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Figure 3.33 – The hypoxic treatment does not cause a change in the number of 
detectable TH+ neurons 
Scatter plot (WT and Grin2D-null data combined) showing the number of tyrosine 
hydroxylase-positive (TH+) cells observable within the SNc region of each 100 µM-thick 
slice: there were no differences based on either oxygen status or genotype. There was a mean 
of 12.0 ± 2.7 TH+ cells per slice following normoxic treatment (n=14), and a mean of 11.8 ± 
0.82 TH+ cells per slice following hypoxic treatment (n=14). 
 
  
  
 
 
 
CHAPTER 4 
 
DISCUSSION 
  
Chapter 4 – Discussion 
 
128 
 
Chapter 4 – Discussion 
 
129 
 
4 Discussion 
The focus of this thesis was to investigate the expression of functional NMDARs in SNc-DA 
neurons, as well as how the GluN2D subunit within NMDARs expressed either synaptically 
or across the neuronal surface may allow the neuron to react to various potentially excitotoxic 
conditions such as inhibited glutamate reuptake, increased excitatory burst input, and 
hypoxia-ischemia. To achieve this, whole-cell patch clamp electrophysiology was used in 
acute mouse brain slices, as well as cell viability assaying and immunofluorescent staining. 
The role of GluN2D has not been extensively studied, and as expression of this subunit can be 
removed with only relatively minor phenotypic effects, its role in SNc-DA neurons was able 
to be explored by comparing data from wild type and Grin2D-null animals. Firstly, functional 
synaptic NMDAR expression was examined using presynaptic stimulation along with 
pharmacological intervention. 
4.1 Characterisation of synaptic NMDARs in SNc-DA neurons of Grin2D-null 
mice 
Results from pharmacological intervention into glutamatergic synaptic transmission onto 
SNc-DA neurons showed that genetically engineered mice lacking expression of the GluN2D 
subunit likely had a different synaptic NMDAR subunit profile to wild type animals. The 
data, discussed below, suggested that wild type animals had a lower proportion of NMDAR 
current mediated by GluN2B, as well as a higher proportion mediated by GluN2D, in 
comparison to the Grin2D-null animals, highlighting a functional role of GluN2D at 
glutamatergic synapses onto SNc-DA neurons. 
4.1.1 Constitutive NMDAR expression at Grin2D-null synapses 
Removal of the GluN2D subunit is a useful tool for exploring its role in SNc-DA neurons. In 
order to evaluate whether overall synaptic NMDAR expression is altered in the genetically 
modified animals, AMPAR/NMDAR current ratios (A/N ratios) were measured. The A/N 
ratio is appropriate as it is not possible to elucidate the number of synapses activated by the 
stimulating electrode, and of course this will differ in each experiment. Therefore, the 
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amplitude of the current through NMDARs compared to AMPARs is much more useful, as 
the expression of AMPARs should not be altered in Grin2D-null mice. 
Development during the age ranges tested is not a basic consistent alteration of either 
NMDAR or AMPAR number: rather, both are altered concurrently over time (Wu et al. 1996; 
Petralia et al. 1999). There is therefore no linear relationship between A/N and age, and only 
results within the same age group can be compared by genotype. However, across the ages, 
genotype did not have an effect on the A/N ratio value, which indicates that removal of the 
GluN2D subunit does not alter the amplitude of the current passing through synaptic 
NMDARs, and it is therefore likely that constitutive expression at the synapse remained 
unaltered in Grin2D-null mice. This result initially suggests that GluN2D is either being 
replaced by another GluN2 subunit within the receptor, or is not present at the synapse (or is 
present only in small numbers). To investigate this further, subunit-specific pharmacological 
inhibition was applied to synaptic NMDAR-EPSCs. 
 
4.1.2 Altered properties of synaptic NMDARs in Grin2D-null mice 
Pharmacological inhibition data was obtained using GluN2B-preferring inhibitor ifenprodil 
and measuring its effect on synaptic NMDAR-EPSCs. Ifenprodil is an ideal compound to use 
in SNc-DA neurons in which the only present GluN2 subunits are likely to be GluN2B and 
GluN2D (Brothwell et al. 2008), as its affinity for GluN2D is the lowest of any of the 
subunits with an IC50 of 76 µM, whereas the IC50 for GluN2B is just 0.1 µM (Hess et al. 
1998). Results showed that in both P7 and P21 mice there was a significantly greater 
percentage inhibition of NMDAR-EPSCs in Grin2D-null mice in comparison to wild type: 
this suggests that in mice lacking the GluN2D subunit, GluN2D is replaced by GluN2B 
within the NMDAR. If triheteromeric GluN1/GluN2B/GluN2D NMDARs are expressed at 
synapses onto SNc-DA neurons in wild type mice, it appears likely that they are replaced with 
diheteromeric GluN1/GluN2B receptors in Grin2D-null mice. The increase in ifenprodil 
inhibition in Grin2D-null mice compared to wild type was approximately 16 % at both age 
groups, and it is possible that this difference accounts for the proportion of GluN2D-mediated 
synaptic current in wild type animals. 
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There was a trend of decreasing inhibition of GluN2B by ifenprodil in the two P21 age 
groups, in comparison to those at P7. This suggests that there is a smaller percentage of 
GluN2B at the synapse in the older mice, consistent with earlier reports of a developmental 
decrease in diheteromeric GluN1/GluN2B NMDARs in SNc-DA neurons and potentially 
moving to the triheteromeric GluN1/GluN2B/GluN2D configuration with development 
(Brothwell et al. 2008): ifenprodil may have a less powerful inhibitory effect on 
triheteromeric NMDARs which also contain GluN2D, in comparison to GluN1/GluN2B 
diheteromers. 
Application of GluN2D-preferring inhibitor DQP-1105 gave a small inhibition which was 
significantly larger in both P7 and P21 wild type in comparison to Grin2D-null animals. This 
suggests that GluN2D is present at the synapse at both age groups. However, the comparisons 
based on genotype were close to the p=0.05 threshold for significance: because the inhibition 
by DQP is low (as a percentage of the total NMDAR-mediated current) this makes it more 
difficult to detect a difference in inhibition based on genotype, especially considering the 
inherent variability in EPSC amplitudes. However, the differences in inhibition based on 
genotype were around 15 % at P7 and 9 % at P21, close to the 16 % difference based on 
genotype in the ifenprodil experiments above. As argued above, the smaller percentage 
inhibition at P21 may be caused by DQP having a less powerful inhibitory effect on 
triheteromeric NMDARs which also contain GluN2B, in comparison to GluN1/GluN2D 
diheteromers.  
Overall, in the mice lacking GluN2D, there was significantly less inhibition by DQP, and 
significantly more inhibition of GluN2B by ifenprodil: together this suggests that GluN2D is 
present at the synapse in wild type mice, and that in Grin2D-null animals the GluN2D subunit 
is replaced by GluN2B within synaptic NMDARs. 
NMDAR-EPSC decay time constants did not differ between genotypes which may imply that 
GluN2D does not make up a large proportion of synaptic NMDAR currents under the above 
conditions; something which is supported by the relatively small but concrete difference in 
ifenprodil sensitivities. 
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4.2 Activity-dependent regulation of NMDA receptors 
The effects of burst firing of glutamatergic afferents onto SNc-DA neurons were explored in 
this thesis: in summary, results showed a downregulation of NMDAR-mediated synaptic 
currents. This downregulation, discussed in detail below, only occurred if the burst protocol 
was applied at a holding potential of -20 mV, and only if the stimulation was applied whilst 
holding at this potential. The downregulation may possibly have a Ca2+-dependent 
component, as holding at +40 mV to dissuade cation influx prevented the effect, whilst Ca2+ 
chelation did not. Summated NMDAR-mediated currents, which may also include 
perisynaptic or extrasynaptic receptors, were depressed in a similar fashion, though 
significantly less so, potentially indicating differential regulation of these NMDAR 
populations, or a presynaptic effect. The GluN2D subunit appears not to have any key role in 
the observed regulation, as Grin2D-null animals displayed a matching effect. 
 
4.2.1 Reduction in NMDA-EPSC amplitude in response to high frequency burst firing of 
excitatory afferents 
Glutamatergic synapses in general can be potentiated or depressed by various presynaptic 
stimulation patterns, often through NMDAR-mediated alteration of synaptic AMPARs 
(Montgomery et al. 2005). However, both long-term potentiation (LTP) and long-term 
depression (LTD) of NMDAR-mediated currents can also be induced by presynaptic activity 
(Montgomery et al. 2005; Harnett et al. 2009; Hunt and Castillo 2012). A paradigm was used 
which is similar to another previously applied to neurons in the calyx of held synapse (Joshi et 
al. 2007), where it elicited downregulation of NMDAR-EPSC amplitudes. The paradigm, 
stimulating glutamatergic afferents onto SNc-DA neurons, was one of high frequency burst 
firing (100 Hz x 3, every 1 s for 60 s). These afferents originating from the STN increase their 
firing in PD, and burst firing frequency is close to 100 Hz, and so was logical paradigm to 
adopt to apply to SNc-DA neurons which are characteristically lost in this disease, and indeed 
to measure any changes in NMDAR-mediated currents. Excessive Ca2+ influx through 
NMDARs is implicated in excitotoxicity through activation of cell death signalling pathways 
(Choi 1987; Hardingham and Bading 2010; Surmeier et al. 2010, 2011), and the increased 
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NMDAR activity occurring as a result of increased burst firing input may also promote cell 
death (Dong et al. 2009). 
The 20-25 minute timeframe (1200-1500 s) was originally selected as being enough for longer 
term modulatory effects to take place: in the large auditory synapse, depression of NMDAR-
EPSCs was pronounced at 20 minutes (Joshi et al. 2007). The results presented in this thesis 
showed that there was a significant reduction in NMDAR-EPSC amplitudes 1200-1500 s 
following the IP in wild type animals. No such downregulation was observed in the control 
group in which the holding current was switched to -20 mV (as it is in the treatment group) 
but no stimulation applied, and indeed NMDAR-EPSC amplitudes following the IP in the 
wild type treatment group were significantly depressed in comparison to this control group, 
indicating that the observed reduction is in response to the stimulation provided within the IP 
at -20 mV. This downregulation is a process which may occur by the binding of regulatory 
molecules to one or more subunits, and as the above synaptic pharmacology data supports the 
presence of GluN2D at synapses on SNc-DA neurons its potential role of in this regulation 
was next explored. 
Mice lacking the GluN2D subunit displayed a similar reduction in NMDAR-EPSC amplitude 
in response to the IP: the lack of the GluN2D subunit did not affect this form of activity-
dependent regulation, as there was no difference between the data in wild type and Grin2D-
null animals. Therefore the GluN2D subunit is unlikely to be involved in the mechanism by 
which activity-dependent regulation takes place at glutamatergic synapses on SNc-DA 
neurons. 
A holding potential of +40 mV was chosen for recording the assaying pulses in all 
experiments where afferent fibres were activated using a stimulating electrode, as there is a 
decreased NMDAR magnesium blockade at this potential. Additionally, the driving force on 
Ca2+ ions is reduced and there is therefore less likelihood of activating Ca2+-dependent 
regulatory mechanisms. In the activity dependent regulation experiments it was deemed 
sensible to also perform a control in which the IP was applied as in the regular treatment 
group, except that the holding potential remained +40 mV, rather than moving to -20 mV. In 
this group there was no significant downregulation, suggesting that Ca2+ influx is reduced 
enough at +40 mV to prevent a significant effect on NMDAR regulation: indeed, the assaying 
pulses are applied at a lower frequency; a single pulse every 10 s or a 50 Hz burst every 20 s, 
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as opposed to a 100 Hz burst every 1 s. Therefore applying assaying pulses where the 
postsynaptic cell is held at +40 mV are unlikely to lead to significant NMDAR regulation. 
A specific Ca2+ influx profile can be essential for plasticity to occur: high frequency burst 
firing activity has previously been found in the hippocampus to induce either LTP or LTD of 
NMDAR-EPSCs, depending on intracellular Ca2+ conditions (Harney and Anwyl 2012). Low 
Ca2+ buffering allowed NMDAR-LTP to occur using 200 Hz HFS, whereas increasing this 
buffering caused depression of NMDAR-EPSCs. The results in this thesis showed that in 
SNc-DA neurons where the IP was applied at -20 mV along with a high concentration of fast 
Ca2+ chelator BAPTA (10 mM) present in the patch pipette, there was a significant 
downregulation of NMDAR-EPSCs similar to that observed in the normal wild type IP 
treatment group. The equilibrium potential of Ca2+ is +150 mV, and therefore a much stronger 
inhibition of Ca2+ activity may be expected by BAPTA than by simply holding at +40 mV; 
yet as above, holding at +40 whilst applying the IP appeared to inhibit the activity dependent 
reduction in NMDAR-EPSC amplitude. One reason BAPTA may fail to reduce the effect of 
the IP because it does not diffuse far enough away from the soma to effectively buffer Ca2+ at 
more distal synapses. Additionally, the reason that holding at +40 mV during the IP inhibits 
downregulation may be due to a consequent reduction in the initial spike in Ca2+ 
concentration required by low affinity kinases to effect synaptic plasticity, though high 
transient spikes in [Ca2+] most often lead to potentiation, rather than depression (Lüscher and 
Malenka 2012). The initial spike in [Ca2+] will be higher at -20 mV, and it is possible that 
BAPTA is not fast enough at chelating the Ca2+ moving into the cell to prevent a high initial 
peak: some, but not all of it is likely to be chelated quickly, but that which does not come into 
contact with BAPTA immediately may still bind to its target molecule. To make a final 
conclusion on the role of Ca2+ in the activity-dependent NMDAR regulation observed here, it 
may be prudent to repeat the WT IP -20 mV treatment group with Ba2+  replacing Ca2+ in the 
perfused Ringer solution, as well as the intracellular solution, in order to inhibit calcium-
dependent regulatory processes; or potentially using an increased BAPTA concentration. 
Intracellular BAPTA (10 mM) caused a change in the mean potential of the neurons at which 
there was zero net current (VIzero) of 19.55 mV; from -8.25 to +11.3 mV. A decrease in 
intracellular [Ca2+] may cause an increase in overall VIzero due to a combination of an increase 
in the Ca2+ reversal potential, and an inhibition of the persistent inward Na+ current (INaP) at 
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depolarised potentials: INaP is involved in the generation of natural rhythmic burst firing 
activity in STN neurons (Darbon et al. 2004), and is mediated via TTX-sensitive voltage-
gated sodium channels (though INaP–mediating channels are distinct from those underlying the 
upward stroke of the action potential). Previous work has shown that INaP channels require a 
minimum concentration of intracellular Ca2+ in order to properly function, and that the 
currents mediated by them are therefore eliminated by high BAPTA in neocortical neurons 
(Schwindt et al. 1992). Altering INaP and therefore excitability is unlikely to affect the data 
obtained here in those recordings made with BAPTA, as the purpose was to limit intracellular 
Ca2+ and measure NMDAR regulation, rather than measure neuronal excitability or firing; and 
in any case a distinct effect on NMDAR regulation was not observed with the addition of 
BAPTA. 
The paradigm used in this thesis is similar to another previously applied to neurons in the 
calyx of held synapse (Joshi et al. 2007), where it elicited a reduction in NMDAR-EPSC 
amplitude, likely through a mechanism whereby NMDARs are removed from the 
postsynaptic membrane in order to increase temporal fidelity at this synapse, thereby enabling 
functional auditory signal processing. Whilst NMDAR-EPSCs are similarly depressed by 
high frequency stimulation in SNc-DA neurons as shown here, the reason for downregulation 
is likely to differ from that applicable in the calyx of held. One reason is neuroprotection: a 
downregulation in NMDAR activity in response to an upward shift in input burst firing 
activity would be a mechanism for limiting the amount of Ca2+ influx such that it does not 
lead to toxicity. Another similar but distinct ‘motive’ for downregulation of NMDAR activity 
in this scenario is to limit excitability of SNc-DA neurons such that they do not modulate into 
their burst firing phase for too long in response to sustained high frequency input. 
Other paradigms similar to that used in this thesis (IE stimulation of glutamatergic afferents at 
100 Hz in some configuration) have also been shown to cause depression of synaptic 
NMDAR activity in neurons of the nucleus accumbens (GluN2A-mediated; Chergui, 2011; 
Kombian and Malenka, 1994); and, conversely, potentiation of synaptic NMDAR activity in 
neurons of the hippocampus (Scaffer-CA1; Bashir et al. 1991; Berretta et al. 1991; Grosshans 
et al. 2002) and amygdala (Gean et al. 1993; Hunt and Castillo 2012), demonstrating that the 
effect of high intensity glutamatergic input is highly dependent on tissue type, as well as 
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various other factors such as NMDAR subunit profile, mGluR activation, and downstream 
signalling profile which may be distinct by neuron type (Hunt and Castillo 2012). 
Other work in SNc-DA and VTA neurons found that high frequency presynaptic stimulation 
(70 stimuli at 50 Hz) can result in LTP of synaptic NMDAR-EPSCs when applied with burst 
firing in the postsynaptic neuron (five APs at 20 Hz; Harnett et al. 2009a). Conversely, 
presynaptic stimulation alone caused a small but significant LTD of NMDAR-EPSCs. The 
authors also found that a larger depression of NMDAR EPSCs was induced when the burst 
was applied preceding (by 250 ms) the applied synaptic stimulation. However, the authors did 
not differentiate between VTA and SNc dopaminergic neurons. In the results presented in this 
thesis, the induction paradigm caused a depression of NMDAR-EPSCs amplitudes which was 
dependent on the presence of high frequency presynaptic bust firing, and in this case a 
depolarised holding potential of -20 mV was also required for the depression to occur: whilst 
postsynaptic firing was not elicited, this depolarised holding potential was applied before (2-5 
s) before initiation of high frequency presynaptic burst stimulation, and sustained throughout. 
Additionally, in the work presented here the assaying NMDAR-EPSCs were elicited using 
physiological [Mg2+] (1 mM), but at +40 mV to relieve Mg2+ block. The Harnett study used 
low [Mg2+] (0.1 mM) at a resting holding potential of -62 mV, and it is therefore possible that 
one or more of these factors (along with the different stimulation frequency) may contribute 
to a different response. 
It would be of interest to ascertain whether the form of synaptic NMDAR downregulation 
observed here is due to internalisation. Both AMPA and NMDA downregulation in the 
hippocampus have been shown to be due to internalisation via dynamin-dependent 
endocytosis (Carroll et al. 1999; Lau and Zukin 2007), and NMDAR downregulation in the 
Calyx of Held is both Ca2+- and dynamin-dependent (Joshi et al. 2007). In SNc-DA neurons, 
NMDAR ‘rundown’ elicited by repeated application of NMDA via perfusion has previously 
been found to be Ca2+ and dynamin dependent (Wild et al. 2014): however, there was also 
rundown in an ifenprodil-insensitive portion of the current, potentially mediated by GluN2D-
containg NMDARs, which was not Ca2+-dependent. 
The key result here with regards to activity dependent synaptic regulation is that NDMAR-
EPSC amplitude was significantly reduced in the wild type and Grin2D-null treatment groups 
in comparison to the control group in which holding potential was moved to -20 mV and no 
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stimulation applied. Therefore is possible to draw the conclusion that the application of high 
frequency burst stimulation (at a depolarized potential of -20 mV, as it is here) was the cause 
of the reduction, and that GluN2D is not involved. 
 
4.2.2 Summated NMDA-EPSC amplitudes were also reduced in response to high 
frequency burst firing of excitatory afferents 
Summated assaying EPSCs were elicited along with single EPSCs within each experiment 
because some perisynaptic NMDARs are likely to be recruited as a result of trains of stimuli 
applied to glutamatergic fibres onto SNc-DA neurons (Wild et al. 2015), and this was 
therefore a method to determine if perisynaptic NMDARs were being differentially regulated 
compared with synaptic NMDARs, and/or whether significant differences arise due to the 
removal of GluN2D when perisynaptic NMDARs are additionally stimulated. For example, if 
there is a difference in the number of GluN2D-containing NMDARs at the synapse vs. the 
peri/extrasynaptic zones, there may be a difference in regulation if either GluN2B or GluN2D 
is essential to that regulation. In the Joshi et al. study at the calyx of held, synaptic NMDAR-
EPSCs remained stable whilst summated responses were depressed, which may suggest that 
perisynaptic or extrasynaptic NMDARs activated by glutamate spillover were being 
preferentially downregulated (Joshi et al. 2007). However, the giant calyx synapse is very 
different morphologically in comparison to typical small CNS synapses which may lead to 
different transmitter release and spillover profiles and, an indeed NMDAR configurations and 
downstream signalling processes. 
Overall, summated NMDAR-EPSCs showed a similar pattern of regulation to single EPSCs. 
However, the proportional changes observed in both single and summated EPSCs were 
recorded within the same experiment, and so this allows pairing of the data: this led to the 
observation that there is in fact a small but highly significant difference in regulation between 
these two measures. The results showed that single (synaptic) EPSCs at the 1200-1500 s time 
period were smaller, proportionally, than summated EPSCs, when normalised to their pre-IP 
amplitude. That this difference in proportional regulation is small would be expected given 
the fact that the same synaptic population of NMARs may compromise much of the peak 
current (Wild et al. 2015). 
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There are several possibilities why this occurs. Firstly, it was observed that in post-hoc 
comparison that there was no difference in this effect between the treatment groups: that is, 
there is a significant difference between regulation of single and summated responses, but 
treatment has no significant effect on this difference. This suggests that the overall effect here 
is not a result of the IP, but some other factor. An interesting result which may explain this 
was that the NMDAR paired pulse ratio also slightly increased over the course of the 
experiment, regardless of the treatment group: this means that there is an increase in 
summation, which could be caused by several factors. Firstly, this would occur if the synaptic 
population of NMDARs were being preferentially downregulated in comparison to those 
additionally activated by a second pulse, or indeed trains of stimuli. Secondly, this could also 
occur if NMDARs were being recruited into the perisynaptic zone. Thirdly, it may be a 
presynaptic factor: potentially, an increase in the probability of vesicular glutamate release 
(Pves) at the second (and subsequent) stimulus in the train, which could occur due to a 
decreased capacity for presynaptic Ca2+ clearance (Scullin et al. 2012). Lastly, the increase in 
PPR and summation may be due to increased glutamate spillover from the synapse over the 
course of the experiment due to decreased GluT function. The multitude of possibilities for 
the change in NMDAR-PPR and therefore the difference in normalised single and peak 
summated NMDAR-EPSCs after 20-25 minutes means that it is not possible to be certain if 
there is in fact a difference in activity-dependent regulation between the synaptic and 
peri/extrasynaptic zones, although clearly some activity-dependent regulation is occurring as 
evidenced by the significant difference between controls performed in these experiments. 
Further experiments may clarify some of the above questions: for example, examining 
activity-dependent regulation of perisynaptic (spillover-activated) NMDARs would be clearer 
by using an activity-dependent and irreversible NMDAR blocker: application of MK-801 via 
the perfusion whilst eliciting single NMDAR-EPSCs every 10-20 s would allow blockade of 
the synaptic population only, and the remainder of the experiment could subsequently (after 
washout) be performed as described in this thesis. Single EPSCs should remain at zero 
amplitude whilst any current elicited by applying trains of stimuli are likely to be outside the 
synapse; activated by glutamate spillover. Subsequently then, any changes in summated, 
perisynaptic NMDAR-EPSC amplitudes could be examined. Additionally, single assaying 
stimuli should still be applied throughout the experiment to monitor the status of the 
pharmacologically blocked synaptic NMDAR population: if the single EPSC were to recover 
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at all over the course of the experiment then this would indicate either reinsertion of 
NMDARs at the synapse, or trafficking of NMDARs into the synaptic zone from the 
perisynaptic zone or elsewhere on the cell surface. 
 
4.3 The role of GluN2D and the NMDAR in responding to ambient glutamate 
Extrasynaptic NMDARs in the hippocampus are arranged in high density regions opposing 
astrocytic processes (Jourdain et al. 2007; Petralia 2012), and glutamate released from these 
processes may activate them and therefore influence neuronal excitability and network 
synchrony (Angulo et al. 2004; Fellin et al. 2004). The importance of GluN2D in sensitivity 
of SNc-DA neurons to ambient extracellular glutamate was explored in wild type and 
Grin2D-null mice under normal conditions; and under conditions where glutamate transport is 
compromised such as may occur in neurodegenerative disease. Results suggested that small 
NMDAR-mediated currents are present in SNc-DA neurons in response to ambient glutamate, 
which is not released in an action-potential-dependent manner. GluN2D is also shown to have 
a pivotal role in allowing the SNc-DA neurons to respond to this ambient glutamate, or to 
potentially allow nearby glial cells to modulate their excitability. In addition, inhibition of 
GluTs caused an increase in excitatory current; almost all of which was mediated by 
NMDARs; and part of that by GluN2D-containing NMDARs, as evidenced by a significantly 
smaller amount of this current in Grin2D-null mice. Together these data contribute to 
evidence that GluN2D may be a useful target for pharmacological inhibition in PD. 
 
4.3.1 Ambient extracellular glutamate in the SNc elicits NMDAR-mediated currents in 
dopamine neurons, which are unaffected by pharmacological inhibition of action 
potential firing 
Work in the hippocampus suggests that extrasynaptic NMDARs are activated by ambient 
extracellular glutamate in order to maintain a tonic level of excitability (Sah et al. 1989; 
Angulo et al. 2004; Fellin et al. 2004). As the level of desensitisation in NMDARs is much 
lower than AMPARs, they are likely to mediate the majority of excitation in response to this 
ambient glutamate (Iacobucci and Popescu 2017). The effect of NMDAR blocker DAP5 was 
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investigated on current flow in SNc-DA cells at a holding potential of -50 mV. A small but 
highly significant decrease in inward current was observed, which persisted when neuronal 
firing was inhibited using TTX, indicating that NMDARs are being activated by ambient 
extracellular glutamate which does not have an immediate action potential-dependent origin 
(Wild et al. 2015). It is possible that some of this glutamate is present as a result of previous 
firing before application of TTX; though the bath perfusion and the endogenous activity of 
glutamate reuptake transporters might be expected to reduce this to zero. It is possible that 
this glutamate may be released from glial cells as has been suggested in the hippocampus 
(Parpura et al. 1994; Bezzi et al. 1998; Angulo et al. 2004; Fellin et al. 2004), and therefore it 
may be useful in future to ascertain whether this is the case in the SNc by application of the 
glial toxin fluoroacetate (Muir et al. 1986; Tremblay et al. 2011). It is also possible that the 
source of ambient glutamate in the SNc could be presynaptic, but in the form of non-action 
potential-dependent spontaneous release leading to miniature EPSCs. The vacuolar H+-
ATPase pump establishes the proton gradient across the vesicular membrane which drives 
transmitter uptake into synaptic vesicles (Le Meur et al. 2007): it may be prudent to inhibit 
H+-ATPase activity using bafilomycin A1 (Drose & Altendorf, 1997) in order to elucidate 
whether ambient glutamate in SNc-DA neurons is of vesicular origin. Indeed, in the 
hippocampus this compound had no effect on ambient glutamate, which may again indicate a 
glial origin (Le Meur et al. 2007). 
In mice lacking the GluN2D subunit, there was no significant effect of D-AP5 application, 
and indeed there was significantly less D-AP5-sensitive tonic current in comparison to wild 
type mice. This is a novel result, and suggests that specifically GluN2D-containing NMDARs 
have a role in mediating tonic NMDAR activity in response to ambient glutamate in SNc-DA 
neurons. The difference in DAP5-blockable current observed between genotypes may suggest 
that it is the increased glutamate affinity and low Mg2+ block characteristics conferred by the 
presence of GluN2D which allows it to contribute significantly to baseline levels of current in 
response to low levels of ambient glutamate; a function which has previously been predicted 
(Wyllie et al. 1998). When GluN2D is removed, potentially replaced with GluN2B, these 
properties are altered. This sensitivity of GluN2D to ambient glutamate may have a function 
in maintaining a tonic level of excitability in SNc-DA neurons, and/or in allowing modulation 
of neuronal excitability by glial cells. 
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4.3.2 Ambient glutamate in the SNc is regulated by glutamate reuptake transporters  
Pharmacological inhibition of glutamate transporter activity using TBOA led to significant 
increases in inward current in SNc-DA neurons, suggesting that glutamate reuptake is very 
important under baseline conditions to prevent increased NMDAR activity. The amplitude of 
the current change elicited by TBOA was highly variable, which indicates that cells are not 
exposed to similar levels of ambient glutamate, or that they have varying numbers of nearby 
tonically active GluTs. This variability may also be an artifact of working in slices, where 
some neurons are more likely to be exposed to surface bath flow (and therefore wash away 
ambient glutamate) than others deeper in the tissue. 
Application of TBOA caused similar increases in inward current in both wild type and 
Grin2D-null mice. Whilst there was no difference based on genotype on the overall change in 
current based on glutamate transporter blockade, the variability in the data means it was more 
difficult to detect a difference. Results Figure 3.28A suggests that in some neurons, all of 
which were wild type, there was a much greater influx of current in response to GluT 
blockage than in others. However, this current included activity from both NMDARs and 
AMPARs (though as above these rapidly desensitise): in these same experiments there was in 
fact a significantly lower amount of D-AP5-sensitive current under conditions of GluT 
inhibition in Grin2D-null mice (Figure 3.28B), implying that there in indeed still a difference 
in NMDAR-mediated currents under these conditions. Therefore, GluN2D-containing 
NMDARs are mediating cation influx into SNc-DA neurons under conditions of GluT 
blockade: this is further evidence that GluN2D is a good potential target for inhibition in 
neurodegenerative illnesses (such as PD) which may include GluT dysfunction as part of their 
pathophysiology (Lipton 2004; Kotermanski and Johnson 2009; van Marum 2009; Emre et al. 
2010; Wild et al. 2013, 2015). 
TBOA was always applied with compound LY 341495 (‘LY’), an antagonist of Group II 
mGluRs: this is because it has been found that increased extracellular glutamate caused by 
application of TBOA activates these receptors and inhibits presynaptic glutamate release 
(Wild et al. 2015). This does not occur in response to small events such as that resulting in a 
single EPSC, as they have been found to be unmodified by LY; but only in conditions where 
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extracellular glutamate increases dramatically, such as when reuptake is compromised (Wild 
et al. 2015). Therefore to assess directly the role of glutamate transporters, this presynaptic 
feedback mechanism was inhibited. 
 
4.4 Bath application of NMDA elicits larger currents in Grin2D-null mice in 
comparison to wild type at very high concentrations only 
The dose-response data obtained from bath application of NMDA (Figure 3.30) appears to 
show no difference based on genotype at low or moderate concentrations, which may suggest 
that numbers of NMDARs across the cell are similar. However, an interesting result here was 
that as the curves begin to plateau at high concentrations of NMDA the curves separated, with 
Grin2D-null animals displaying larger peak current in response to these concentrations (1-10 
mM). If GluN2B is indeed replacing GluN2D within the receptor in these animals, it is likely 
that due to the larger peak current and shorter timeframe required for GluN2B to become 
ready to reopen (at peak agonist concentrations where immediate reopening is likely), it 
confers a capability for greater conductance at the highest levels NMDA/glutamate saturation, 
despite a lower affinity for NMDA and glutamate (Hess et al. 1998). GluN2D on the other 
hand has a lower conductance, and also much slower channel kinetics (2000 ms to deactivate, 
as opposed to 300 ms for GluN2B), meaning that immediate reactivation is not possible. 
Therefore GluN2D, with its lower Mg2+ block and higher glutamate affinity, is ideally suited 
to maintaining a baseline current flow in response to low levels of ambient glutamate, and its 
presence in a triheteromeric receptor may = attenuate peak current flow in response to very 
high agonist concentrations. 
The results in P21 mice exploring NMDAR desensitisation response to 10 mM NMDA 
showed that desensitisation was significantly increased in mice lacking GluN2D (Figure 
3.31). This is a good indicator of the presence of GluN2D within NMDARs on SNc-DA 
neurons, and indeed that they are replaced with diheteromeric GluN1/GluN2B NMDARs in 
Grin2D-null animals, as previous studies have shown that, overall, GluN2B subunits 
desensitise to a much higher extent than GluN2D (Wyllie et al. 1998; Vance et al. 2011). 
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4.5 Hypoxic conditions cause significant but comparable cell death in both wild 
type and Grin2D-null mice 
Hypoxic conditions, such as may be caused by ischemia, quickly leads to metabolic stress and 
excitotoxicity in neurons (Lai et al. 2014). Low oxygen availability prevents replenishment of 
ATP levels, thereby disrupting ionic gradients maintained by ATP-powered Na+/K+ pumps 
and so causes depolarisation. Because of this excitation, glutamate is also released from 
excitatory neurons leading to increased extracellular glutamate and therefore an increase in 
NMDAR-mediated Ca2+ influx, and consequent neuronal cell death (Dugan and Choi 1999; 
Lai et al. 2014). 
GluN2D-containing NMDARs decrease their Popen in response to low O2 (Bickler et al. 2003), 
a property which is likely to confer hypoxic resistance in neonates, and also in the naked mole 
rat, a creature which has evolved to survive in a low oxygen and high CO2 environment 
(Larson and Park 2009; Schuhmacher et al. 2015). Therefore, the question of whether its 
presence in SNc-DA neurons conferred any additional resistance to hypoxia-related 
excitotoxicity was explored using a previously tested hypoxic treatment protocol in acute 
slices in both wild type and Grin2D-null animals, along with a propidium iodide cell viability 
assay and anti-tyrosine hydroxylase fluorescent staining in order to identify dopaminergic 
neurons. 
After fixing and labeling, the SNc region was identified as in previous experiments using 
proximity to MT, and fluorescent imaging clearly identified dopaminergic neurons within. 
Much thinner slices were used here in order to facilitate counting of all SNc-DA neurons 
within each slice. A non-stereological method was used as the applied insult was relatively 
mild (15% O2 for 40 minutes): instead, for each slice produced, a cut was made along the 
midline and one hemisphere randomly assigned to the high oxygen treatment group, and one 
to the hypoxic treatment group. This method prioritised the sensitivity afforded by being able 
to pair the results above analysis of total SNc volume. Previous research recording whole cell 
electrophysiological data showed that the hypoxic treatment applied here still allowed 60% of 
mouse hippocampal neurons to recover, regaining fully functional EPCS transmission after 
high O2 is restored (Larson and Park 2009). Importantly then, the results presented in this 
thesis showed that the hypoxic treatment had no effect on the mean number of SNc-DA 
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neurons per 100 µm slice, indicating that all neurons affected by the treatment were still 
available for counting. 
Paired two-factor ANOVA analysis revealed that the hypoxic treatment had the desired effect 
in that it caused a very highly significant yet submaximal increase in the percentage of SNc-
DA neurons displaying fluorescent PI nuclear staining (Figure 3.32). The same test also 
revealed that the presence or absence of GluN2D had no effect on SNc-DA cell survival, 
which may mean that this subunit confers no practical resistance to these neurons under 
hypoxic conditions, for example in ischemia. However, there is no data on the precise 
threshold that oxygen levels must reach in order to alter the Popen of GluN2D-containing 
NMDARs: therefore, it is very possible that by using a relatively mild hypoxic insult Popen 
remained unchanged. When originally demonstrating the effect in NMDARs in xenopus 
laevis oocytes, Bickler et al. saturated the perfusate solution with a very low concentration of 
oxygen (3 % O2 /estimated 20–25 mm Hg in solution; Bickler et al., 2003), whereas the 
method used in this thesis was chosen as it had previously been shown to lead to partial 
recovery in mouse neurons (Larson and Park 2009). It is possible that, whilst the method does 
begin to cause damage to mouse neurons, 15 % O2 does not in fact lower the saturation 
enough to effect a change in the GluN2D subunit. In support of this, a recently performed 
study has found that SNc-DA cells are surprisingly resistant to episodes of complete anoxia 
(Karunasinghe et al. 2017), though subunit composition was not a factor examined in this 
work. Further experiments should be performed using very low or complete anoxia in order to 
confirm whether a GluN2D-mediated resistance to these conditions is inherent in SNc-DA 
neurons. It is also possible that GluN2D may be less likely to alter the overall physiological 
properties of the NMDAR if it is present in a triheteromeric GluN1/GluN2B/GluN2D 
configuration, which is most likely in SNc-DA neurons of older mice (Brothwell et al. 2008). 
 
In conclusion, the results presented in this thesis have provided evidence that the GluN2D 
subunit expressed within NMDARs both synaptically and across the neuronal surface, and 
investigated how they may allow SNc-DA neurons to react to various potentially excitotoxic 
conditions. A form of synaptic plasticity has been demonstrated in SNc-DA neurons which 
results in downregulation of NMDARs in response to high frequency excitatory burst input, 
and in which GluN2D does not play a mechanistic role. GluN2D-containging NMDARs are 
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shown to have a role in detection of ambient extracellular glutamate, and indeed mediate 
larger currents in response to reuptake dysfunction. Lastly, a hypoxia study showed that the 
subunit does not confer a practical resistance to lowered oxygen levels, though further 
investigation is called for in this area. In summary, NMDARs have diverse roles in SNc-DA 
neurons which may both serve to maintain normal function and protect the cell in potentially 
pathological conditions. 
  
References 
147 
 
 
References 
Abraham WC. Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci 
9: 387, 2008. 
Acker TM, Yuan H, Hansen KB, Vance KM, Ogden KK, Jensen HS, Burger PB, 
Mullasseril P, Snyder JP, Liotta DC, Traynelis SF. Mechanism for noncompetitive 
inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. 
Mol Pharmacol 80: 782–795, 2011. 
Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. 
Trends Neurosci 12: 366–375, 1989. 
Alsaloum M, Kazi R, Gan Q, Amin J, Wollmuth LP. A Molecular Determinant of 
Subtype-Specific Desensitization in Ionotropic Glutamate Receptors. J Neurosci 36: 2617–
2622, 2016. 
Amico-Ruvio SA, Murthy SE, Smith TP, Popescu GK. Zinc Effects on NMDA Receptor 
Gating Kinetics. Biophys J 100: 1910–1918, 2011. 
Angulo MC, Kozlov AS, Charpak S, Audinat E. Glutamate released from glial cells 
synchronizes neuronal activity in the hippocampus. J Neurosci Off J Soc Neurosci 24: 6920–
6927, 2004. 
Ascher P, Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of 
mouse central neurones in culture. J Physiol 399: 247–266, 1988. 
Assous M, Had-Aissouni L, Gubellini P, Melon C, Nafia I, Salin P, Kerkerian-Le-Goff L, 
Kachidian P. Progressive Parkinsonism by acute dysfunction of excitatory amino acid 
transporters in the rat substantia nigra. Neurobiol Dis 65: 69–81, 2014. 
Asztely F, Erdemli G, Kullmann DM. Extrasynaptic glutamate spillover in the 
hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron 18: 
281–293, 1997. 
Band M, Malik A, Joel A, Avivi A. Hypoxia associated NMDA receptor 2 subunit 
composition: developmental comparison between the hypoxia-tolerant subterranean mole-rat, 
Spalax, and the hypoxia-sensitive rat. J Comp Physiol [B] 182: 961–969, 2012. 
Bashir ZI, Alford S, Davies SN, Randall AD, Collingridge GL. Long-term potentiation of 
NMDA receptor-mediated synaptic transmission in the hippocampus. Nature 349: 156–158, 
1991. 
Baucum AJ. Proteomic Analysis of Postsynaptic Protein Complexes Underlying Neuronal 
Plasticity. ACS Chem Neurosci 8: 689–701, 2017. 
References 
148 
 
Benveniste M, Clements J, Vyklický L, Mayer ML. A kinetic analysis of the modulation of 
N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J 
Physiol 428: 333–357, 1990. 
Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. 
Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72: 507–520, 1994. 
Berretta N, Berton F, Bianchi R, Brunelli M, Capogna M, Francesconi W. Long-term 
Potentiation of NMDA Receptor-mediated EPSP in Guinea-pig Hippocampal Slices. Eur J 
Neurosci 3: 850–854, 1991. 
Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta 
F, Senar-Sancho SA, Guiral L, Cardullo F. Identification and characterisation of novel 
NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J 
Pharmacol Exp Ther 335: 636–644, 2010. 
Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281–
285, 1998. 
Bickler PE, Buck LT. Adaptations of vertebrate neurons to hypoxia and anoxia: maintaining 
critical Ca2+ concentrations. J Exp Biol 201: 1141–1152, 1998. 
Bickler PE, Donohoe PH, Buck LT. Hypoxia-induced silencing of NMDA receptors in 
turtle neurons. J Neurosci Off J Soc Neurosci 20: 3522–3528, 2000. 
Bickler PE, Fahlman CS, Taylor DM. Oxygen sensitivity of NMDA receptors: relationship 
to NR2 subunit composition and hypoxia tolerance of neonatal neurons. Neuroscience 118: 
25–35, 2003. 
Bickler PE, Hansen BM. Hypoxia-tolerant neonatal CA1 neurons: relationship of survival to 
evoked glutamate release and glutamate receptor-mediated calcium changes in hippocampal 
slices. Brain Res Dev Brain Res 106: 57–69, 1998. 
Blandini F. An update on the potential role of excitotoxicity in the pathogenesis of 
Parkinson’s disease. Funct Neurol 25: 65–71, 2010. 
Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia 
circuitry in Parkinson’s disease. Prog Neurobiol 62: 63–88, 2000. 
Blanke ML, VanDongen AMJ. Activation Mechanisms of the NMDA Receptor [Online]. 
In: Biology of the NMDA Receptor, edited by Van Dongen AM. CRC Press/Taylor & Francis 
http://www.ncbi.nlm.nih.gov/books/NBK5274/. 
Blythe SN, Wokosin D, Atherton JF, Bevan MD. Cellular mechanisms underlying burst 
firing in substantia nigra dopamine neurons. J Neurosci Off J Soc Neurosci 29: 15531–15541, 
2009. 
Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J 
Anat 196 ( Pt 4): 527–542, 2000. 
References 
149 
 
Brickley SG, Misra C, Mok MHS, Mishina M, Cull-Candy SG. NR2B and NR2D subunits 
coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to 
extrasynaptic sites. J Neurosci Off J Soc Neurosci 23: 4958–4966, 2003. 
Brothwell SLC, Barber JL, Monaghan DT, Jane DE, Gibb AJ, Jones S. NR2B- and 
NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta 
dopaminergic neurones. J Physiol 586: 739–750, 2008. 
Burnashev N, Schoepfer R, Monyer H, Ruppersberg JP, Günther W, Seeburg PH, 
Sakmann B. Control by asparagine residues of calcium permeability and magnesium 
blockade in the NMDA receptor. Science 257: 1415–1419, 1992. 
Carroll RC, Beattie EC, Xia H, Lüscher C, Altschuler Y, Nicoll RA, Malenka RC, von 
Zastrow M. Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl 
Acad Sci U S A 96: 14112–14117, 1999. 
Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of 
synaptic plasticity in the dorsal striatum. Eur J Neurosci 13: 1071–1077, 2001. 
Charara A, Smith Y, Parent A. Glutamatergic inputs from the pedunculopontine nucleus to 
midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde 
labeling combined with postembedding glutamate and GABA immunohistochemistry. J 
Comp Neurol 364: 254–266, 1996. 
Chen B-S, Roche KW. Regulation of NMDA Receptors by Phosphorylation. 
Neuropharmacology 53: 362–368, 2007. 
Chergui K. Dopamine induces a GluN2A-dependent form of long-term depression of NMDA 
synaptic responses in the nucleus accumbens. Neuropharmacology 60: 975–981, 2011. 
Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci Off J Soc Neurosci 7: 
369–379, 1987. 
Clague MJ, Urbé S. Ubiquitin: same molecule, different degradation pathways. Cell 143: 
682–685, 2010. 
Clapham DE. Calcium signaling. Cell 131: 1047–1058, 2007. 
Clark BA, Cull-Candy SG. Activity-dependent recruitment of extrasynaptic NMDA 
receptor activation at an AMPA receptor-only synapse. J Neurosci Off J Soc Neurosci 22: 
4428–4436, 2002. 
Clements JD. Transmitter timecourse in the synaptic cleft: its role in central synaptic 
function. Trends Neurosci 19: 163–171, 1996. 
Collins MO, Husi H, Yu L, Brandon JM, Anderson CNG, Blackstock WP, Choudhary 
JS, Grant SGN. Molecular characterisation and comparison of the components and 
multiprotein complexes in the postsynaptic proteome. J Neurochem 97: 16–23, 2006. 
References 
150 
 
Colquhoun D, Jonas P, Sakmann B. Action of brief pulses of glutamate on AMPA/kainate 
receptors in patches from different neurones of rat hippocampal slices. J Physiol 458: 261–
287, 1992. 
Costa BM, Feng B, Tsintsadze TS, Morley RM, Irvine MW, Tsintsadze V, Lozovaya NA, 
Jane DE, Monaghan DT. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity 
of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of 
extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J Pharmacol Exp 
Ther 331: 618–626, 2009. 
Darbon P, Yvon C, Legrand J-C, Streit J. INaP underlies intrinsic spiking and rhythm 
generation in networks of cultured rat spinal cord neurons. Eur J Neurosci 20: 976–988, 2004. 
Davies J, Watkins JC. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-
amino-4-phosphonobutyrate in the cat spinal cord. Brain Res 235: 378–386, 1982. 
DeLong MR, Wichmann T. Circuits and Circuit Disorders of the Basal Ganglia. Arch 
Neurol 64: 20–24, 2007. 
Diamond JS, Jahr CE. Transporters Buffer Synaptically Released Glutamate on a 
Submillisecond Time Scale. J Neurosci 17: 4672–4687, 1997. 
Dingledine R, Borges K, Bowie D, Traynelis SF. The Glutamate Receptor Ion Channels. 
Pharmacol Rev 51: 7–62, 1999a. 
Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. 
Pharmacol Rev 51: 7–61, 1999b. 
Dong X, Wang Y, Qin Z. Molecular mechanisms of excitotoxicity and their relevance to 
pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 30: 379–387, 2009. 
Dravid SM, Erreger K, Yuan H, Nicholson K, Le P, Lyuboslavsky P, Almonte A, 
Murray E, Mosely C, Barber J, French A, Balster R, Murray TF, Traynelis SF. Subunit-
specific mechanisms and proton sensitivity of NMDA receptor channel block. J Physiol 581: 
107–128, 2007. 
Dubois CJ, Lachamp PM, Sun L, Mishina M, Liu SJ. Presynaptic GluN2D receptors 
detect glutamate spillover and regulate cerebellar GABA release. J Neurophysiol 115: 271–
285, 2016. 
Dugan LL, Choi DW. Excitotoxic injury in Hypoxia-Ischemia [Online]. 
https://www.ncbi.nlm.nih.gov/books/NBK27972/ [2 Sep. 2017]. 
Dupuis JP, Ladépêche L, Seth H, Bard L, Varela J, Mikasova L, Bouchet D, Rogemond 
V, Honnorat J, Hanse E, Groc L. Surface dynamics of GluN2B-NMDA receptors controls 
plasticity of maturing glutamate synapses. EMBO J 33: 842–861, 2014. 
Dzubay JA, Jahr CE. The Concentration of Synaptically Released Glutamate Outside of the 
Climbing Fiber–Purkinje Cell Synaptic Cleft. J Neurosci 19: 5265–5274, 1999. 
References 
151 
 
Ehlers MD, Zhang S, Bernhardt JP, Huganir RL. Inactivation of NMDA Receptors by 
Direct Interaction of Calmodulin with the NR1 Subunit. Cell 84: 745–755, 1996. 
Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann 
A, Zdravkovic S, Bladström A, Jones R, 11018 Study Investigators. Memantine for 
patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, 
double-blind, placebo-controlled trial. Lancet Neurol 9: 969–977, 2010. 
von Engelhardt J, Bocklisch C, Tönges L, Herb A, Mishina M, Monyer H. GluN2D-
containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and 
pyramidal cells in juvenile mice. Front Cell Neurosci 9: 95, 2015. 
Evans RH, Francis AA, Jones AW, Smith DA, Watkins JC. The effects of a series of 
omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino 
acid-induced responses in isolated spinal cord preparations. Br J Pharmacol 75: 65–75, 1982. 
Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G. Neuronal synchrony 
mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. 
Neuron 43: 729–743, 2004. 
Feng B, Morley RM, Jane DE, Monaghan DT. The effect of competitive antagonist chain 
length on NMDA receptor subunit selectivity. Neuropharmacology 48: 354–359, 2005. 
Feng B, Tse HW, Skifter DA, Morley R, Jane DE, Monaghan DT. Structure-activity 
analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-
carbonyl) piperazine-2,3-dicarboxylic acid. Br J Pharmacol 141: 508–516, 2004. 
Flavell SW, Greenberg ME. Signaling mechanisms linking neuronal activity to gene 
expression and plasticity of the nervous system. Annu Rev Neurosci 31: 563–590, 2008. 
Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A. Calcineurin Links Ca2+ 
Dysregulation with Brain Aging. J Neurosci Off J Soc Neurosci 21: 4066–4073, 2001. 
Furukawa H, Gouaux E. Mechanisms of activation, inhibition and specificity: crystal 
structures of the NMDA receptor NR1 ligand-binding core. EMBO J 22: 2873–2885, 2003. 
Furukawa H, Singh SK, Mancusso R, Gouaux E. Subunit arrangement and function in 
NMDA receptors. Nature 438: 185–192, 2005. 
Futai K, Okada M, Matsuyama K, Takahashi T. High-Fidelity Transmission Acquired via 
a Developmental Decrease in NMDA Receptor Expression at an Auditory Synapse. J 
Neurosci 21: 3342–3349, 2001. 
Gallagher MJ, Huang H, Pritchett DB, Lynch DR. Interactions between ifenprodil and the 
NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271: 9603–9611, 1996. 
Galvan A, Devergnas A, Wichmann T. Alterations in neuronal activity in basal ganglia-
thalamocortical circuits in the parkinsonian state. Front Neuroanat 9, 2015. 
References 
152 
 
Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT. 
Nedd4 is a Specific E3 Ubiquitin Ligase for the NMDA Receptor Subunit GluN2D. 
Neuropharmacology 74, 2013. 
Gean PW, Chang FC, Huang CC, Lin JH, Way LJ. Long-term enhancement of EPSP and 
NMDA receptor-mediated synaptic transmission in the amygdala. Brain Res Bull 31: 7–11, 
1993. 
Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor 
control. Science 265: 1826–1831, 1994. 
Groc L, Bard L, Choquet D. Surface trafficking of N-methyl-d-aspartate receptors: 
Physiological and pathological perspectives. Neuroscience 158: 4–18, 2009. 
Groc L, Heine M, Cousins SL, Stephenson FA, Lounis B, Cognet L, Choquet D. NMDA 
receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A 103: 
18769–18774, 2006. 
Grosshans DR, Clayton DA, Coultrap SJ, Browning MD. LTP leads to rapid surface 
expression of NMDA but not AMPA receptors in adult rat CA1. Nat Neurosci 5: 27–33, 
2002. 
Grubbs FE. Sample Criteria for Testing Outlying Observations. Ann Math Stat 21: 27–58, 
1950. 
Hage TA, Sun Y, Khaliq ZM. Electrical and Ca(2+) signaling in dendritic spines of 
substantia nigra dopaminergic neurons. eLife 5, 2016. 
Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson’s disease: 
networks, models and treatments. Trends Neurosci 30: 357–364, 2007. 
Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: 
implications for neurodegenerative disorders. Nat Rev Neurosci 11: 682–696, 2010. 
Harnett MT, Bernier BE, Ahn K-C, Morikawa H. Burst-Timing-Dependent Plasticity of 
NMDA Receptor-Mediated Transmission in Midbrain Dopamine Neurons. Neuron 62: 826–
838, 2009. 
Harney SC, Anwyl R. Plasticity of NMDA receptor-mediated excitatory postsynaptic 
currents at perforant path inputs to dendrite-targeting interneurons. J Physiol 590: 3771–3786, 
2012. 
Harney SC, Jane DE, Anwyl R. Extrasynaptic NR2D-Containing NMDARs Are Recruited 
to the Synapse during LTP of NMDAR-EPSCs. J Neurosci 28: 11685–11694, 2008. 
Harney SC, Rowan M, Anwyl R. Long-term depression of NMDA receptor-mediated 
synaptic transmission is dependent on activation of metabotropic glutamate receptors and is 
altered to long-term potentiation by low intracellular calcium buffering. J Neurosci Off J Soc 
Neurosci 26: 1128–1132, 2006. 
References 
153 
 
Harris AZ, Pettit DL. Extrasynaptic and synaptic NMDA receptors form stable and uniform 
pools in rat hippocampal slices. J Physiol 584: 509–519, 2007. 
Harris AZ, Pettit DL. Recruiting Extrasynaptic NMDA Receptors Augments Synaptic 
Signaling. J Neurophysiol 99: 524–533, 2008. 
Häusser MA, de Weille JR, Lazdunski M. Activation by cromakalim of pre- and post-
synaptic ATP-sensitive K+ channels in substantia nigra. Biochem Biophys Res Commun 174: 
909–914, 1991. 
Hayes D, Wiessner M, Rauen T, McBean GJ. Transport of L-[14C]cystine and L-
[14C]cysteine by subtypes of high affinity glutamate transporters over-expressed in HEK 
cells. Neurochem Int 46: 585–594, 2005. 
Hebb DO. The Organization of Behavior: A Neuropsychological Theory. Psychology Press, 
1949. 
Herman MA, Jahr CE. Extracellular glutamate concentration in hippocampal slice. J 
Neurosci Off J Soc Neurosci 27: 9736–9741, 2007. 
Herron CE, Lester RA, Coan EJ, Collingridge GL. Frequency-dependent involvement of 
NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature 322: 265–268, 
1986. 
Hess SD, Daggett LP, Deal C, Lu C-C, Johnson EC, Veliçelebi G. Functional 
Characterisation of Human N-Methyl-d-Aspartate Subtype 1A/2D Receptors. J Neurochem 
70: 1269–1279, 1998. 
Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, Monaghan DT, 
Sacktor TC. Distinct NMDA receptor subpopulations contribute to long-term potentiation 
and long-term depression induction. J Neurosci Off J Soc Neurosci 20: RC81, 2000. 
Hu B, Zheng F. Molecular determinants of glycine-independent desensitization of 
NR1/NR2A receptors. J Pharmacol Exp Ther 313: 563–569, 2005. 
Huang Z, Gibb AJ. Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D 
NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones. J 
Physiol 592: 2059–2078, 2014. 
Hunt DL, Castillo PE. Synaptic plasticity of NMDA receptors: mechanisms and functional 
implications. Curr Opin Neurobiol 22: 496–508, 2012. 
Iacobucci GJ, Popescu GK. NMDA receptors: linking physiological output to biophysical 
operation. Nat Rev Neurosci 18: 236–249, 2017. 
Iino M, Ozawa S, Tsuzuki K. Permeation of calcium through excitatory amino acid receptor 
channels in cultured rat hippocampal neurones. J Physiol 424: 151–165, 1990. 
Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S, Mishina M. Reduced 
spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor 
channel. Brain Res Mol Brain Res 33: 61–71, 1995. 
References 
154 
 
Jamur MC, Oliver C. Permeabilization of cell membranes. Methods Mol Biol Clifton NJ 
588: 63–66, 2010. 
Jang M, Um KB, Jang J, Kim HJ, Cho H, Chung S, Park MK. Coexistence of 
glutamatergic spine synapses and shaft synapses in substantia nigra dopamine neurons. Sci 
Rep 5: 14773, 2015. 
Jensen AA, Fahlke C, Bjørn-Yoshimoto WE, Bunch L. Excitatory amino acid transporters: 
recent insights into molecular mechanisms, novel modes of modulation and new therapeutic 
possibilities. Curr Opin Pharmacol 20: 116–123, 2015. 
Jespersen A, Tajima N, Fernandez-Cuervo G, Garnier-Amblard EC, Furukawa H. 
Structural insights into competitive antagonism in NMDA receptors. Neuron 81: 366–378, 
2014. 
Jones MV, Westbrook GL. The impact of receptor desensitization on fast synaptic 
transmission. Trends Neurosci 19: 96–101, 1996. 
Jones S, Gibb AJ. Functional NR2B- and NR2D-containing NMDA receptor channels in rat 
substantia nigra dopaminergic neurones. J Physiol 569: 209–221, 2005. 
Joshi I, Yang Y-M, Wang L-Y. Coincident activation of metabotropic glutamate receptors 
and NMDA receptors (NMDARs) downregulates perisynaptic/extrasynaptic NMDARs and 
enhances high-fidelity neurotransmission at the developing calyx of Held synapse. J Neurosci 
Off J Soc Neurosci 27: 9989–9999, 2007. 
Jourdain P, Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute 
C, Tonello F, Gundersen V, Volterra A. Glutamate exocytosis from astrocytes controls 
synaptic strength. Nat Neurosci 10: 331–339, 2007. 
Karakas E, Simorowski N, Furukawa H. Subunit arrangement and phenylethanolamine 
binding in GluN1/GluN2B NMDA receptors. Nature 475: 249–253, 2011. 
Karunasinghe RN, Grey AC, Telang R, Vlajkovic SM, Lipski J. Differential spread of 
anoxic depolarization contributes to the pattern of neuronal injury after oxygen and glucose 
deprivation (OGD) in the Substantia Nigra in rat brain slices. Neuroscience 340: 359–372, 
2017. 
Kennedy MB. Signal-processing machines at the postsynaptic density. Science 290: 750–
754, 2000. 
Kharazia VN, Weinberg RJ. Immunogold localization of AMPA and NMDA receptors in 
somatic sensory cortex of albino rat. J Comp Neurol 412: 292–302, 1999. 
Kita H, Kitai ST. Efferent projections of the subthalamic nucleus in the rat: light and 
electron microscopic analysis with the PHA-L method. J Comp Neurol 260: 435–452, 1987. 
Kombian SB, Malenka RC. Simultaneous LTP of non-NMDA- and LTD of NMDA-
receptor-mediated responses in the nucleus accumbens. Nature 368: 242–246, 1994. 
References 
155 
 
Kopell BH, Rezai AR, Chang JW, Vitek JL. Anatomy and physiology of the basal ganglia: 
implications for deep brain stimulation for Parkinson’s disease. Mov Disord Off J Mov Disord 
Soc 21 Suppl 14: S238-246, 2006. 
Kotecha SA, Jackson MF, Al-Mahrouki A, Roder JC, Orser BA, MacDonald JF. Co-
stimulation of mGluR5 and N-methyl-D-aspartate receptors is required for potentiation of 
excitatory synaptic transmission in hippocampal neurons. J Biol Chem 278: 27742–27749, 
2003. 
Kotermanski SE, Johnson JW. Mg2+ imparts NMDA receptor subtype selectivity to the 
Alzheimer’s drug memantine. J Neurosci Off J Soc Neurosci 29: 2774–2779, 2009. 
Koutsilieri E, Riederer P. Excitotoxicity and new antiglutamatergic strategies in Parkinson’s 
disease and Alzheimer’s disease. Parkinsonism Relat Disord 13 Suppl 3: S329-331, 2007. 
Krupp JJ, Vissel B, Heinemann SF, Westbrook GL. Calcium-dependent inactivation of 
recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol Pharmacol 50: 
1680–1688, 1996. 
Krupp JJ, Vissel B, Heinemann SF, Westbrook GL. N-terminal domains in the NR2 
subunit control desensitization of NMDA receptors. Neuron 20: 317–327, 1998. 
Kwon H-B, Castillo PE. Long-term potentiation selectively expressed by NMDA receptors 
at hippocampal mossy fiber synapses. Neuron 57: 108–120, 2008. 
Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: Identifying novel targets for 
neuroprotection. Prog Neurobiol 115: 157–188, 2014. 
Larkum ME, Nevian T. Synaptic clustering by dendritic signalling mechanisms. Curr Opin 
Neurobiol 18: 321–331, 2008. 
Larson J, Park TJ. Extreme hypoxia tolerance of naked mole-rat brain. Neuroreport 20: 
1634–1637, 2009. 
Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric 
disorders. Nat Rev Neurosci 8: 413–426, 2007. 
LaVinka PC, Brand A, Landau VJ, Wirtshafter D, Park TJ. Extreme tolerance to 
ammonia fumes in African naked mole-rats: animals that naturally lack neuropeptides from 
trigeminal chemosensory nerve fibers. J Comp Physiol A Neuroethol Sens Neural Behav 
Physiol 195: 419–427, 2009. 
Le Meur K, Galante M, Angulo MC, Audinat E. Tonic activation of NMDA receptors by 
ambient glutamate of non-synaptic origin in the rat hippocampus. J Physiol 580: 373–383, 
2007. 
Lee C-H, Lü W, Michel JC, Goehring A, Du J, Song X, Gouaux E. NMDA receptor 
structures reveal subunit arrangement and pore architecture. Nature 511: 191–197, 2014. 
Lee H-K. Synaptic plasticity and phosphorylation. Pharmacol Ther 112: 810–832, 2006. 
References 
156 
 
Lin Y, Jover-Mengual T, Wong J, Bennett MVL, Zukin RS. PSD-95 and PKC converge in 
regulating NMDA receptor trafficking and gating. Proc Natl Acad Sci 103: 19902–19907, 
2006. 
Lipton SA. Paradigm shift in NMDA receptor antagonist drug development: molecular 
mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer’s disease 
and other neurologic disorders. J Alzheimers Dis JAD 6: S61-74, 2004. 
Lissin DV, Gomperts SN, Carroll RC, Christine CW, Kalman D, Kitamura M, Hardy S, 
Nicoll RA, Malenka RC, von Zastrow M. Activity differentially regulates the surface 
expression of synaptic AMPA and NMDA glutamate receptors. Proc Natl Acad Sci U S A 95: 
7097–7102, 1998. 
Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, 
Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating 
excitotoxic neuronal death both in vitro and in vivo. J Neurosci Off J Soc Neurosci 27: 2846–
2857, 2007. 
Logan SM, Partridge JG, Matta JA, Buonanno A, Vicini S. Long-lasting NMDA receptor-
mediated EPSCs in mouse striatal medium spiny neurons. J Neurophysiol 98: 2693–2704, 
2007. 
Lossi SAL. Cell death and proliferation in acute slices and organotypic cultures of 
mammalian CNS. Prog Neurobiol 88: 221–45, 2009. 
Lozovaya NA, Grebenyuk SE, Tsintsadze TS, Feng B, Monaghan DT, Krishtal OA. 
Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape “superslow” afterburst 
EPSC in rat hippocampus. J Physiol 558: 451–463, 2004. 
Lüscher C, Malenka RC. NMDA Receptor-Dependent Long-Term Potentiation and Long-
Term Depression (LTP/LTD). Cold Spring Harb Perspect Biol 4, 2012. 
Magnin M, Morel A, Jeanmonod D. Single-unit analysis of the pallidum, thalamus and 
subthalamic nucleus in parkinsonian patients. Neuroscience 96: 549–564, 2000. 
Maki BA, Popescu GK. Extracellular Ca2+ ions reduce NMDA receptor conductance and 
gating. J Gen Physiol 144: 379–392, 2014. 
Martel M-A, Ryan TJ, Bell KFS, Fowler JH, McMahon A, Al-Mubarak B, Komiyama 
NH, Horsburgh K, Kind PC, Grant SGN, Wyllie DJA, Hardingham GE. The subtype of 
GluN2 C-terminal domain determines the response to excitotoxic insults. Neuron 74: 543–
556, 2012. 
van Marum RJ. Update on the use of memantine in Alzheimer’s disease. Neuropsychiatr Dis 
Treat 5: 237–247, 2009. 
Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA 
responses in spinal cord neurones. Nature 309: 261–263, 1984. 
References 
157 
 
McCullumsmith RE, Sanacora G. Regulation of Extrasynaptic Glutamate Levels as a 
Pathophysiological Mechanism in Disorders of Motivation and Addiction. 
Neuropsychopharmacology 40: 254–255, 2015. 
Mesbahi-Vasey S, Veras L, Yonkunas M, Johnson JW, Kurnikova MG. All atom NMDA 
receptor transmembrane domain model development and simulations in lipid bilayers and 
water. PLOS ONE 12: e0177686, 2017. 
Meyerson JR, Kumar J, Chittori S, Rao P, Pierson J, Bartesaghi A, Mayer ML, 
Subramaniam S. Structural mechanism of glutamate receptor activation and desensitization. 
Nature 514: 328–334, 2014. 
Misra C, Brickley SG, Farrant M, Cull-Candy SG. Identification of subunits contributing 
to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum. J Physiol 
524 Pt 1: 147–162, 2000. 
Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T. Lower sensitivity 
to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor 
epsilon 4 subunit. J Neurosci Off J Soc Neurosci 22: 2335–2342, 2002. 
Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn 
neurones of the adult rat spinal cord. J Physiol 523 Pt 3: 621–628, 2000. 
Momiyama A, Feldmeyer D, Cull-Candy SG. Identification of a native low-conductance 
NMDA channel with reduced sensitivity to Mg2+ in rat central neurones. J Physiol 494 ( Pt 
2): 479–492, 1996. 
Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE. Pharmacological Modulation of 
NMDA Receptor Activity and the Advent of Negative and Positive Allosteric Modulators. 
Neurochem Int 61: 581–592, 2012. 
Montgomery JM, Selcher JC, Hanson JE, Madison DV. Dynamin-dependent NMDAR 
endocytosis during LTD and its dependence on synaptic state. BMC Neurosci 6: 48, 2005. 
Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and 
regional expression in the rat brain and functional properties of four NMDA receptors. 
Neuron 12: 529–540, 1994. 
Morley RM, Tse H-W, Feng B, Miller JC, Monaghan DT, Jane DE. Synthesis and 
pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as 
NMDA receptor antagonists. J Med Chem 48: 2627–2637, 2005. 
Mosley CA, Acker TM, Hansen KB, Mullasseril P, Andersen KT, Le P, Vellano KM, 
Bräuner-Osborne H, Liotta DC, Traynelis SF. Quinazolin-4-one derivatives: A novel class 
of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J 
Med Chem 53: 5476–5490, 2010. 
Moussawi K, Riegel A, Nair S, Kalivas PW. Extracellular Glutamate: Functional 
Compartments Operate in Different Concentration Ranges. Front Syst Neurosci 5, 2011. 
References 
158 
 
Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as possible markers for glial 
metabolism in vivo. Brain Res 380: 336–340, 1986. 
Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL, Santangelo 
R, Orr AG, Le P, Vellano KM, Liotta DC, Traynelis SF. A subunit-selective potentiator of 
NR2C- and NR2D-containing NMDA receptors. Nat Commun 1: 90, 2010. 
Nafia I, Re DB, Masmejean F, Melon C, Kachidian P, Kerkerian-Le Goff L, Nieoullon 
A, Had-Aissouni L. Preferential vulnerability of mesencephalic dopamine neurons to 
glutamate transporter dysfunction. J Neurochem 105: 484–496, 2008. 
Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the 
primate subthalamic nucleus: evidence for ordered but reversed body-map transformations 
from the primary motor cortex and the supplementary motor area. J Neurosci Off J Soc 
Neurosci 16: 2671–2683, 1996. 
Nelson AB, Kreitzer AC. Reassessing Models of Basal Ganglia Function and Dysfunction. 
Annu Rev Neurosci 37: 117–135, 2014. 
Neuhoff H, Neu A, Liss B, Roeper J. Ih Channels Contribute to the Different Functional 
Properties of Identified Dopaminergic Subpopulations in the Midbrain. J Neurosci 22: 1290–
1302, 2002. 
Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-
activated channels in mouse central neurones. Nature 307: 462–465, 1984. 
Ogden KK, Traynelis SF. New advances in NMDA receptor pharmacology. Trends 
Pharmacol Sci 32: 726–733, 2011. 
Pál B. Astrocytic Actions on Extrasynaptic Neuronal Currents. Front Cell Neurosci 9, 2015. 
Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor 
properties, synaptic plasticity and disease. Nat Rev Neurosci 14: 383–400, 2013. 
Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin 
Pharmacol 7: 39–47, 2007. 
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic 
nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20: 128–
154, 1995. 
Park TJ, Reznick J, Peterson BL, Blass G, Omerbašić D, Bennett NC, Kuich PHJL, 
Zasada C, Browe BM, Hamann W, Applegate DT, Radke MH, Kosten T, Lutermann H, 
Gavaghan V, Eigenbrod O, Bégay V, Amoroso VG, Govind V, Minshall RD, Smith ESJ, 
Larson J, Gotthardt M, Kempa S, Lewin GR. Fructose-driven glycolysis supports anoxia 
resistance in the naked mole-rat. Science 356: 307–311, 2017. 
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated 
astrocyte-neuron signalling. Nature 369: 744–747, 1994. 
References 
159 
 
Parsons MP, Raymond LA. Extrasynaptic NMDA Receptor Involvement in Central 
Nervous System Disorders. Neuron 82: 279–293, 2014. 
Patt S, Gertz HJ, Gerhard L, Cervós-Navarro J. Pathological changes in dendrites of 
substantia nigra neurons in Parkinson’s disease: A Golgi study. Histol Histopathol 6: 373–
380, 1991. 
Pearlstein E, gouty-colomer  laurie-anne, Michel FJ, Cloarec R, Hammond C. 
Glutamatergic synaptic currents of nigral dopaminergic neurons follow a postnatal 
developmental sequence. Front Cell Neurosci 9: 210, 2015. 
Pérez-Otaño I, Larsen RS, Wesseling JF. Emerging roles of GluN3-containing NMDA 
receptors in the CNS. Nat Rev Neurosci 17: 623–635, 2016. 
Pérez-Otaño I, Luján R, Tavalin SJ, Plomann M, Modregger J, Liu X-B, Jones EG, 
Heinemann SF, Lo DC, Ehlers MD. Endocytosis and synaptic removal of NR3A-containing 
NMDA receptors by PACSIN1/syndapin1. Nat Neurosci 9: 611–621, 2006. 
Perszyk RE, DiRaddo JO, Strong KL, Low C-M, Ogden KK, Khatri A, Vargish GA, 
Pelkey KA, Tricoire L, Liotta DC, Smith Y, McBain CJ, Traynelis SF. GluN2D-
Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal 
Interneurons and Regulate Interneuron Activity. Mol Pharmacol 90: 689–702, 2016. 
Peterson BL, Park TJ, Larson J. Adult naked mole-rat brain retains the NMDA receptor 
subunit GluN2D associated with hypoxia tolerance in neonatal mammals. Neurosci Lett 506: 
342–345, 2012. 
Petralia RS. Distribution of Extrasynaptic NMDA Receptors on Neurons. Sci World J 2012: 
e267120, 2012. 
Petralia RS, Al-Hallaq RA, Wenthold RJ. Trafficking and Targeting of NMDA Receptors 
[Online]. In: Biology of the NMDA Receptor, edited by Van Dongen AM. CRC Press/Taylor 
& Francis http://www.ncbi.nlm.nih.gov/books/NBK5290/ [24 Aug. 2017]. 
Petralia RS, Esteban JA, Wang YX, Partridge JG, Zhao HM, Wenthold RJ, Malinow R. 
Selective acquisition of AMPA receptors over postnatal development suggests a molecular 
basis for silent synapses. Nat Neurosci 2: 31–36, 1999. 
Petralia RS, Wang YX, Hua F, Yi Z, Zhou A, Ge L, Stephenson FA, Wenthold RJ. 
Organization of NMDA receptors at extrasynaptic locations. Neuroscience 167: 68–87, 
2010a. 
Petralia RS, Wang YX, Hua F, Yi Z, Zhou A, Ge L, Stephenson FA, Wenthold RJ. 
Organization of NMDA receptors at extrasynaptic locations. Neuroscience 167: 68–87, 
2010b. 
Piallat B, Polosan M, Fraix V, Goetz L, David O, Fenoy A, Torres N, Quesada J-L, 
Seigneuret E, Pollak P, Krack P, Bougerol T, Benabid AL, Chabardès S. Subthalamic 
neuronal firing in obsessive-compulsive disorder and Parkinson disease. Ann Neurol 69: 793–
802, 2011. 
References 
160 
 
Pisani A, Martella G, Tscherter A, Costa C, Mercuri NB, Bernardi G, Shen J, Calabresi 
P. Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism 
impairment: Role of Na+/K+ ATPase. Neurobiol Dis 23: 54–60, 2006. 
Plested AJR. Structural mechanisms of activation and desensitization in neurotransmitter-
gated ion channels. Nat Struct Mol Biol 23: 494–502, 2016. 
Rebola N, Lujan R, Cunha RA, Mulle C. Adenosine A2A receptors are essential for long-
term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57: 121–
134, 2008. 
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid 
Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: 
implications for Parkinson’s disease. Nat Rev Neurosci 11: 760–772, 2010. 
Reiner A, Medina L, Veenman CL. Structural and functional evolution of the basal ganglia 
in vertebrates. Brain Res Brain Res Rev 28: 235–285, 1998. 
Remple MS, Bradenham CH, Kao CC, Charles PD, Neimat JS, Konrad PE. Subthalamic 
nucleus neuronal firing rate increases with Parkinson’s disease progression. Mov Disord 26: 
1657–1662, 2011. 
Roeper J, Hainsworth AH, Ashcroft FM. Tolbutamide reverses membrane 
hyperpolarisation induced by activation of D2 receptors and GABAB receptors in isolated 
substantia nigra neurones. Pflugers Arch 416: 473–475, 1990. 
Röper J, Ashcroft FM. Metabolic inhibition and low internal ATP activate K-ATP channels 
in rat dopaminergic substantia nigra neurones. Pflugers Arch 430: 44–54, 1995. 
Rosenmund C, Feltz A, Westbrook GL. Synaptic NMDA receptor channels have a low 
open probability. J Neurosci 15: 2788–2795, 1995. 
Sah P, Hestrin S, Nicoll RA. Tonic activation of NMDA receptors by ambient glutamate 
enhances excitability of neurons. Science 246: 815–818, 1989. 
Salter MW, Dong Y, Kalia LV, Liu XJ, Pitcher G. Regulation of NMDA Receptors by 
Kinases and Phosphatases [Online]. In: Biology of the NMDA Receptor, edited by Van 
Dongen AM. CRC Press/Taylor & Francis http://www.ncbi.nlm.nih.gov/books/NBK5288/. 
Salussolia CL, Prodromou ML, Borker P, Wollmuth LP. Arrangement of subunits in 
functional NMDA receptors. J Neurosci Off J Soc Neurosci 31: 11295–11304, 2011. 
Sandoval R, González A, Caviedes A, Pancetti F, Smalla K-H, Kaehne T, Michea L, 
Gundelfinger ED, Wyneken U. Homeostatic NMDA receptor down-regulation via brain 
derived neurotrophic factor and nitric oxide-dependent signalling in cortical but not in 
hippocampal neurons. J Neurochem 118: 760–772, 2011. 
Sather W, Dieudonné S, MacDonald JF, Ascher P. Activation and desensitization of N-
methyl-D-aspartate receptors in nucleated outside-out patches from mouse neurones. J 
Physiol 450: 643–672, 1992. 
References 
161 
 
Sato H, Arawaka S, Hara S, Fukushima S, Koga K, Koyama S, Kato T. Authentically 
Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of 
Familial Parkinson’s Disease. J Neurosci 31: 16884–16894, 2011. 
Schneggenburger R. Simultaneous measurement of Ca2+ influx and reversal potentials in 
recombinant N-methyl-D-aspartate receptor channels. Biophys J 70: 2165–2174, 1996. 
Schneggenburger R. Altered voltage dependence of fractional Ca2+ current in N-methyl-D-
aspartate channel pore mutants with a decreased Ca2+ permeability. Biophys J 74: 1790–
1794, 1998. 
Schuhmacher L-N, Husson Z, Smith ESJ. The naked mole-rat as an animal model in 
biomedical research: current perspectives. Open Access Anim. Physiol. 2015. 
Schwindt PC, Spain WJ, Crill WE. Effects of intracellular calcium chelation on voltage-
dependent and calcium-dependent currents in cat neocortical neurons. Neuroscience 47: 571–
578, 1992. 
Scullin CS, Tafoya LC, Wilson MC, Partridge LD. Presynaptic residual calcium and 
synaptic facilitation at hippocampal synapses of mice with altered expression of SNAP-25. 
Brain Res 1431: 1–12, 2012. 
Semerdjieva S, Abdul-Razak HH, Salim SS, Yáñez-Muñoz RJ, Chen PE, Tarabykin V, 
Alifragis P. Activation of EphA Receptors Mediates the Recruitment of the Adaptor Protein 
Slap, Contributing to the Downregulation of N-Methyl-d-Aspartate Receptors. Mol Cell Biol 
33: 1442–1455, 2013. 
Sheldon AL, Robinson MB. The Role of Glutamate Transporters in Neurodegenerative 
Diseases and Potential Opportunities for Intervention. Neurochem Int 51: 333–355, 2007. 
Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of 
striatal synaptic plasticity. Science 321: 848–851, 2008. 
Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, 
Nakajima T. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid 
transporters. Mol Pharmacol 53: 195–201, 1998. 
Shulman JM, De Jager PL, Feany MB. Parkinson’s disease: genetics and pathogenesis. 
Annu Rev Pathol 6: 193–222, 2011. 
Siegler Retchless B, Gao W, Johnson JW. A single GluN2 subunit residue controls NMDA 
receptor channel properties via intersubunit interaction. Nat Neurosci 15: 406–413, S1-2, 
2012. 
Singh V, Carman M, Roeper J, Bonci A. Brief ischemia causes long-term depression in 
midbrain dopamine neurons. Eur J Neurosci 26: 1489–1499, 2007. 
Sornarajah L, Vasuta OC, Zhang L, Sutton C, Li B, El-Husseini A, Raymond LA. 
NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95. J 
Neurophysiol 99: 3052–3062, 2008. 
References 
162 
 
Standaert DG, Testa CM, Young AB, Penney JB. Organization of N-methyl-D-aspartate 
glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1–16, 
1994. 
Steigerwald F, Pötter M, Herzog J, Pinsker M, Kopper F, Mehdorn H, Deuschl G, 
Volkmann J. Neuronal Activity of the Human Subthalamic Nucleus in the Parkinsonian and 
Nonparkinsonian State. J Neurophysiol 100: 2515–2524, 2008. 
Stephenson-Jones M, Ericsson J, Robertson B, Grillner S. Evolution of the basal ganglia: 
dual-output pathways conserved throughout vertebrate phylogeny. J Comp Neurol 520: 2957–
2973, 2012. 
Stocca G, Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in 
developing rat cortical neurons. J Physiol 507 ( Pt 1): 13–24, 1998. 
Suárez F, Zhao Q, Monaghan DT, Jane DE, Jones S, Gibb AJ. Functional heterogeneity 
of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones. Eur J 
Neurosci 32: 359–367, 2010. 
Sugihara H, Moriyoshi K, Ishii T, Masu M, Nakanishi S. Structures and properties of 
seven isoforms of the NMDA receptor generated by alternative splicing. Biochem Biophys 
Res Commun 185: 826–832, 1992. 
Sun H, Feng Z. Neuroprotective role of ATP-sensitive potassium channels in cerebral 
ischemia. Acta Pharmacol Sin 34: 24–32, 2013. 
Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging, and selective 
neuronal vulnerability in Parkinson’s disease. Cell Calcium 47: 175–182, 2010. 
Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT. The role of calcium and 
mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic 
neurons in Parkinson’s disease. Neuroscience 198: 221–231, 2011. 
Surmeier DJ, Mercer JN, Chan CS. Autonomous pacemakers in the basal ganglia: who 
needs excitatory synapses anyway? Curr Opin Neurobiol 15: 312–318, 2005. 
Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson 
disease. Nat Rev Neurosci 18: 101–113, 2017. 
Swanger SA, Vance KM, Pare J-F, Sotty F, Fog K, Smith Y, Traynelis SF. NMDA 
Receptors Containing the GluN2D Subunit Control Neuronal Function in the Subthalamic 
Nucleus. J Neurosci Off J Soc Neurosci 35: 15971–15983, 2015. 
Tajima N, Karakas E, Grant T, Simorowski N, Diaz-Avalos R, Grigorieff N, Furukawa 
H. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil. Nature 534: 
63–68, 2016. 
Takei K, Mundigl O, Daniell L, Camilli PD. The synaptic vesicle cycle: a single vesicle 
budding step involving clathrin and dynamin. J Cell Biol 133: 1237–1250, 1996. 
References 
163 
 
Takumi Y, Ramírez-León V, Laake P, Rinvik E, Ottersen OP. Different modes of 
expression of AMPA and NMDA receptors in hippocampal synapses. Nat Neurosci 2: 618–
624, 1999. 
Tasca CI, Dal-Cim T, Cimarosti H. In vitro oxygen-glucose deprivation to study ischemic 
cell death. Methods Mol Biol Clifton NJ 1254: 197–210, 2015. 
Tepper JM, Damlama M, Trent F. Postnatal changes in the distribution and morphology of 
rat substantia nigra dopaminergic neurons. Neuroscience 60: 469–477, 1994. 
Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL. 
Characterisation of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-
aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 
272: 5157–5166, 1997. 
Tomitori H, Suganami A, Saiki R, Mizuno S, Yoshizawa Y, Masuko T, Tamura Y, 
Nishimura K, Toida T, Williams K, Kashiwagi K, Igarashi K. Structural changes of 
regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and 
GluN2B through the binding of spermine and ifenprodil. J Pharmacol Exp Ther 343: 82–90, 
2012. 
Tong ZY, Overton PG, Clark D. Antagonism of NMDA receptors but not AMPA/kainate 
receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the 
prefrontal cortex. J Neural Transm Vienna Austria 1996 103: 889–904, 1996. 
Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit 
composition at nascent hippocampal synapses in vitro. J Neurosci Off J Soc Neurosci 19: 
4180–4188, 1999. 
Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen 
KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, 
regulation, and function. Pharmacol Rev 62: 405–496, 2010. 
Tremblay M-È, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The Role of 
Microglia in the Healthy Brain. J Neurosci 31: 16064–16069, 2011. 
Vance KM, Simorowski N, Traynelis SF, Furukawa H. Ligand-specific deactivation time 
course of GluN1/GluN2D NMDA receptors. Nat Commun 2: 294, 2011. 
Villarroel A, Regalado MP, Lerma J. Glycine-independent NMDA receptor desensitization: 
localization of structural determinants. Neuron 20: 329–339, 1998. 
Wang L, Kitai ST, Xiang Z. Modulation of excitatory synaptic transmission by endogenous 
glutamate acting on presynaptic group II mGluRs in rat substantia nigra compacta. J Neurosci 
Res 82: 778–787, 2005. 
Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-Brain Mapping of 
Direct Inputs to Midbrain Dopamine Neurons. Neuron 74: 858–873, 2012. 
Watanabe M, Inoue Y, Sakimura K, Mishina M. Developmental changes in distribution of 
NMDA receptor channel subunit mRNAs. NeuroReport 3: 1138–1140, 1992. 
References 
164 
 
Watanabe M, Inoue Y, Sakimura K, Mishina M. Distinct distributions of five N-methyl-D-
aspartate receptor channel subunit mRNAs in the forebrain. J Comp Neurol 338: 377–390, 
1993. 
Watanabe M, Mishina M, Inoue Y. Distinct distributions of five NMDA receptor channel 
subunit mRNAs in the brainstem. J Comp Neurol 343: 520–531, 1994. 
Wenzel A, Fritschy JM, Mohler H, Benke D. NMDA receptor heterogeneity during 
postnatal development of the rat brain: differential expression of the NR2A, NR2B, and 
NR2C subunit proteins. J Neurochem 68: 469–478, 1997. 
Wenzel A, Scheurer L, Künzi R, Fritschy JM, Mohler H, Benke D. Distribution of 
NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. Neuroreport 7: 45–48, 
1995. 
Wild AR, Akyol E, Brothwell SLC, Kimkool P, Skepper JN, Gibb AJ, Jones S. 
Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra 
pars compacta dopamine neurones. Neuropharmacology 73: 138–146, 2013. 
Wild AR, Bollands M, Morris PG, Jones S. Mechanisms regulating spill‐over of synaptic 
glutamate to extrasynaptic NMDA receptors in mouse substantia nigra dopaminergic neurons. 
Eur J Neurosci 42: 2633–2643, 2015. 
Wild AR, Jones S, Gibb AJ. Activity-dependent regulation of NMDA receptors in substantia 
nigra dopaminergic neurones. J Physiol 592: 653–668, 2014. 
Wilson CJ, Young SJ, Groves PM. Statistical properties of neuronal spike trains in the 
substantia nigra: Cell types and their interactions. Brain Res 136: 243–260, 1977. 
Wollmuth LP, Kuner T, Sakmann B. Intracellular Mg2+ interacts with structural 
determinants of the narrow constriction contributed by the NR1-subunit in the NMDA 
receptor channel. J Physiol 506 ( Pt 1): 33–52, 1998a. 
Wollmuth LP, Kuner T, Sakmann B. Adjacent asparagines in the NR2-subunit of the 
NMDA receptor channel control the voltage-dependent block by extracellular Mg2+. J 
Physiol 506: 13–32, 1998b. 
Wu G, Malinow R, Cline HT. Maturation of a central glutamatergic synapse. Science 274: 
972–976, 1996. 
Wyllie DJ, Béhé P, Colquhoun D. Single-channel activations and concentration jumps: 
comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol 510 ( 
Pt 1): 1–18, 1998. 
Wyllie DJ, Béhé P, Nassar M, Schoepfer R, Colquhoun D. Single-channel currents from 
recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes. Proc Biol Sci 
263: 1079–1086, 1996. 
Wyllie DJA, Livesey MR, Hardingham GE. Influence of GluN2 subunit identity on NMDA 
receptor function. Neuropharmacology 74: 4–17, 2013. 
References 
165 
 
Yamamoto H, Kamegaya E, Hagino Y, Takamatsu Y, Sawada W, Matsuzawa M, Ide S, 
Yamamoto T, Mishina M, Ikeda K. Loss of GluN2D subunit results in social recognition 
deficit, social stress, 5-HT2C receptor dysfunction, and anhedonia in mice. 
Neuropharmacology 112: 188–197, 2017. 
Yi Z, Petralia RS, Fu Z, Swanwick CC, Wang Y-X, Prybylowski K, Sans N, Vicini S, 
Wenthold RJ. The role of the PDZ protein GIPC in regulating NMDA receptor trafficking. J 
Neurosci Off J Soc Neurosci 27: 11663–11675, 2007. 
Yuan H, Hansen KB, Vance KM, Ogden KK, Traynelis SF. Control of N-methyl-D-
aspartate Receptor Function by the NR2 Subunit Amino-Terminal Domain. J Neurosci Off J 
Soc Neurosci 29: 12045–12058, 2009. 
Zhang J, Diamond JS. Distinct perisynaptic and synaptic localization of NMDA and AMPA 
receptors on ganglion cells in rat retina. J Comp Neurol 498: 810–820, 2006. 
Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ, Traynelis SF. Allosteric 
interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat 
Neurosci 4: 894–901, 2001. 
Zhou X, Hollern D, Liao J, Andrechek E, Wang H. NMDA receptor-mediated 
excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors. Cell Death 
Dis 4: e560, 2013. 
Zilberter Y, Uteshev V, Sokolova S, Khodorov B. Desensitization of N-methyl-D-aspartate 
receptors in neurons dissociated from adult rat hippocampus. Mol Pharmacol 40: 337–341, 
1991. 
Zorumski CF, Thio LL, Clark GD, Clifford DB. Blockade of desensitization augments 
quisqualate excitotoxicity in hippocampal neurons. Neuron 5: 61–66, 1990. 
 
 
